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ABSTRACT 
 
Progesterone Regulation of Endometrial Factors Supporting Conceptus Growth and 
Development in the Ovine Uterus. (May 2008) 
Michael Carey Satterfield, B.S., Texas A&M University; 
M.S., Texas A&M University 
Co-Chairs of Advisory Committee:     Dr. Thomas E. Spencer 
                                                       Dr. Fuller W. Bazer 
 
 
Progesterone is unequivocally required for the establishment and maintenance of 
pregnancy in all mammals studied.  Its known functions are complex and encompass 
global changes in gene expression.  Therefore, studies were conducted to characterize 
the effects of progesterone on expression of genes for endometrial factors having roles in 
conceptus growth, implantation and establishment of pregnancy. 
The first study characterized the effect of an artificially induced early increase in 
circulating progesterone on conceptus growth and development and regulation of 
expression of galectin-15 (LGALS15), a recently identified protein secreted by the ovine 
uterine luminal epithelium (LE).  Exogenous progesterone beginning on Day 1.5 post-
mating accelerated conceptus development on Days 9 and 12.  On Day 12 the conceptus 
was functionally and morphologically advanced to produce greater quantities of 
interferon tau (IFNT) than blastocysts from control ewes.  Further, the endometrium 
responded to early progesterone and IFNT with early expression of cathepsin L (CTSL), 
radical S-adenosyl methionine domain containing 2 (RSAD2), and LGALS15 within the 
endometrium. 
The second study identifed structural changes within the luminal epithelium 
which could alter the flux of factors into and out of the uterine lumen to maintain 
 iv
appropriate fetal/maternal communication.  In this study, progesterone reduced 
quantities of proteins associated with both tight and adherens junctions during the 
elongation period.  IFNT subsequently increased these proteins after conceptus 
elongation. 
The third and fourth studies identified progesterone-regulated genes which have 
been implicated as having importance to implantation in sheep, mouse, and human.  
WNT signaling was transiently downregulated by progesterone, while members of 
several growth factor families are upregulated including insulin-like growth factor 
binding proteins (IGFBPs) 1 and 3, hepatocyte growth factor (HGF) and fibroblast 
growth factor 7 (FGF7), which may enhance conceptus growth. 
Collectively, these studies assess the role of progesterone in altering gene uterine 
expression to establish a favorable environment for conceptus development.  The long-
term goals of these studies are to establish biomarkers of receptivity to conceptus 
development and implantation, enhance our understanding of gene and pathway 
regulation in early pregnancy loss, and identify genes which may be targeted in 
therapeutic strategies to improve reproductive success in humans and animals. 
 
 
 
 
 
 
 
 
 
 
 v
DEDICATION 
 
To my sons,  
Hunter Lee Satterfield 
& 
Walker Riley Satterfield 
 
With persistence comes reward.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 vi
ACKNOWLEDGEMENTS 
 
My gratitude to those who have guided me along the way to reach this 
achievement can not be expressed adequately.  Specifically, my father and mother were 
always supportive in the attainment of my goals.  To Grandmother, Mams, and Paw Paw 
who in their own ways influenced me to be a better person.  My sisters and brother who 
were always there to support and, of course, express sibling sarcasm or skepticism.  I 
should also recognize my Aunt Lea who lent much needed encouragement to persist 
through and finish even when times were difficult and my drive was lacking.   
In my professional career I have been fortunate to be surrounded by wonderful 
people who have a strong desire to succeed in whatever they do.  To my mentors; Dr 
Fuller Bazer for providing a shining example of the face of science always willing to 
hear new ideas yet always prepared with scientific literature to challenge your thoughts.  
To Dr. Tom Spencer, first for taking a chance on a young Texan with no research 
training and a strong desire to ask questions and supporting him in his education into 
science and second for taking a personal interest in his success to the next level.  A great 
group of committee members, professors, and past and present lab members round out 
the list of people to whom I am greatly indebted for providing the wonderful experience 
I had during my graduate studies.  Thank you!  
 
 
 
 
 
 
 
 vii
TABLE OF CONTENTS 
                                                                                                                                       Page 
ABSTRACT ................................................................................................................  iii 
DEDICATION ...........................................................................................................  v 
ACKNOWLEDGEMENTS ........................................................................................  vi 
TABLE OF CONTENTS ............................................................................................  vii 
LIST OF FIGURES.....................................................................................................  ix 
LIST OF TABLES ......................................................................................................   x 
CHAPTER 
 I INTRODUCTION...............................................................................  1 
 II LITERATURE REVIEW....................................................................  4 
 
   Early Conceptus Development and Implantation in Sheep ......  4 
   Progesterone Actions in Early Pregnancy ................................  7 
   Endometrial Glands as a Source of Histotroph ........................  12 
   Adhesion Molecules in Implantation .......................................  19 
   Epithelial Junctional Complexes ...............................................  23 
  Factors in Endometrial Function & Embryo Development ......   26 
   Progesterone Regulation of Preimplantation Blastocyst  
   Growth and Elongation ............................................................  30 
 Luteal Insufficiency and Efficacy of P4 Supplementation in  
 Enhancing Pregnancy................................................................   31                              
 
III PROGESTERONE REGULATION OF PREIMPLANTATION  
CONCEPTUS GROWTH AND GALECTIN 15 (LGALS15) 
IN THE OVINE UTERUS................................................................... 34 
 
   Introduction ..............................................................................  34 
   Materials and Methods .............................................................  36 
   Results ......................................................................................  41 
 
 
  Discussion ................................................................................  51 
 IV TIGHT AND ADHERENS JUNCTIONS IN THE OVINE UTERUS: 
DIFFERENTIAL REGULATION BY PREGNANCY AND 
PROGESTERONE..............................................................................  55 
 
   Introduction ...............................................................................  55 
   Materials and Methods ..............................................................  57
   Results .......................................................................................  61 
   Discussion .................................................................................  75 
 
 viii
 
CHAPTER                                                                                                                    Page 
 
 V PROGESTERONE REGULATION OF THE ENDOMETRIAL        
WNT SYSTEM IN THE OVINE UTERUS .......................................  81 
 
   Introduction ...............................................................................  81 
   Materials and Methods .............................................................  83 
   Results ......................................................................................  88 
   Discussion ................................................................................  100 
 
 VI PROGESTERONE REGULATION OF CANDIDATE 
PROGESTAMEDINS AND THE IGF SYSTEM IN AN OVINE 
MODEL OF ACCELERATED CONCEPTUS DEVELOPMENT ...  104 
 
   Introduction ..............................................................................  104 
   Materials and Methods .............................................................  107 
   Results ......................................................................................  111 
 
 
  Discussion ................................................................................  123 
 
 
VII SUMMARY AND CONCLUSIONS .................................................  129 
   Summary ..................................................................................   129 
 
 
  Conclusions ..............................................................................  135 
REFERENCES ...........................................................................................................  137 
VITA ..........................................................................................................................  167 
 
 
 
 
 
 
 
 
 
 
 
 
 ix
 
LIST OF FIGURES 
FIGURE                                                                                                                        Page 
2.1 Early pregnancy events in sheep .....................................................................  5 
2.2 The phases of blastocyst implantation in sheep ..............................................  8 
2.3 Schematic illustrating regulation of hormone receptor expression in ovine  
uterine endometrial epithelia during the estrous cycle....................................  11 
 
2.4 Schematic illustration of the pre-attachment, apposition, and adhesion          
stages of superficial implantation in sheep......................................................   21 
 
2.5 Schematic illustration of junctional complexes mediating epithelial cell-cell 
interactions ......................................................................................................  25 
 
3.1 Concentrations of progesterone in serum of ewes treated daily with either       
corn oil (CO) vehicle or progesterone (P4) from 36 h post-mating to Day 12 42 
 
3.2 Effects of early exogenous progesterone treatment on blastocyst         
morphology on Days 9 and 12 of pregnancy .................................................  43 
 
3.3 Effects of corn oil (CO), progesterone (P4) or P4 and RU486 on expression       
of progesterone receptor (PGR) protein in endometria from Day 9 (Study      
Two) and Day 12 (Study One) ewes ..............................................................  44 
 
3.4 Western blot analysis of IFNT in uterine flushings from Day 12 ewes ..........  46 
 
3.5 Effects of treatments with corn oil (CO), progesterone (P4) or P4 and         
RU486 on endometrial CTSL and RSAD2 mRNA ..........................................  47 
 
3.6 Effects of treatments with corn oil (CO), progesterone (P4) or P4 and         
RU486 on endometrial LGALS15 mRNA.......................................................  49 
 
3.7 Effects of treatment of ewes with corn oil (CO), progesterone (P4) or P4          
and RU486 on endometrial LGALS15 protein in the uterus ..........................  50 
 
4.1 Immunolocalization of TJP2 and OCLN proteins in the ovine endometrium 
during the estrous cycle and pregnancy (Study One)......................................  62 
 
 
 x
 
FIGURE                                                                                                                        Page 
4.2 Immunolocalization of CLDN1, CLDN2, CLDN3, and CLDN4 proteins in     
ovine endometria during the estrous cycle and pregnancy (Study One).........  64 
 
4.3 In situ localization of CDH1 and CTNNB1 mRNAs in ovine endometria       
during the estrous cycle and pregnancy (Study One)......................................  66 
 
4.4 Immunolocalization of CDH1 and CTNNB1 proteins in ovine endometria    
during the cycle and pregnancy (Study One) ..................................................  68 
 
4.5 Effects of corn oil (CO), progesterone (P4), or P4 and RU486 (P4+RU) on    
TJP2 and OCLN protein in endometria from Day 9 (Study Two) and Day          
12 (Study Three) ewes.....................................................................................  70 
 
4.6 Effects of corn oil (CO), progesterone (P4) or P4 and RU486 (P4+RU) on   
CLDN proteins in endometria from Day 9 (Study Two) and Day 12 (Study 
Three) ewes .....................................................................................................  71 
 
4.7 Effects of corn oil (CO), progesterone (P4) or P4 and RU486 (P4+RU) on   
CDH1 and CTNNB1 mRNA in endometria from Day 9 (Study Two) and         
Day 12 (Study Three) ewes.............................................................................  73 
 
4.8 Effects of corn oil (CO), progesterone (P4) or P4 and RU486 (P4+RU) on   
CDH1 and CTNNB1 protein in endometria from Day 9 (Study Two) and         
Day 12 (Study Three) ewes.............................................................................  74 
 
5.1 Effects of treatments with corn oil (CO), progesterone (P4) or P4 and         
RU486 on endometrial WNT5A and WNT11 mRNA ......................................  90 
 
5.2 Effects of corn oil (CO), progesterone (P4) or P4 and RU486 on               
localization of c-JUN and p-JUN protein in endometria from Day 9 (Study     
One) and Day 12 (Study Two) ewes ...............................................................  92 
 
5.3 Effects of treatments with corn oil (CO), progesterone (P4) or P4 and         
RU486 on endometrial WNT2 and WNT7A mRNA ........................................  93 
 
5.4 Effects of treatments with corn oil (CO), progesterone (P4) or P4 and         
RU486 on endometrial FZD6 and DKK1 mRNA ...........................................  95 
 
 
 xi
 
FIGURE                                                                                                                        Page 
 
5.5 Effects of corn oil (CO), progesterone (P4) or P4 and RU486 on          
localization of TCF7L2 protein and LEF1 mRNA in endometria from Day          
9 (Study One) and Day 12 (Study Two) ewes ................................................  96 
 
5.6 Effects of corn oil (CO), progesterone (P4) or P4 and RU486 on localization      
of CREB and p-CREB protein in endometria from Day 9 (Study One) and      
Day 12 (Study Two) ewes...............................................................................  97 
 
5.7 Effects of corn oil (CO), progesterone (P4) or P4 and RU486 on localization      
of MSX1 and MSX2 mRNAs in endometria from Day 9 (Study One) and         
Day 12 (Study Two) ewes...............................................................................  99 
 
6.1 Effects of treatments with CO, P4, or P4+RU on endometrial FGF7,          
FGF10, and HGF mRNA ...............................................................................  113 
 
6.2 Effects of treatments with CO, P4, or P4+RU on endometrial IGF1, IGF2,       
and IGF1R mRNA ..........................................................................................  115 
 
6.3 Effects of CO, P4, or P4+RU on total IGF1 protein in the uterine flush ........  116 
 
6.4 Effects of CO, P4, or P4+RU on endometrial IGFBP2, IGFBP4, IGFBP5, 
IGFBP6, IGFBP7, and PAPP-A mRNAs .......................................................   118 
 
6.5 Localization of stromal IGFBPs in ovine endometria.....................................  119 
 
6.6 Localization of stromal IGFBPs in ovine endometria.....................................  120 
 
6.7 Effects of treatments with CO, P4, or P4+RU on endometrial IGFBP1 and 
IGFBP3 mRNA...............................................................................................  122 
 
 
 
 
 
 
 
 xii
 
LIST OF TABLES 
TABLE                                                                                                                        Page 
2.1 Components of uterine histotroph in sheep and cattle. ...................................  16 
 
2.2 Summary of studies evaluating the efficacy and timing of supplementing      
cattle with P4 in an attempt to improve pregnancy rates ................................  33 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 1
CHAPTER I 
INTRODUCTION 
 
Establishment of pregnancy requires a complex dialogue between the maternal 
endometrium and the developing conceptus (embryo/fetus and associated 
extraembryonic membranes).  Progesterone, from the corpus luteum, orchestrates a 
myriad of temporal and spatial changes in the endometrium to establish a dynamic and 
optimal uterine microenvironment for conceptus growth and development.  The 
conceptus must in turn signal its presence to the endometrium to maintain pregnancy and 
continue production of progesterone by the corpus luteum.  In ruminant species, the 
elongating conceptus secretes large quantities of IFNT (interferon tau) which is the 
pregnancy recognition signal (Roberts et al. 1999; Spencer and Bazer 2004; Spencer et 
al. 2007b).  IFNT acts on the luminal (LE) and superficial glandular (GE) of the 
maternal endometrium to inhibit transcription of the estrogen receptor alpha (ESR1) 
gene that indirectly blocks upregulation of the oxytocin receptor (OXTR) (Fleming et al. 
2001; Fleming et al. 2006; Spencer et al. 1995a).  Blockade of the OXTR abrogates the 
mechanisms for oxytocin-induced release of luteolytic prostaglandin F2α (PGF) to 
prevent luteolysis and maintain the corpus luteum for production of progesterone.  
Conceptus development during this period is supported by uterine secretions, 
collectively referred to as histotroph, which are primarily regulated by progesterone 
(Bazer 1975; Bazer et al. 1979b; Fazleabas et al. 1994; Kane et al. 1997; Roberts and 
Bazer 1988).  Studies of the uterine gland knockout ewe (UGKO) established that 
secretions of the endometrial epithelia are essential for peri-implantation conceptus 
elongation and survival (Gray et al. 2002; Gray et al. 2001c).  The endometrial LE and 
GE are the main sources of uterine secretions.  Histotroph is comprised of a number of 
factors including ions, amino acids, sugars, growth factors, enzymes, adhesion proteins, 
cytokines, hormones, and transport proteins.   
 
 
This dissertation follows the style of Molecular Reproduction and Development. 
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Regulation of these factors or factors responsible for their transport into the uterine 
lumen are hypothesized to be either directly or indirectly under the control of 
progesterone. 
 Studies characterizing temporal and spatial alterations in gene expression during 
the peri-implantation period in rodents and primates have established a time sensitive 
window of receptivity of the maternal endometrium to implantation by the blastocyst 
(Achache and Revel 2006; Dey et al. 2004; Fazleabas et al. 1999; Paria et al. 2000).  
Those species undergo a rapid implantation process characterized by nidation of the 
blastocyst into the uterine stroma and the initiation of a decidual response, which is 
easily observed and characterized by expression of gene markers of decidualization.  
Alternatively, implantation in domesticated species of livestock is relatively superficial 
with the blastocyst remaining within the uterine lumen.  The timing of implantation in 
domestic livestock species is more protracted and involves transformation of the 
spherical blastocyst into an elongated, filamentous conceptus prior to apposition, 
adhesion, and attachment, a process which takes several days following elongation to the 
filamentous form (Guillomot 1995; Guillomot et al. 1993).  Despite gross developmental 
differences between livestock, humans and rodents, the establishment of a window of 
receptivity and the importance of reciprocal cross-talk is equally important across these 
species.  Asynchronous embryo transfer experiments in sheep illustrated the requirement 
for the embryo and uterus to exhibit developmental synchrony within 2 days to maintain 
pregnancy (Rowson and Moor 1966b).  Later studies added to this knowledge and 
further demonstrated that the blastocyst is capable of accelerating or decelerating its 
growth pattern in response to the stage of the uterus in an attempt to maintain 
appropriate synchrony (Lawson and Cahill 1983; Lawson et al. 1983).  Further 
investigation illustrated that progesterone is responsible for establishing the maternal 
uterine microenvironment, thereby indirectly regulating conceptus development in sheep 
(Kleemann et al. 2001; Kleemann et al. 1994), as well as cattle (Garrett et al. 1988b). 
Collectively, available studies established a fundamental role for maternal 
progesterone in initiating conceptus/maternal communications to orchestrate 
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implantation and maintain a successful pregnancy.  Therefore, studies were conducted to 
identify endometrial changes in response to progesterone which may be developmental 
hallmarks for blastocyst growth and development as well as the initiation of implantation 
in sheep.  
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CHAPTER II 
LITERATURE REVIEW 
 
Early Conceptus Development and Implantation in Sheep 
Implantation in sheep and other ruminants is classified as synepitheliochorial 
(Wooding 1992).  Approximately 24-30 h after onset of estrus (Day 0) the ovarian 
follicle(s) ovulates in response to a surge of Luteinizing Hormone from the anterior 
pituitary.  The unfertilized ova enter the oviduct and are fertilized by sperm at the 
ampullary-isthmic junction.  Following fertilization, the single cell embryo, encased in 
the mucopolysaccharide zona pellucida, undergoes multiple mitotic divisions within the 
oviduct resulting in a 32-64 cell morula embryo that enters the uterus around Day 4 
(Figure 2.1) (Bindon 1971; Chang and Rowson 1965; Rowson and Moor 1966a).  The 
embryo continues to develop within the zona pellucida and undergoes compaction which 
segregates individual cells within the embryo (termed morula at this stage) and is 
believed to be important for determining the developmental fate of each cell.  
Compaction results in the formation of the inner cell mass, which gives rise to the fetus, 
and the trophoblast, that forms the placenta.  At this time, formation of adherens, tight, 
and gap junctions between adjacent cells initiate complex cell-cell communication and 
mediate changes in cell shape and attachment, resulting in the formation of a fluid-filled 
blastoceole which marks the transformation of the morula to a blastocyst (Bindon 1971; 
Chang and Rowson 1965; Rowson and Moor 1966a; Ziomek and Johnson 1980).  The 
blastocoele is surrounded by trophoblast cells while the inner cell mass comprises a 
smaller group of cells localized to a single pole of the embryo.  The blastoceole 
continues to increase in volume resulting in stretching of the zona pellucida and, in 
response to enzymes from the trophectoderm, hatching of the blastocyst occurs around 
Day 8.  The spherical hatched blastocyst of 200-400 µm expands in diameter until 
around Day 10.    
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FIG. 2.1.  Early pregnancy events in sheep.  The embryo enters the uterus on Day 4 after 
mating (Day 0 = estrus/mating) at the morula stage of development and then develops 
into a blastocyst on Day 6.  Between Days 8 and 9, the blastocyst sheds the zona 
pellucida by enzymatic lysis by uterine- and/or blastocyst-derived enzymes including 
proteases and glycosidases.  After Day 10, the blastocyst elongates into a tubular and 
then into a filamentous conceptus that appears to be immobilized in the uterine lumen in 
close association with the endometrial luminal epithelium (LE) followed by unstable 
adhesion.  Between Days 16 and 22, the trophoblast begins to adhere firmly to LE by 
interdigitation between uterine epithelial microvilli and projections of the trophectoderm 
cells, and/or penetration of trophoblast papillae into the superficial duct of uterine glands 
(sGE).  During this time, the trophoblast giant cells migrate, appose, and fuse to the 
apical surface of endometrial LE to form syncytial plaques.  Eventually, as a part of 
synepitheliochorial placentation in sheep, syncytial plaques cover the caruncular surface 
and aid in formation of placentome formed by fusion of placental cotyledons and 
endometrial caruncles.  Adapted from (Spencer et al. 2007a) and originally drawn by Dr. 
Greg A. Johnson. 
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The blastocyst then undergoes a morphological transition from a spherical (<1 mm) to 
tubular and then elongated filamentous conceptus by Day 14 reaching 10 cm or more in 
length by Day 14 and 25 cm or more by Day 17 (Guillomot et al. 1993) 
Blastocyst elongation is a uterine dependent event as neither blastocysts or 
trophoblastic vesicles elongate in vitro, but do so when transferred into the uterus 
(Flechon et al. 1986; Heyman et al. 1984).  Elongation of blastocysts results in the 
developmentally regulated synthesis and secretion of the pregnancy recognition signal, 
IFNT (Farin et al. 1989; Gray et al. 2002; Guillomot et al. 1990), which acts in a 
paracrine manner on the endometrium to inhibit development of the luteolytic 
mechanism required for pulsatile release of prostaglandin F2α from the uterine 
epithelium, thereby maintaining the continued secretion of progesterone from the 
ovarian corpus luteum (Spencer et al. 2007b; Thatcher et al. 1989).  IFNT is produced 
exclusively by the mononuclear trophectoderm cells of sheep conceptuses from Days 10-
25.  Secretion of IFNT is directly related to the stage of development of the blastocyst or 
length of the filamentous conceptus.  In addition to pregnancy recognition, IFNT induces 
or enhances the expression of a number of genes within the endometrium that are 
hypothesized to further support pregnancy (Hansen et al. 1999; Spencer et al. 2007b).  A 
subpopulation of mononuclear trophoblast cells become binucleated by Day 16 and 
begin to migrate and form a syncytium with uterine LE (Wooding 1992).  Trophoblast 
binucleate and multinucleated syncytiotrophoblast cells produce placental hormones 
such as placental lactogen (CSH1) and pregnancy associated glycoproteins (PAG) which 
also alter endometrial gene expression to support pregnancy (Spencer and Bazer 2002; 
Spencer et al. 1999b; Spencer et al. 2004b; Wooding 1992).   
The phases of implantation in ruminant species include: (1) shedding of the zona 
pellucida; (2) precontact and blastocyst orientation; (3) apposition; (4) adhesion; and (5) 
endometrial invasion albeit limited in comparison to invasive implanting species (Figure 
2.2) (Guillomot 1995).  During the elongation period, apposition of the conceptus 
trophectoderm and endometrial LE is followed by attachment and interdigitation of 
cytoplasmic projections of trophectoderm cells and microvilli of the LE (Guillomot 
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1995; Guillomot et al. 1981).  This interdigitation ensures firm adhesion of the fetal 
maternal interface in both caruncular and intercaruncular areas by Day 16 of pregnancy.  
By Day 18, the interdigitation between the conceptus and endometrium is extensive and 
impairs the ability to recover the conceptus intact from the uterine lumen via surgical 
flushing.  Importantly, progesterone is the predominant circulating hormone during this 
developmental process and is believed to be instrumental in regulating uterine support of 
this process (Spencer and Bazer 2002; Spencer et al. 2007b; Spencer et al. 2004b). 
 
Progesterone Actions in Early Pregnancy 
 Successful pregnancy in mammals unequivocally requires the actions of 
progesterone.  Following ovulation of the dominant follicle, the follicular theca and 
granulosa cells differentiate into small and large luteal cells, respectively (Leymarie and 
Martal 1993).  This transformation marks formation of the corpus luteum (CL) which 
begins secreting large quantities of progesterone into the circulation to support 
pregnancy.  In the sheep, the corpus luteum begins secreting progesterone around Day 3 
of pregnancy with a steady increase to Day 7 at which times luteal phase progesterone 
concentrations are maximal.  Progesterone is maintained at high levels throughout 
pregnancy.  In sheep, the chorion produces sufficient quantities of P4 by Day 60 of 
gestation to maintain pregnancy even in ovariectomized ewes (Casida and Warwick 
1945; Ricketts and Flint 1980). 
Progesterone support of pregnancy is predominantly via actions on the uterus 
which both accommodate and nurture the developing fetus to term.  The actions of 
progesterone in support of pregnancy are multifaceted and encompass roles in uterine 
gland morphogenesis and function, cell adhesion, derivation of factors supporting 
conceptus development, implantation, and pregnancy recognition; all of which are 
essential components for early pregnancy success (Spencer and Bazer 2002; Spencer et 
al. 2004a; Spencer et al. 2007a; Spencer et al. 2007b; Spencer et al. 2004b).   
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FIG. 2.2.  The phases of blastocyst implantation in sheep.  Shedding of the zona 
pellucida (Phase1): The embryo enters the uterus on Day 4. The blastocyst is formed on 
Day 6 and the zona pellucida is shed on Day 8 or 9 due to blastocyst growth and uterine 
and/or trophectoderm enzymes. After Day 10, the blastocyst elongates and develops into 
a tubular and then into a filamentous conceptus. Precontact and blastocyst orientation 
(Phase 2): Between Days 9 and 14, there is no definitive cellular contact between 
conceptus trophectoderm and endometrial epithelium, but the blastocyst appears to be 
positioned and immobilized in the uterus. During this time, elongation of the blastocyst 
plays and production of IFNT are coordinate in the sheep uterus. Apposition (Phase 3): 
The conceptus trophectoderm associates closely with the endometrial LE followed by 
unstable adhesion. In ruminants, the trophoblast develops finger-like villi or papillae that 
penetrate into opening of uterine glands into the uterine lumen. This event has been 
hypothesized to anchor the peri-attachment conceptus and allow it to absorb histotroph 
from uterine glands. Adhesion (Phase 4): On Day 16, the trophoblast begins to adhere 
firmly to the endometrial LE. The interdigitation of the trophectoderm and endometrial 
LE occurs in both the caruncular and intercaruncular areas of the endometrium. During 
this time, the mononuclear trophectoderm cells differentiate into trophoblast giant 
binucleate cells. Adapted from (Spencer et al. 2007a) and originally drawn by Dr. Greg 
A. Johnson. 
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 The actions of progesterone are mediated primarily by the nuclear progesterone 
receptor (PGR) (Bagchi et al. 2003; Conneely et al. 2002).  Nuclear steroid receptors 
exist in a modular structure that has distinct functional domains including an activation 
function domain, a ligand binding domain, a DNA binding domain, and a hinge region 
(Bain et al. 2007).  In addition, steroid receptors contain a relatively less well defined N-
terminal region.  It is variation in this region of the PGR that gives rise to different 
isoforms.  Indeed, null mutation of the Pgr gene in mice renders them infertile, and they 
exhibit multiple reproductive defects including impaired ovulation, uterine hyperplasia, 
and failed decidualization (Lydon et al. 1995).  Wild-type embryos transferred into 
progesterone receptor knockout (PRKO) females failed to implant indicating that the 
implantation failure is not due to an embryonic defect but rather a uterine defect.  In 
mice and humans, a single gene yields multiple isoforms of the PGR (Kastner et al. 
1990; McDonnell et al. 1994).  Information regarding the presence of multiple isoforms 
of PGR in ruminant species is limited.  Analysis of the bovine oviduct using a mouse 
antibody that recognizes both PGR-A and PGR-B identified two putative bands 
hypothesized to be PGR-A and PGR-B, although the biological significance of this 
finding has not been determined (Ulbrich et al. 2003).  In mice, selective deletion of 
PGR-A isoform resulted in fertility defects linked to failed decidualization that were 
milder than deletion of both isoforms suggesting functional differences between the PGR 
isoforms in vivo (Mulac-Jericevic et al. 2000).  Experiments were then designed to 
determine expression of a number of known progesterone regulated genes in these 
mutant mice.  Gene expression of calcitonin (Calca), histidine decarboxylase (Hdc), and 
amphiregulin (Areg) was increased in uterine epithelia by progesterone during the 
receptive phase of implantation (Das et al. 1995; Paria et al. 1998; Zhu et al. 1998).  
Lactoferrin (Ltf), a secretory product of the epithelia induced by estrogen and inhibited 
by progesterone (McMaster et al. 1992), was also studied.  PRKO mice exhibited 
dysregulation of each of these genes in response to loss of P4 signaling.  In contrast, 
specific mutation, characterized by the PRAKO, only exhibited loss of Calca and Areg 
expression while expression of Hdc and Ltf was unaffected (Mulac-Jericevic et al. 2000).  
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Further, microarray analysis of human breast cancer cells identified differential gene 
regulation by distinct PGR isoforms (Richer et al. 2002).  Collectively, these findings 
demonstrate that the different PGR isoforms maintain functional independence in 
regards to regulating transcription of specific genes involved in pregnancy.   
Interestingly, in all mammalian species studied to date, both LE and GE of uteri 
exhibit loss of PGR prior to becoming receptive to implantation and establishment of 
pregnancy (Geisert et al. 1994; Lessey et al. 1988; Robinson et al. 2001; Spencer and 
Bazer 1995; Tan et al. 1999).  Loss of PGR results from downregulation of the PGR 
gene by continuous exposure of the endometrium to progesterone.  In sheep, 8 to 10 days 
of continuous progesterone exposure results in loss of PGR protein from LE (Figure 2.3) 
(Spencer and Bazer 1995; Wathes and Hamon 1993).  Loss of PGR protein in the GE 
ensues following an additional 2 days of P4 exposure.  Despite loss of PGR within the 
epithelia, the endometrial stroma continues to express PGR throughout pregnancy.  
Maintenance of PGR within the stroma suggests that the direct actions of progesterone 
are mediated on and via this cell type.  Interestingly, a number of changes in gene 
expression and uterine function observed in the epithelia are directly linked to the 
actions of P4 (Spencer et al. 2007b).  The absence of PGR within these cell types is a 
developmental conundrum which has resulted in two distinct hypotheses.  First, these 
changes may be mediated in response to P4 by unknown factors from the PGR positive 
stroma which act in a paracrine manner on the adjacent epithelium to modulate P4 
actions (i.e., a progestamedin(s)).  Alternatively, loss of PGR may be sufficient to 
initiate a developmental cascade which alters gene expression within the epithelia to 
promote differentiated functions.   
Recently, a family of membrane progesterone receptors, which have been shown 
to mediate rapid non-genomic cellular changes in response to P4, were identified 
(Ashley et al. 2006; Karteris et al. 2006; Zhu et al. 2003a; Zhu et al. 2003b).  At least 
one of these receptors has been identified in the sheep uterus; however, the role these 
receptors in pregnancy are unknown (Ashley et al. 2006).  Importantly, blockade of P4 
signaling through its classical nuclear receptor using an antagonist specific to the nuclear 
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receptor results in pregnancy loss (Baird 2002; Roblero and Croxatto 1991), illustrating 
the importance of nuclear receptor signaling in the maintenance of pregnancy.  
Collectively, the mechanisms by which P4 mediates its actions may be as diverse as the 
roles of P4 in establishment and maintenance of pregnancy.   
 
 
 
 
FIG. 2.3.  Schematic illustrating regulation of hormone receptor expression in the ovine 
uterine endometrial epithelium during the estrous cycle.  During estrus and metestrus, 
OXTR are present on uterine epithelia, because estrogen levels are high and increase 
expression of ESR1 and OXTR.  The PGR is present, but low circulating levels of 
progesterone result in insufficient numbers of activated PGR to suppress ESR1 and 
OXTR synthesis.  During diestrus, endometrial ESR1 and estradiol in plasma are low, 
and progesterone levels begin to increase with formation of the CL.  Progesterone acts 
through its receptor to maintain the “progesterone block” to ESR1 and OXTR synthesis 
for 8 to 10 days.  During late diestrus (~Days 11 to 12 of the cycle), progesterone 
negatively autoregulates PGR gene expression, which allows for increases in ESR1 and 
OXTR synthesis.  The increase in OXTR expression is facilitated by increasing secretion 
of estrogen by ovarian follicles and then decreasing secretion of progesterone.  The 
pulsatile release of oxytocin from the CL and posterior pituitary activates OXTR on 
endometrial epithelia and induces release of luteolytic pulses of PGF to regress the CL.  
Legend:  E2, estrogen; ESR1, estrogen receptor alpha; OXT, oxytocin; OXTR, oxytocin 
receptor; P4, progesterone; PGF, prostaglandin F2 alpha; PGR, progesterone receptor.  
Adapted from (Spencer and Bazer 2002). 
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Endometrial Glands as a Source of Histotroph 
Mammalian uteri contain a vast network of uterine glands which synthesize and 
secrete or transport a complex array of molecules collectively referred to as histotroph.  
These molecules include growth factors, ions, amino acids, nutrient transport proteins, 
hormones, enzymes, proteases, protease inhibitors, glucose, cytokines, lymphokines, and 
many other factors (Bazer 1975; Carson et al. 2000; Gray et al. 2001a; Roberts and 
Bazer 1988).  Histotroph emanates from both the LE and GE;  and each respective cell 
type is unique in contributing factors to the uterine milieu.  The importance of these 
secretions has been evidenced in both primate and subprimate species as regulators of 
conceptus development and survival, pregnancy recognition, and 
implantation/placentation (Burton et al. 2002; Gray et al. 2002; Gray et al. 2001c).  
Interestingly, in species exhibiting delayed implantation, alterations in uterine secretions 
have been implicated in regulation of this process (Zhu et al. 1998).  The utilization of 
knockout technology in mice has identified several factors including leukemia inhibitory 
factor (Lif) and Calca that are secreted exclusively from the uterine glands and are 
required for uterine receptivity and implantation (Stewart et al. 1992; Zhu et al. 1998).  
The prolonged nature of pre-implantation conceptus development in domesticated 
species of livestock such as the pig, cow, horse, and sheep suggests that endometrial 
support of conceptus development mediated primarily via histotroph is of critical 
importance in these species.   
Studies of the uterine gland knockout ewe (UGKO) revealed an essential role for 
uterine secretions in early conceptus development and initiation of pregnancy 
recognition signals (Gray et al. 2002; Gray et al. 2001c).  The UGKO ewe model is 
produced by the continuous administration of a synthetic, non-metabolizable progestin to 
neonatal ewe lambs from birth to postnatal Day 56 (Gray et al. 2000a).  This 
inappropriate progestin exposure permanently ablates, epigenetically, development of 
endometrial glands from the LE.  UGKO ewes have no apparent defect in development 
of the myometrium or other Müllerian duct-derived structures in the female reproductive 
tract or function of the hypothalamic-pituitary-ovarian axis (Gray et al. 2001b; Gray et al. 
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2000b).  The adult UGKO endometrium is devoid of glands and has a markedly reduced 
LE surface area.  UGKO ewes exhibit defects in that they are unable to experience 
normal estrous cysles or to support early embryonic development exhibited by failure of 
the blastocyst to elongate.  The defect in blastocyst development is manifest following 
hatching from the zona pellucida as blastocysts transferred from normal synchronous 
ewes into UGKO recipients also experience implantation failure (Gray et al. 2001c).  
Further, early conceptus development prior to Day 9 of pregnancy, was not affected by a 
lack of uterine histotroph (Gray et al. 2002; Gray et al. 2001c) suggesting that 
development to the blastocyst stage does not require uterine secretions.  Following 
hatching from the zona pellucida, around Day 8, the blastocyst is in direct contact with 
contents of the uterine lumen.  A lack of glandular secretions results in failure of 
blastocysts to develop and elongate normally, experience reduced secretion of IFNT to 
induce interferon stimulated genes important for pregnancy, and ultimately conceptus 
demise by Day 14 of pregnancy.  Uterine development and pregnancy success in adult 
cows is also compromised following neonatal progestin treatment of heifers (Bartol et al. 
1995). 
Analyses of molecular components in uteri of UGKO ewes indicated that failure 
of blastocysts to elongate was not due to alterations in expression of steroid hormones, 
the anti-adhesive factor mucin 1 (MUC1), integrins on the surface of LE, or IFNT 
responsiveness of the endometrium (Gray et al. 2000a; Gray et al. 2002).  However, 
uterine luminal contents recovered from UGKO ewes contained low to undetectable 
amounts of galectin-15 (LGALS15), glycosylated cell adhesion molecule 1 
(GLYCAM1), and secreted phosphoprotein 1 (SPP1, also known as osteopontin), which 
collectively act as adhesion molecules and are hypothesized to regulate apposition and 
attachment of trophectoderm to the LE, an action likely required for elongation of the 
blastocyst (Gray et al. 2006; Gray et al. 2004; Gray et al. 2002).  Undoubtedly, other 
essential unidentified molecules in histotroph are reduced in flushings from UGKO ewes 
and may contribute to the infertile phenotype of these ewes. 
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Indeed, histotroph is a complex fluid comprised of not only proteins, but also 
lipids, amino acids, and sugars, complicating the task of identifying specific components.  
Gene expression analyses may be used to identify candidate genes in endometria 
encoding proteins possibly present in histotroph.  However, genetic approaches do not 
identify histotrophic components of non-endometrial origin such as those from serum or 
conceptus derived factors.  Two-dimensional gel electrophoresis of uterine fluids from a 
number of species isolated a number of proteins, however, efforts to establish their 
identity has remained limited (Ashworth and Bazer 1989a; Ashworth and Bazer 1989b; 
Fazleabas et al. 1988; Kayser et al. 2006; MacLaughlin et al. 1986).  In human uterine 
fluid samples, 24 proteins were identified throughout the menstrual cycle as unique 
compared to those found in serum (MacLaughlin et al. 1986).  In pigs, two-dimensional 
gel electrophoresis followed by a more sensitive labeling technique, identified 280 total 
proteins of which 132 were affected by pregnancy, day, or the interaction of day and 
pregnancy (Kayser et al. 2006).  In sheep, Ashworth and Bazer (Ashworth and Bazer 
1989b) identified 30 endometrial proteins present in uterine luminal fluid.  Of these, 13 
proteins were absent on Day 8 but present on Day 10 indicating changes in secretory 
function of the endometrium with longer exposure to progesterone.  Recent work, 
utilized proteomic approaches and mass spectrometry to identify components of uterine 
histotroph or components of the endometrial proteome, have yielded limited findings 
despite the availability of improved protein sequence databases (TABLE 2.1).  In 
addition to IFNT, the primary secretory product of the developing conceptus, these 
studies identified aldose reductase, cytoplasmic actin, and transferrin as proteins of 
conceptus origin present in uterine luminal fluid (Lee et al. 1998b).  Berendt et al. 
(Berendt et al. 2005) reported an increase in four endometrial proteins associated with 
pregnancy on Day 18 in cattle including Rho GDP dissociation inhibitor beta; 20 alpha-
hydroxysteroid dehydrogenase, soluble NADP+-dependent isocitrate dehydrogenase 1, 
and acyl-CoA-binding protein.  Analyses of non-protein components of histotroph in 
pigs identified distinct changes in amino acids, lipids, and sugars that occur in the 
uterine lumen as well as fetal fluids as pregnancy progresses (Geisert et al. 1982; Kwon 
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et al. 2003a; Kwon et al. 2003b).  In humans, glucose and amino acids are important for 
pre-implantation embryo development (Devreker et al. 2000; Leese 1995).  Both amino 
acids and their transporters have been implicated in blastocyst implantation and 
differentiation of the trophoblast through modulation of nutrient-sensing pathways 
(Martin and Sutherland 2001; Martin et al. 2003).  In mice and humans, lipids and their 
metabolites regulate aspects of endometrial function and placental development (Schaiff 
et al. 2006; Schaiff et al. 2007).  Revisiting classical two-dimensional studies with 
modern protein identification techniques should soon enhance understanding of the 
functional significance of individual components of histotroph and their effects on 
blastocyst development and implantation.  Upon identification, null mutagenesis studies 
in mice, similar to those used to implicate Lif and Calca in implantation, or the 
utilization of antisense knockdown technologies in other species will enhance functional 
understanding of the roles of these proteins in vivo.   
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TABLE 2.1.  Components of uterine histotroph in sheep and cattlea.                
Name Component Cycle Pregnancy Bovine Reference 
B2M Beta2-microglobulin NDa 16 ND (Vallet et al. 
1991) 
SPP1 Secreted 
phosphoprotein 1 
(Osteopontin) 
ND 15-Term Yes (Johnson et al. 
1999b) 
GRP Gastrin-releasing 
Peptide 
16 17-20, 115-
145 
Yes (Giraud et al. 
1993; Whitley et 
al. 1998) 
ISG15 Interferon Stimulated 
Gene 15 
 13-19 Yes (Johnson et al. 
1999c) 
GLYCAM1 Glycosylated Cell 
Adhesion Molecule-1 
1-11 13-19 ND (Spencer et al. 
1999a) 
 Endothelin 12-16 15-20 ND (Riley et al. 1994) 
UTMP Uterine Milk Proteins 
(Serpins) 
13-15 15-150 Yes (Moffatt et al. 
1987a; Stewart et 
al. 2000) 
LGALS15 Galectin 15 10-14 10-18 No (Gray et al. 2004) 
CTSL Cathepsin L 10-12 10-20 ND (Song et al. 2005) 
CST3 Cystatin C 12 12-20 ND (Song et al. 
2006b) 
STC1 Stanniocalcin One 10-16 10-120 ND (Song et al. 
2006a) 
CXCL10 Chemokine Ligand 10  14-20 ND (Imakawa et al. 
2006; Nagaoka et 
al. 2003) 
IGF1 Insulin-like Growth 
Factor-1 
3-16 3-22 Yes (Cann et al. 1998; 
Ko et al. 1991) 
 a ND = Not determined     
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TABLE 2.1. Cont. 
    
Name Component Cycle Pregnancy Bovine Reference 
IGF2 Insulin-like Growth 
Factor-2 
10-16 10-16 Yes (Ko et al. 1991) 
IGFBP2 
IGFBP3 
Insulin-Like Growth 
Factor Binding 
Proteins 2 &3 
12-15 ND Yes (Peterson et al. 
1998) 
TGFB Transforming Growth 
Factor Beta1-3 
13-16 14-30 Yes (Dore et al. 1996) 
CSF2 Granulocyte-
Macrophage Colony 
Stimulating Factor 
 17 ND (Imakawa et al. 
1993) 
LIF Leukemia Inhibitory 
Factor 
4-16 4-20 ND (Vogiagis et al. 
1997) 
PAF Platelet Activating 
Factor 
14-15  ND (Battye et al. 
1996) 
FGF2 Fibroblast Growth 
Factor 2 
ND ND Yes (Michael et al. 
2006) 
TIMP1 
TIMP2 
Tissue Inhibitor of 
Matrix 
metalloproteinases 1 & 
2 
4-16 4-20 ND (Hampton et al. 
1995) 
CXCL6 Granulocyte 
Chemotactic Protein-2 
ND ND Yes (Teixeira et al. 
1997) 
 Beta-N-acetylglucos-
aminidase 
13 7-18 ND (Roberts et al. 
1976) 
GLB1 Beta-D-galactosidase 13-15 13-15 ND (Roberts et al. 
1976) 
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 TABLE 2.1. Cont.     
Name Component Cycle Pregnancy Bovine Reference 
NAGA Beta-N-acetylgalactos-
aminidase 
13 7-18 ND (Roberts et al. 
1976) 
 Alpha-L-fucosidase 13 17-18 ND (Roberts et al. 
1976) 
 Alpha-D-glucosidase  13-15 ND (Roberts et al. 
1976) 
OAS1 2’-5’-
oligo(A)synthetase 
ND 16 ND (Mirando et al. 
1991) 
 Glucose  140 Yes (Bazer et al. 
1979a) 
 Prostaglandin F2-alpha 13-15 30-144 Yes (Moffatt et al. 
1987b) 
 Prostaglandin E2 14  Yes (Vallet et al. 
1988) 
 Amino acids  30-140 Yes (Kwon et al. 
2003a) 
MX1 Mx1 15 15-17 Yes (Toyokawa et al. 
2007) 
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Adhesion Molecules in Implantation 
 
Mucin 1 (MUC1) 
 In the uterus, the pre-implantation blastocyst approaches a glycocalyx, including 
mucins, which are large transmembrane glycoproteins expressed at the apical surface of 
epithelia in the reproductive tracts of a number of species (Brayman et al. 2004).  The 
extracellular domain of MUC1 contains a large amount of glycans (Aplin and Hey 1995) 
with the core protein of 120-220 kDa and can reach over 400kDa with glycosylation.    
Given that mucins contain a large number of glycans recognizable by blastocysts or 
secreted animal lectins, they may be involved in the initial apposition phase of 
implantation (Aplin and Hey 1995; Brayman et al. 2004).  Expression of MUC1 and 
MUC4 on the uterine LE is hypothesized to block accessibility of trophoblast integrin 
receptors to their ligands for cell-cell and cell-extracellular matrix adhesion, both of 
which are necessary for the initial phases of implantation (Burghardt et al. 2002; Carson 
et al. 2000).  In sheep, removal of MUC1 from the LE correlates with loss of the PGR 
(Figure 2.4) (Johnson et al. 2001a) and may be required for the exposure of other 
glycoproteins involved in trophoblast adhesion.  Immunoreactive MUC1 in the LE 
decreases from Days 9-17 of pregnancy in ewes (Johnson et al. 2001a).  In contrast, total 
MUC1 expression increases in the LE of rabbits and humans during uterine receptivity; 
however, MUC1 is locally reduced at the site(s) of implantation (Brayman et al. 2004; 
Carson et al. 2000).  Regardless of the mechanism, loss of MUC1 is hypothesized to be 
necessary to expose other glycoproteins involved in adhesion between the trophoblast 
and LE.   
 
Integrins  
Integrins encompass a family of heterodimeric intrinsic transmembrane 
glycoprotein receptors that regulate cell differentiation, motility, and adhesion (Giancotti 
and Ruoslahti 1999).  In the uterus, integrins play a pivotal role in extracellular matrix 
(ECM) interactions to transduce cell signals in both the epithelia and trophoblast 
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(Burghardt et al. 2002; Johnson et al. 2001a; Johnson et al. 2003).  Integrins likely 
function in implantation to induce cytoskeletal reorganization, stabilize adhesion, and 
mediate cell migration, proliferation, and differentiation (Giancotti and Ruoslahti 1999).  
Altered integrin expression correlates with causes of infertility (Lessey 1998), null 
mutations of several integrins results in peri-implantation lethality (Hynes 1996), and 
functional inhibition of specific integrins decreases the number of implantation sites 
(Hynes 1996).  In sheep, the integrin subunits α (v, 4, and 5) and β (1, 3, and 5) are 
constitutively expressed on the apical surfaces of uterine LE and conceptus 
trophectoderm during the peri-implantation period (Johnson et al. 2001a), and are not 
changed in a spatial or temporal manner in response to hormones or conceptus derived 
signals.  However, alterations in temporal and spatial expression of integrin ligands 
during this period support a role for integrins in regulating conceptus attachment and 
adhesion in sheep.  In other species, such as the pig, mouse, and humans, the putative 
window of implantation is framed by interactions between specific integrins and ECM 
proteins (Burghardt et al. 2002; Carson et al. 2000; Lessey 2002). 
  
Glycosylated Cell Adhesion Molecule (GLYCAM1) 
GLYCAM1 is a sulfated glycoprotein secreted by endothelial cells that mediates  
leukocyte-endothelial cell adhesion (Lasky et al. 1992) and has a functional role as a 
carbohydrate ligand for the lectin domain of leukocyte cell-surface selectin (SELL or L-
selectin) in the lymphoid system (Rosen 1993).  Ligation of SELL by GLYCAM1 
activates β1 and β2 integrins and promotes firm adhesion to fibronectin (Giblin et al. 
1997; Hwang et al. 1996).  In humans, trophoblast SELL is believed to mediate 
interactions with the LE that may be important for establishment of pregnancy 
(Genbacev et al. 2003).  The expression pattern of GLYCAM1 in the ovine uterus 
suggests that it may be a mediator of implantation (Spencer et al. 1999a).  GLYCAM1 
expression increases in the endometrial LE and superficial (sGE) between Days 1 and 5 
and then decreases between Days 11 and 15 in cyclic ewes.  In contrast, GLYCAM1 is 
low between Days 11 and 13 of pregnancy, increases on Day 15 and is abundant by  
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FIG. 2.4.  Schematic illustration of the pre-attachment, apposition, and adhesion stages 
of superficial implantation in sheep.  Preattachment (A) involves shedding of the zona 
pellucida, followed by conceptus expansion, as well as precontact and blastocyst 
orientation.  MUC1 expression prevents contact with integrin subunits and/or 
carbohydrate receptors.  Apposition (B) involves a decrease in MUC1 expression by the 
LE and extension of trophoblast papillae into the mouth of uterine glands to aid in access 
to histotroph and elongation of the conceptus.  Adhesion (C) between the apical surfaces 
of the conceptus trophectoderm and LE is mediated by uterine secretory proteins such as 
SPP1 (osteopontin), GLYCAM1, LGALS15, binding to receptors.  Trophoblast 
binucleate cells fuse with the LE cells to form syncytial plaques, but are not invasive 
beyond this single cell layer (Spencer et al. 2004a).   
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Days 17 and 19 (Spencer et al. 1999a).  In uterine flushings, GLYCAM1 increases from 
Days 11 and 13 to Days 15 and 17.  GLYCAM1 is also detected in conceptus 
trophoblast from Days 13-19.  Therefore, GLYCAM1 is hypothesized to be a secretory 
product of the maternal endometrium that mediates conceptus-maternal interactions 
during implantation in sheep. 
 
Galectin 15 (LGALS15) 
 Galectins are a family of proteins that contain a conserved carbohydrate 
recognition domain that binds β-galactosides.  Binding results in the cross-linking of 
glycoproteins and glycolipid receptors on the cell surface to initiate a biological response 
(Yang and Liu 2003).  LGALS15 was initially characterized as a P4 modulated 14-kDa 
protein located in crystalline inclusion bodies in uterine epithelia and conceptus 
trophectoderm (Kazemi et al. 1990).     
Functional studies of other galectins identified fundamental processes intrinsic to 
implantation including roles in cell growth, differentiation, apoptosis, cell adhesion, 
chemoattraction, and migration (Yang and Liu 2003) which support the hypothesis that 
LGALS15 is involved in blastocyst implantation in sheep (Spencer et al. 2004a).  Indeed, 
LGALS15 stimulates proliferation of ovine trophectoderm cells and also acts as an anti-
apoptotic agent in response to staurosporine induced apoptosis (Farmer et al. 2007).  
Additionally, LGALS15 stimulated trophectoderm cell migration and attachment by 
binding integrins through its conserved RGD sequence (Farmer et al. 2007; Lewis et al. 
2007).  Collectively, results indicate that LGALS15 may play a role in mediating 
blastocyst elongation and implantation.  
 
Secreted Phosphoprotein 1 (SPP1) 
 Secreted phosphoprotein 1, also known as osteopontin, is an acid phosphorylated 
glycoprotein molecule that is detected and secreted from the epithelia of a number of 
tissues (Butler et al. 1996).  SPP1 is a component of the extracellular matrix and binds to 
specific integrin heterodimers via its conserved RGD sequence to promote cell adhesion, 
 23
spreading and migration (Butler et al. 1996).  In sheep, the uterine glands synthesize and 
secrete SPP1 during the peri-implantation period, a time when the conceptus is 
developing a firm adhesion to the uterine LE (Johnson et al. 1999a; Johnson et al. 
1999b).  Synthesis of SPP1 by the glands is dependent upon progesterone as 
administration of a PGR antagonist ablates SPP1 mRNA expression (Johnson et al. 
2000).  SPP1 then binds integrin heterodimers expressed by the trophectoderm and 
uterine LE to stimulate morphological changes of the conceptus trophectoderm as well 
as induce adhesion between the LE and trophectoderm essential for implantation and 
placentation.     
 
Epithelial Junctional Complexes 
Regulation of epithelial organization, structure, and subsequent function is 
modulated by two forms of junctional complexes: tight junctions and adherens junctions.  
Tight junctions are located on the plasma membrane and facilitate cellular polarity, cell-
cell contact, and adhesion (Figure 2.5).  Tight junctions function as barriers that regulate 
the passage of ions, water, and molecules through the paracellular space.  In addition, 
tight junctions maintain the proper distribution of proteins and lipids within domains of 
the plasma membrane (Gonzalez-Mariscal et al. 2003). Proteins known to be associated 
with the formation of tight junctions are classified into one of three families of 
molecules: junctional adhesion molecules (JAM), occludins (OCLN), and claudins 
(CLDNs).   
Transepithelial paracellular permeability can be regulated by both OCLN and 
CLDNs (Tsukita et al. 2001). Zona occludens contain members of a submembranous 
class of proteins [tight junction proteins (TJP)] that bind both CLDNs and OCLN 
(Wittchen et al. 1999) and function as a scaffold to bring structurally diverse proteins 
into close proximity at tight junctions (Gonzalez-Mariscal et al. 2000a). The amount of 
OCLN and TJP1 present in a tissue is inversely related to the permeability of that tissue 
(Gonzalez-Mariscal et al. 2000b). Regulation of tight-junction-dependent transepithelial 
paracellular permeability is mediated by multiple factors including calcium (Gonzalez-
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Mariscal et al. 1985; Gonzalez-Mariscal et al. 1990), growth factors, kinases, and second 
messengers (Balda et al. 1991), as well as hormones including P4, prolactin, and 
placental lactogen (Nguyen et al. 2001). 
Adherens junctions formed by classical cadherin/catenin complexes mediate 
epithelial organization and function.  E-cadherin (CDH1) facilitates cell to cell adhesion 
within epithelia through homodimeric attachment to other CDH1 molecules on adjacent 
cells.  These cadherins are first bound by intracytoplasmic Beta-catenin (CTNNB1) 
(McCrea and Gumbiner 1991; McCrea et al. 1991).  Alpha-Catenin (CTNNA1) is 
subsequently recruited to the complex (Aberle et al. 1994) and binds to the actin 
cytoskeleton to facilitate cellular organization and shape (Rimm et al. 1995). Stable cell 
to cell adhesion is mediated by the phosphorylation state of CTNNB1 (Lilien and 
Balsamo 2005).  Homodimeric CDH1 interactions as well as other cell adhesion 
molecules have also been implicated in the relative invasive capabilities of tumors 
(Cowin et al. 2005; Okegawa et al. 2002).  
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FIG. 2.5.  Schematic illustration of junctional complexes mediating epithelial cell-cell 
interactions.  Tight junctions are formed from a large family of proteins including 
occludins, claudins, and junctional adhesion molecules bound intracellularly to zonula 
occludens proteins which then stabilize the junctional complex via interaction with the 
actin cytoskeleton.  Tight junctions mediate cell polarity and paracellular permeability 
which is the trafficking of molecules between adjacent epithelial cells.  Adherens 
junctions are formed across adjacent epithelial cells via calcium dependent homodimeric 
interactions of E-cadherin proteins.  Intracellular E-cadherin is bound by beta catenin 
which recruits and binds alpha catenin to form a cadherin/catenin complex.  This 
complex binds the actin cytoskeleton and intermediate filaments to regulate cell shape 
and polarity.  (Schematic from Nastech Pharmaceutical Company Inc. 
http://www.nastech.com/nastech/junctions_biology)      
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Factors in Endometrial Function & Embryo Development  
 
Cathepsin L (CTSL) 
Cathepsins are peptidases that functionally degrade extracellular matrix, 
catabolize intracellular proteins, and process prohormones to regulate uterine receptivity 
for implantation and trophoblast invasion (Afonso et al. 1997).  Specifically, CTSL is 
induced by P4 in LE and sGE of the ovine endometrium between Days 10 and 12 of both 
the estrous cycle and pregnancy and further increased by IFNT in pregnant ewes (Song 
et al. 2005).  Protease activity mediated by cathepsins is balanced by their inhibitor, 
cystatin C, which is also regulated by P4 and IFNT in pregnancy (Song et al. 2006b).  A 
balance of proteolytic activity is likely required to modify the glycocalyx on endometrial 
LE and trophectoderm during the apposition and adhesion phases of implantation 
(Carson et al. 2000).  
 
Wingless-type Mouse Mammary Tumor Virus Integration Site (WNT) Family 
WNT genes are homologous to the Drosophila segment polarity gene wingless 
(wg).  In humans and mice, the WNT family encodes a group of 19 highly conserved 
secreted glycoproteins that regulate cell and tissue growth and differentiation as well as 
components of junctional complexes (Davies 2002; Davies and Fisher 2002; Robinson et 
al. 2000).  WNTs associate with their extracellular surface receptors, frizzled (FZD), in 
both an autocrine and paracrine manner to mediate intracellular signal transduction 
pathways (Dale 1998).  The ten FZDs are a family of seven transmembrane G protein-
coupled receptors that possess an extracellular cysteine-rich domain for WNT binding 
(Liu et al. 1999; Wang et al. 1996).  FZD then binds to low-density lipoprotein receptor-
related proteins 5 and 6 (LRP5/6) which serve as coreceptors (Pinson et al. 2000).  
Another family of proteins, termed secreted FZD-related proteins (SFRPs) produced by 
six different genes, exert inhibitory effects on WNT signaling by competing with WNT 
ligands for the FZD receptor and forming a nonfunctional complex with FZDs in a 
dominant-negative manner (Bafico et al. 1999; Kawano and Kypta 2003).  WNT 
 27
signaling is also antagonized by four Dickkopf (DKK) genes which encode secreted 
proteins that bind the LRP coreceptor (Nusse 2001).  In the canonical WNT signaling 
pathway, FZD receptors inhibit glycogen synthase kinase 3 beta (GSK3B), resulting in 
stabilization of the transcriptional regulator CTNNB1 (Logan and Nusse 2004; Pandur et 
al. 2002b).  Nuclear CTNNB1 interacts with transcription factors, most notably members 
of the transcription factor 7 (T-cell specific, HMG-box) (TCF7/LEF) family, to regulate 
transcription of genes such as JUN (c-Jun) (Mann et al. 1999), LEF1/TCF7 (Roose et al. 
1999), MET (c-Met) (Boon et al. 2002), and MSX2 (msh homeobox homolog 2) (Hussein 
et al. 2003; Willert et al. 2002).  The noncanonical or planar cell polarity pathways, 
activated by WNT5A and WNT11, mediate cell polarity, cell movements during 
gastrulation, and other processes modifying the actin cytoskeleton via small GTPases of 
the Rho family, such as Rho, Rac, and Cdc42 (Huelsken and Birchmeier 2001; Kuhl et al. 
2000; Pandur et al. 2002a; Yamanaka et al. 2002).  Rac activation stimulates c-Jun N-
terminal kinase (JNK) activity (Boutros et al. 1998; Habas et al. 2003; Veeman et al. 
2003).  JNK activation plays essential roles in organogenesis by regulating cell survival, 
apoptosis, and proliferation (Nishina et al. 2004). 
During implantation, WNTs play a critical role in coordinating uterine-conceptus 
interactions required for implantation in mice, and perhaps other mammals (Mohamed et 
al. 2005).  In  sheep, WNT7A was the first gene known to be induced by IFNT between 
Days 12 and 16 of pregnancy specifically within LE and sGE (Kim et al. 2003).  A 
recent study cataloged members of the WNT signaling family and a number of 
downstream target genes present in the ovine endometrium and identified roles for WNT 
signaling in regulation of conceptus growth and development (Hayashi et al. 2007).  In 
addition to actions on the conceptus, WNTs are hypothesized to elicit paracrine and/or 
autocrine actions on the LE and sGE to regulate expression of target genes implicated in 
uterine receptivity and implantation, including LGALS15, CST3, and CTSL.  Known 
alterations in uterine epithelial architecture may also be regulated by WNT signaling as 
limited results illustrate regulation of several tight junction associated proteins by 
members of the WNT family (Mankertz et al. 2004; Miwa et al. 2001).     
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Insulin-Like Growth Factor Family 
The insulin-like growth factor (IGF) family consists of IGF1, IGF2, IGF1 
receptor (IGF1R) and IGF2 receptor (IGF2R), and 7 high affinity IGF binding proteins 
(IGFBPs 1-7) which modulate IGF activity (Wang and Chard 1999).  IGF1 and IGF2 
possess both mitogenic and differentiative properties and have long been implicated in 
early embryonic and placental development in multiple species including humans, 
rodents, pigs, and domesticated ruminants (Baker et al. 1993; D'Ercole 1987; DeChiara 
et al. 1990; Gluckman et al. 1992; Wathes et al. 1998; Zhou and Bondy 1992).  The 
IGF1R demonstrates high affinity for IGF1 and moderate affinity for IGF2 and is the 
primary functional receptor associated with pregnancy (Wang and Chard 1999).  
Confounding clear understanding of the roles of IGFs are the actions of the IGFBPs 
which can both enhance or retard IGF actions.  IGFBPs bind IGFs with high affinity 
although relative affinity is altered by phosphorylation state of the IGFBP.  Further, wide 
arrays of proteolytic molecules cleave IGFBPs from IGF yielding free IGF to act on 
adjacent cells expressing IGF1R.  These molecules include, matrix metalloproteinases 
(MMPs), kallikriens, cathepsins, pregnancy associated plasma protein-A (PAPP-A), 
calpain, and serine proteases (Bunn and Fowlkes 2003; Ghosh et al. 2005; Rajah et al. 
1995).  Collectively, the mechanisms regulating IGF actions involve the availability of 
receptors, the presence and phosphorylation state of IGFBPs, and the activity of 
available proteases to regulate local concentrations of free IGF.         
Gene mutagenesis studies in mice indicated critical roles for both Igf1 and Igf2 in 
embryonic, placental, and fetal growth (Baker et al. 1993; DeChiara et al. 1990; Liu et al. 
1993).  Further, IGF1 null-mice are infertile.  In pigs, proteolytic cleavage of IGFBPs to 
yield free IGF has been associated with the elongation period of conceptus development 
(Lee et al. 1998a).  Studies in the cow revealed the presence of mRNAs encoding 
IGFBPs, 1, 2, 3, 4, and 5 within the endometrium during early conceptus elongation 
(Keller et al. 1998).  Early embryonic and fetal development in cows can be stimulated 
by components of the growth hormone-IGF system (Moreira et al. 2002a; Moreira et al. 
2002b).  Administration of bovine somatototropin (bST) that enhances pregnancy rates 
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in lactating dairy cows, possibly via alterations in the IGF system, increased pregnancy 
rate, conceptus length and IFNT secretion on Day 17 (Bilby et al. 2006a; Bilby et al. 
2006b).  These effects were accompanied by increased concentrations of IGF1 in serum.  
Functional results elucidating a clear role of the IGF system in post-hatching blastocyst 
development in either ewes or cows are not available. 
 
Stromal Cell-Derived Growth Factors 
 Actions of P4 on the endometrial epithelium in the absence of a functional PGR 
are a reproductive conundrum limiting the understanding of the process of implantation.  
Fibroblast growth factor 7 (FGF7), FGF10, and hepatocyte growth factor (HGF), are 
secreted by stromal cells and act via receptors on adjacent epithelial cells.  Available 
results indicate that stromal cells of the primate uterus express FGF7 in response to P4 
(Koji et al. 1994; Rubin et al. 1995).  FGF7 and FGF10 both act via a specific isoform of 
the FGF receptor 2 (FGFR2IIIb), while the receptor for HGF is a proto-oncogene c-met 
(MET).  HGF is expressed by fibroblasts and smooth muscle cells of the uterus, placenta, 
and ovaries in rodents, humans, sheep and horses (Chen et al. 2000a) although its 
regulation by P4 has not been determined.  HGF expression is increased by estrogen in 
the primate uterus and mouse ovary indicating that steroid hormones regulation of gene 
expression.  Both FGF7 and HGF are powerful mitogens on epithelial cells stimulating 
proliferation, migration, and differentiation.  Stromal FGF10 has critical roles in 
development of lung, brain, and limbs, as mice lacking Fgf10 fail to develop (Sekine et 
al. 1999). 
 In sheep, FGF10 mRNA is detected at moderate levels throughout the stroma 
during the estrous cycle and early pregnancy.  In contrast, FGF7 mRNA is localized in 
the media intima of uterine blood vessels consistent with expression within the spiral 
arteries of the primate endometrium (Brenner et al. 1997).  The distinct spatial 
expressions of these growth factors suggest non-redundant functions in regulating 
uterine biology and conceptus development.  HGF is expressed and temporally regulated 
in the adult ovine uterus although hormonal regulation has not been elucidated (Chen et 
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al. 2000a).  In addition to the uterine LE, both MET and FGFR2 are expressed in 
conceptus trophectoderm suggesting that HGF, FGF7, and FGF10 may stimulate 
conceptus development directly as well as modulating epithelial functions.         
 
 
Progesterone Regulation of Preimplantation Blastocyst Growth and Elongation 
 Progesterone stimulates and/or maintains endometrial functions necessary for 
conceptus growth, implantation, placentation, and development throughout pregnancy 
(Bazer et al. 1979b; Spencer and Bazer 2002; Spencer et al. 2004b).  Circulating 
concentrations of progesterone affect not only blastocyst growth, but also its survival 
during early pregnancy (Mann et al. 2006; Mann 1999).  In cattle, rapid blastocyst 
development and ultimately successful establishment of pregnancy correlates positively 
with increasing circulating levels of progesterone (Mann and Lamming 2001; Sreenan 
and Diskin 1983).  Low circulating concentrations of progesterone during the early luteal 
phase of both heifers and ewes are associated with growth-retarded conceptuses which 
secrete reduced amounts of IFNT (Mann and Lamming 2001; Nephew et al. 1991).  
Indeed, administration of early exogenous progesterone from Days 2 to 5 or Days 5 to 9 
enhanced conceptus size and development in beef heifers on Day 14 (Garrett et al. 
1988b) and in dairy cattle on Day 16, respectively (Mann et al. 2006).  It is hypothesized 
that these developmental changes in response to progesterone are mediated by the 
stimulatory effects of progesterone on endometrial function and result in increased 
blastocyst growth and survival.  Indeed, endometrial secretions were increased on Day 5 
in explant cultures from heifers receiving early exogenous progesterone (Garrett et al. 
1988b).  A similar phenomenon has been observed in sheep with the early administration 
of progesterone during metestrus and early diestrus (Kleemann et al. 1994).  The effects 
of early progesterone treatment were still detected at Day 74 of pregnancy with 
increased fetal weights (Kleemann et al. 2001).  Genetic regulation of factors responsible 
for the accelerated development of the blastocyst has not been identified.  A number of 
progesterone stimulated genes have been identified in ovine endometria which are 
expressed in uterine epithelia that paradoxically lose progesterone receptor protein 
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immediately prior to induction of these genes and initiation of morphogenesis of 
spherical blastocysts into filamentous conceptuses (Spencer et al. 2004b).   
 
 
Luteal Insufficiency and Efficacy of P4 Supplementation in Enhancing Pregnancy 
Low fertility in dairy cattle has reached an epidemic proportions throughout the 
world with a 20-30% reduction in conception rates over the past 5 decades (Lucy 2001).  
These findings correlate with an increase in calving intervals and near doubling of the 
number of artificial inseminations (AI) per conception.  Low concentrations of 
circulating progesterone has been implicated in early pregnancy failure (Mann 1999) 
although other factors such as excess urea in blood may also play a role in reduced 
fertility (Larson et al. 1997).  The reduction in circulating P4 and increase in urea in 
blood are linked to extreme alterations in metabolic state of the modern dairy cow which 
has resulted in a doubling of milk production per cow since the 1950s.  Abnormal luteal 
function and reduced pregnancy rates are correlated with milk yield, dry matter intake, 
total digestible nutrients, and digestible crude protein in dairy cattle (Hommeida et al. 
2004).  Similar findings in sheep have identified a negative correlation between feed 
intake and concentrations of P4 in blood (Parr et al. 1987; Parr et al. 1993a).  The 
reduction in P4 is believed to be due to increased hepatic blood flow and the clearance of 
P4 by the liver (Parr et al. 1993b).  Correlative data has indicated that pregnancy success 
in cattle is improved with an early and rapid rise in circulating P4 between Days 4 and 5 
(Mann and Lamming 2001; Stronge et al. 2005).  A delayed rise in P4 after Day 5 
resulted in retarded conceptus growth and little or no production of IFNT.  In addition, 
administration of early exogenous progesterone beginning on Day 1.5 post-estrus 
increased conceptus length by 10-fold on Day 14 (Garrett et al. 1988b).  In light of these 
observations, and in response to the need to improve conception rates and prevent 
increased costs due to reproductive losses, researchers have attempted to improve 
pregnancy rates by supplementing high producing dairy cattle with exogenous P4.  
These studies have aimed to determine the efficacy of supplementation for enhancing 
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pregnancy rates and establish the appropriate timing of P4 supplementation for maximal 
effect (Table 2.2). 
Multiple factors limit the ability to interpret and integrate the above findings into 
a unified strategy for improving pregnancy rates; including parity, production status, 
timing of supplementation, and numbers of animals per study.  In addition, the modern 
dairy is evolving rapidly and comparisons of results from studies in different eras present 
challenges.  A general interpretation of the findings summarized in Table 2.2 suggests 
that for P4 supplementation to be beneficial to pregnancy, it must be applied to mature, 
lactating cows, during early stages of diestrus (Days 4-9).  Researchers have begun to 
assess effects of P4 supplementation on conceptus development during the peri-
implantation period to elucidate mechanisms of P4 action.  Indeed, P4 supplementation 
from Days 5-9, but not Days 12-16 increased trophoblast length and IFNT production by 
the conceptus on Day 16 (Mann et al. 2006).  Early exogenous progesterone in sheep 
also advanced conceptus develop (Kleemann et al. 1994); however, P4 supplementation 
during the early luteal phase yielded varied results suggesting either no effect (Diskin 
and Niswender 1989; Kenyon et al. 2005) or improved pregnancy rates (Parr et al. 1987).  
The improvement in pregnancy rates was associated with overfed ewes that had reduced 
circulating progesterone prior to exogenous treatment.  Diskin et al. (Diskin and 
Niswender 1989) suggested that supplemental P4, at least in sheep, may not improve 
pregnancy rates under normal conditions when fertility is normally high.  Nonetheless, 
P4 supplementation is a potential strategy for improving pregnancy rates in both sheep 
and cattle with reduced fertility, necessitating further research into mechanisms by 
which pregnancy rates may be increased.  Enhanced conceptus development is 
hypothesized to result from increased secretory activity of the uterine endometrium, 
providing the conceptus a uterine milieu rich in factors required for development and 
survival.   
The aim of the present studies were to employ molecular biology and functional 
genomics approaches to identify endometrial factors that enhance conceptus growth and 
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development in response to P4 as a first step toward improving rates of early embryo 
survival and pregnancy success in ruminants.             
 
 
 
 
 
TABLE 2.2.  Summary of studies evaluating the efficacy and timing of supplementing 
cattle with P4 in an attempt to improve pregnancy rate. 
Parity/ 
Status 
Duration 
of P4 
Supp. 
Effect on 
Pregnancy 
Ratea
Day of Preg 
Determination
Reference 
Heifers  
and Cows 
D2-9 Increase 
 
150 (Johnson 1958) 
Cows D5 Increase  (Wiltbank 
1956) 
Beef Heifer 
Dairy Cows 
D5 
D10 
Increase. 
No effect 
 (Sreenan and 
Diskin 1983) 
Lactating 
cows 
D5-12 
D10-17 
Increase 
Increase 
55 (Robinson et 
al. 1989) 
Heifers D1-8 
D2-9 
Decrease 
Decrease 
40-51 (Van Cleeff et 
al. 1996) 
Heifers D7-13 No effect 45 (Van Cleeff et 
al. 1991) 
Anestrous 
cows 
D4-11 
D5-12 
No effect >42 (Hanlon et al. 
2005) 
Lactating 
cows 
D3.5-10 Increase >40 (Larson et al. 
2007) 
Cows D5-17 No effect 
overall 
(Increase. in 
young late 
lactation cows) 
40-47 (Villarroel et 
al. 2004) 
Cows D10-17 No effect 20-25 (Mann et al. 
2001) 
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CHAPTER III 
PROGESTERONE REGULATION OF PREIMPLANTATION CONCEPTUS 
GROWTH AND GALECTIN 15 (LGALS15) IN THE OVINE UTERUS* 
 
Introduction 
Maternal support of conceptus (embryo/fetus and associated membranes) growth 
and development is critical for pregnancy recognition signaling and implantation 
(Ashworth and Bazer 1989b; Gray et al. 2000a). In sheep, morula-stage embryos enter 
the uterus on Days 4 to 5 and the blastocyst, formed by Day 6, contains a blastocoele or 
central cavity surrounded by a monolayer of trophectoderm (Guillomot 1995; Spencer et 
al. 2004a). After hatching from the zona pellucida on Day 8, blastocysts develop into a 
tubular form by Day 11, elongate to 10 cm or more in length by Day 14, and reach 25 cm 
or more in length by Day 17. Factors supporting growth of pre- and peri-implantation 
blastocysts and elongating conceptuses in the uterine lumen are obtained primarily from 
secretions of the uterus and selective transport from maternal blood that are collectively 
referred to as histotroph. This hypothesis is supported by results from studies of 
asynchronous uterine transfer of embryos and trophoblast vesicles (Flechon et al. 1986; 
Lawson et al. 1983) and from studies of uterine gland knockout (UGKO) ewes (Gray et 
al. 2002; Gray et al. 2001c). The endometrial luminal (LE) and glandular (GE) epithelia 
are the main sources of uterine secretions or histotroph. 
During early pregnancy, endometrial functions are regulated primarily by 
progesterone from the corpus luteum and hormones from the placenta (Bazer 1975; 
Bazer et al. 1979b; Roberts and Bazer 1988; Spencer et al. 2004b).  In sheep, pregnancy 
recognition and establishment involves elongation of spherical blastocysts to filamentous 
conceptuses between Days 12 and 16 and production of interferon tau (IFNT) by the 
conceptus (Roberts et al. 1999; Spencer and Bazer 2004).  IFNT is antiluteolytic and acts  
________ 
* Reprinted with permission of:  Satterfield MC et al., 2006 Progesterone Regulation of 
Preimplantation Conceptus Growth and Galectin 15 (LGALS15) in the Ovine Uterus 
Biology of Reproduction Aug;75(2):289-96  Copyright 2006 
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on the endometrium to inhibit development of the luteolytic mechanism, thereby 
maintaining corpus luteum (CL) function and ensuring continued production of P4  
(Spencer et al. 1996). Progesterone acts on the uterus to stimulate and maintain 
endometrial functions necessary for conceptus growth, implantation, placentation and 
development to term (Bazer 1975; Bazer et al. 1979b; Spencer and Bazer 2002; Spencer 
et al. 2004b).  The concentrations of P4 in early pregnancy clearly affect embryonic 
survival during early pregnancy (Mann 1999).  Increasing concentrations of P4 from 
Days 2 to 5 or Days 5 to 9 enhanced conceptus development and size on Day 14 in 
heifers (Garrett et al. 1988a) and Day 16 in cows (Mann et al. 2006), while animals with 
lower concentrations of P4 in the early luteal phase had retarded embryonic development 
(Mann and Lamming 2001; Nephew et al. 1991) and decreased production of interferon 
tau (IFNT) from bovine conceptuses (Mann and Lamming 2001). In both lactating dairy 
cows and heifers, there is a strong positive association between early luteal phase 
concentrations of P4 in plasma and embryonic survival (Larson et al. 1997; Starbuck 
1999; Villa-Godoy et al. 1988).  Indeed, P4 supplementation of cattle after artificial 
insemination increased embryonic survival (Johnson 1958; Mann 1999; Sreenan and 
Diskin 1983; Van Cleeff et al. 1991; Wiltbank 1956). However, the mechanisms through 
which pre-implantation P4 regulates blastocyst survival and growth are not well 
investigated, but presumably are mediated by secretions from the endometrium. In sheep, 
P4 acts on the endometrium to induce a number of genes that encode for proteins 
secreted into the uterine lumen, including galectin 15 (LGALS15) and secreted 
phosphoprotein one (SPP1 or osteopontin) (Gray et al. 2004; Johnson et al. 2000).  
These proteins are hypothesized to regulate conceptus survival, growth, and adhesion 
during implantation (Johnson et al. 2003; Spencer et al. 2004a). 
This study tested the hypotheses that pre-implantation conceptus growth and 
survival in the ovine uterus can be stimulated by progesterone and involves increases in 
expression of specific endometrial genes.  The objectives were to determine effects of 
early progesterone on blastocyst growth and endometrial expression of secreted proteins. 
Results indicate that P4 stimulation of blastocyst growth is manifest after shedding the 
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zona pellucida and is associated with earlier expression of LGALS15 by endometrial 
epithelia.  
Materials and Methods 
Animals 
Mature Suffolk-type ewes (Ovis aries) were observed for onset of estrus (Day 0) 
in the presence of a vasectomized ram and used in experiments only after exhibiting at 
least two estrous cycles of normal duration (16–18 Days).  All experimental and surgical 
procedures were in compliance with the Guide for the Care and Use of Agriculture 
Animals in Research and Teaching and approved by the Institutional Animal Care and 
Use Committee of Texas A&M University. 
Experimental Design 
Study One At estrus, ewes (n = 5) were mated to intact Suffolk rams and 
received daily injections of 25 mg progesterone (P4) in corn oil (CO) vehicle from Days 
1.5 to 6.  On Day 6, the uterine lumen was flushed with 20 ml sterile saline and 
morphology of the blastocyst(s) examined by light microscopy. 
Study Two At estrus, ewes were mated to intact Suffolk rams and assigned 
randomly to receive daily i.m. injections from Days 1.5 to 9 of either corn oil vehicle 
(CO; n = 6) or 25 mg progesterone (P4; n = 6). All ewes were hysterectomized on Day 9.  
The uterine lumen was flushed with 20 ml sterile saline. If pregnant, the morphology of 
the blastocyst(s) was examined by light microscopy, fixed in 4% (wt/vol) 
paraformaldehyde in PBS (pH 7.2), and diameter measured and images recorded using a 
Nikon SMZ800 microscope with camera. 
At hysterectomy, sections (  0.5 cm) from the mid-portion of each uterine horn 
ipsilateral to the CL were fixed in fresh 4% paraformaldehyde. After 24 h, fixed tissues 
were changed to 70% (vol/vol) ethanol for 24 h, dehydrated through a graded series of 
alcohol to xylene, and then embedded in Paraplast-Plus (Oxford Labware, St. Louis, 
MO). The remaining endometrium was physically dissected from myometrium, frozen in 
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liquid nitrogen, and stored at –80°C for subsequent RNA or protein extraction. In 
monovulatory pregnant ewes, uterine tissue samples were marked as either contralateral 
or ipsilateral to the ovary bearing the CL. No tissues from the contralateral uterine horn 
were used for further analysis. 
Study Three At estrus (Day 0), ewes were mated to intact Suffolk rams and 
assigned randomly to receive daily intramuscular (i.m.) injections of either: (a) corn oil 
vehicle from Days 1.5 to 12 (CO, n = 8); (b) 25 mg progesterone (P4; Sigma Chemical 
Co., St. Louis, MO) from Days 1.5 to 12 (P4, n = 7); or (c) 25 mg progesterone (P4; 
Days 1.5 to 8, n = 5) and then P4 and 75 mg RU486 (Sigma), a progesterone receptor 
(PGR) antagonist, from Days 8 to 12 (P4+RU). Blood samples were collected daily from 
CO- and P4-treated ewes beginning on Day 0 via jugular venipuncture. All ewes were 
hysterectomized on Day 12, and the uterine lumen flushed with 20 ml sterile saline. If 
pregnant, the morphology of the blastocyst(s) was examined by light microscopy, fixed 
in 4% paraformaldehyde, and images of blastocysts captured using a Nikon SMZ800 
microscope with camera. The volume of the uterine flush was recorded, clarified by 
centrifugation (3000 g for 30 min at 4°C), aliquoted and frozen at –80°C.  The uteri were 
then processed as described for study 2. 
RNA Isolation 
Total cellular RNA was isolated from frozen ipsilateral endometrium of pregnant 
ewes only (Studies Two and Three) using Trizol reagent (Gibco-BRL, Bethesda, MD) 
according to manufacturer's recommendations. The quantity and quality of total RNA 
were determined by spectrometry and denaturing agarose gel electrophoresis, 
respectively. 
Slot Blot Hybridization Analysis 
Steady-state levels of LGALS15, CTSL, and RSAD2 mRNA in endometria were 
assessed by slot blot hybridization using methods described previously (Spencer et al. 
1999c). Briefly, radiolabeled antisense and sense cRNA probes were generated by in 
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vitro transcription using linearized plasmid templates containing partial cDNAs, RNA 
polymerases, and [ -32P]-UTP. Denatured total endometrial RNA (20 µg) from each ewe 
in Studies One and Two was hybridized with radiolabeled cRNA probes. To correct for 
variation in total RNA loading, a duplicate RNA slot blot membrane was hybridized with 
radiolabeled antisense 18S cRNA (pT718S; Ambion, Austin, TX). Following washing, 
the blots were digested with ribonuclease A and radioactivity associated with slots was 
quantified using a Typhoon 8600 MultiImager (Molecular Dynamics, Piscataway, NJ). 
Data are expressed as relative units (RU).   
In situ Hybridization Analysis 
Location of CTSL, RSAD2, LGALS15, SPP1 and SERPIN (ovine uterine serine 
proteinase inhibitor or uterine milk protein) mRNAs in the ovine uterus were determined 
by radioactive in situ hybridization analysis using methods described previously 
(Spencer et al. 1999c).  Radiolabeled antisense and sense cRNA probes were generated 
by in vitro transcription using linearized partial plasmid cDNA templates, RNA 
polymerases, and [ -35S]-UTP.  Deparaffinized, rehydrated, and deproteinated uterine 
tissue sections were hybridized with radiolabeled antisense or sense cRNA probes. After 
hybridization, washing and ribonuclease A digestion, slides were dipped in NTB-2 liquid 
photographic emulsion (Kodak, Rochester, NY), and exposed at 4°C for 5 Days.  Slides 
were developed in Kodak D-19 developer, counterstained with Gill's hematoxylin 
(Fisher Scientific, Fairlawn, NJ), and then dehydrated through a graded series of alcohol 
to xylene. Coverslips were then affixed with Permount (Fisher).  Images of 
representative fields were recorded under brightfield or darkfield illumination using a 
Nikon Eclipse 1000 photomicroscope (Nikon Instruments Inc., Lewisville, TX) fitted 
with a Nikon DXM1200 digital camera. 
Immunohistochemistry 
Immunocytochemical localization of PGR and LSGAL15 protein in the ovine 
uterus was performed using methods described previously (Dunphy et al. 2000; Gray et 
al. 2004).  PGR protein was detected using a primary mouse monoclonal antibody 
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against human PGR (MA1–411; Affinity Bioreagents, Golden, CO) at a final 
concentration of 0.25 µg/ml and a Vectastain ABC anti-mouse kit (Vector Laboratories, 
Inc., Burlingame, CA). LGALS15 protein was detected using rabbit anti-ovine galectin 
15 antibody (kindly provided by Dr. Els Meeusen, Australia) (Dunphy et al. 2000) at a 
final dilution of 1:10000 and a Vectastain ABC anti-rabbit kit. For both PGR and 
LGALS15, antigen retrieval was performed using boiling citrate buffer as described 
previously (Taylor et al. 2000). Negative controls included substitution of the primary 
antibody with mouse IgG (PGR) or rabbit IgG (LGALS15). Immunoreactive protein was 
visualized using diaminobenzidine tetrahydrochloride (Sigma) as the chromagen. 
Sections were dehydrated and coverslipped affixed with Permount. 
Western Blot Analyses 
Protein content of concentrated flushes was determined using a Bradford protein 
assay (Bio-Rad, Hercules, CA) with BSA as the standard. Uterine flush proteins (30 µg) 
were denatured and separated by 15% SDS-PAGE for both IFNT (Study 1) and 
LGALS15 (Studies 1 and 2).  Western blot analyses were conducted as described 
previously (Spencer et al. 1999a) using enhanced chemiluminescence detection. 
Immunoreactive IFNT was detected using primary rabbit anti-ovine IFNT serum at a 
1:5000 dilution. Rabbit anti-ovine IFNT serum was generated by immunizing rabbits 
with recombinant ovine IFNT (Van Heeke et al. 1996). 
Slot Blot Quantification of Proteins in Uterine Flushings 
Uterine flushings (30 µg for IFNT and 20 µg for LGALS15) were diluted to 200 
µl final volume with Tris buffered saline (TBS). Nitrocellulose membranes (Schleicher 
and Shuell), presoaked with TBS, were loaded into the slot blot apparatus backed by 
Whatman filter paper. The wells were subsequently washed with 200 µl TBS prior to 
addition of the diluted sample, and then washed again with 200 µl TBS. The membrane 
was allowed to air dry and then blocked in 5% (wt/vol) milk/TBS-tween (TBST) for 1 h 
at room temperature. The membrane was incubated in either primary rabbit anti-ovine 
IFNT serum at 1:1000 dilution (30 µg protein per slot) or rabbit anti-ovine LGALS15 
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serum (Dunphy et al. 2000) at 1:2500 dilution (20 µg protein per slot) in 2.5% 
milk/TBST overnight at 4°C. The blot was then washed for 30 min in TBST followed by 
incubation with goat anti-rabbit IgG horseradish peroxidase conjugate at 1:20000 diluted 
in 2.5% milk/TBST for 1 h at room temperature. The blot was washed again for 30 min 
in TBST and immunoreactive proteins were detected using enhanced 
chemiluminescence. Blots were imaged and quantified using a Typhoon 8600 Variable 
Mode Imager (Amersham Biosciences Corp., Piscataway, NJ). The total amounts of 
IFNT and LGALS15 protein were calculated based on the amount of uterine flush 
protein loaded into each well, the concentration of protein in the uterine flush, and the 
recovered volume of the uterine flush recorded at surgery. 
Radioimmunoassay 
Blood samples were allowed to clot for 1 h at room temperature. Serum was then 
collected following centrifugation (3000 x g for 30 min at 4°C) and stored at –20°C for 
hormone analysis. Concentrations of progesterone in serum were determined according 
to manufacturer's specifications using an antiserum highly specific for progesterone 
(DSL-3900 ACTIVE Progesterone Coated-Tube Radioimmunoassay Kit, Diagnostic 
Systems Laboratories, Webster, TX).  The RIA used rabbit anti-progesterone 
immunoglobulin coated tubes and iodinated progesterone. The primary anti-serum cross-
reacts 6.0%, 2.5%, 1.2%, 0.8%, 0.48%, and 0.1% with 5 -Pregnane-3,20-dione, 11-
Deoxycorticosterone, 17 -Hydroxyprogesterone, 5ß-Pregnane-3,20-dione, 11-
Deoxycortisol, and 20 -Dihydroprogesterone, respectively. The progesterone standard 
curve (1.0–190.8 nmol/L) was provided in the assay kit. The intra-assay variation was 
10.1%. Assay results were calculated using the AssayZap Version 3.1 program (Biosoft, 
Ferguson, CA). 
Photomicroscopy 
Photomicrographs of in situ hybridization and immunocytochemistry slides were 
taken using a Nikon Eclipse E1000 photomicroscope (Nikon Instruments, Melville, NY). 
Digital images were captured using a Nikon DXM 1200 digital camera and assembled 
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using Adobe Photoshop 7.0 (Adobe Systems, Seattle, WA). Images of embryos were 
captured using a Nikon SMZ800 microscope with camera. 
Statistical Analyses 
Data from radioimmunoassay, slot blot hybridization, and protein slot blot 
analyses were subjected to least-squares analysis of variance using the General Linear 
Models procedures of the Statistical Analysis System (SAS Institute, Cary, NC). Slot blot 
hybridization data were corrected for differences in sample loading by using the 18S 
rRNA data as a covariate. Protein slot blot data was corrected for differences in 
conceptus number by using them as a covariate. Data are presented as the least-squares 
means (LSM) with overall standard error (SEM).  
 
 
Results
Circulating Progesterone 
Circulating concentrations of progesterone in serum from jugular venous blood 
in Study 3 were determined by radioimmunoassay (Figure 3.1). Progesterone increased 
(linear, P < 0.01) after Day 3 and reached maximal levels by Day 11 in CO ewes. 
Exogenous treatment of ewes with P4 beginning at 36 h postmating increased 
concentrations of P4 in serum after Day 1, and they remained higher in P4 than CO ewes 
to Day 12 (P < 0.0001, Day x Treatment).  
Early Progesterone Enhances Blastocyst Development 
In all studies, ewes assigned to the early P4 treatment group received P4 
beginning 36 h postmating (Day 1.5). In Study 1, embryos recovered on Day 6 from P4 
ewes were morphologically classified as either morulae or blastocysts, with 4 of 5 
possessing an intact zona pellucida (data not shown). In Study 2, hatched blastocysts 
were recovered on Day 9 from both CO- and P4-treated ewes (Figure 2) and blastocyst 
diameters were 220% greater (P < 0.02) for those from P4- (636 ± 64 µm) compared to 
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CO- (282 ± 64 µm) treated ewes. In Study 3, blastocysts recovered from CO-treated 
ewes were spherical to slightly tubular in morphology on Day 12 (Figure 3.2), whereas 
those  recovered from P4-treated ewes were elongated and filamentous. No blastocysts 
were recovered from ewes receiving P4+RU treatment. Therefore, early P4 treatment 
enhanced blastocyst growth and development after hatching from the zona pellucida, but 
did not affect time of blastocyst hatching.
 
 
 
FIG. 3.1.  Concentrations of progesterone in serum of ewes treated daily with either corn 
oil (CO) vehicle or progesterone (P4) from 36 h post-mating to Day 12.  Concentrations 
of progesterone were higher in P4 than CO ewes after Day 1 (Day x treatment, P<0.01).  
Data are presented as LSM [ with overall SE – There is no information here on SEM, so 
you need to either put in SEM bars or just indicate that the graph is based on LSM]. 
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FIG. 3.2.  Effects of early exogenous progesterone treatment on blastocyst morphology 
on Days 9 and 12 of pregnancy.  In Study Two, ewes were treated daily with corn oil 
(CO) vehicle or progesterone (P4) from 36 h post-mating.  On Day 9, blastocyst 
diameter was greater (P<0.02) for ewes receiving P4 (636±64 µm) than CO (282±64 
µm).   In Study Three, ewes were treated daily with CO or P4 from 36 h post-mating to 
Day 12 or P4 from 36 h post-mating to Day 8 and then P4 and RU486 (P4+RU) from 
Days 8 to 12.  Elongated and filamentous conceptuses were recovered from P4-treated 
ewes, while only spherical to early tubular blastocysts were recovered from CO-treated 
ewes.  No blastocysts were recovered from P4+RU treated ewes.  The magnification bar 
represents 400 µm in the representative photomicrographs.  
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Immunolocalization of PGR Protein 
PGR protein was most abundant in endometrial LE and GE with lower levels in 
the stroma of Day 9 CO-treated ewes (Figure 3.3). For P4-treated ewes on Day 9 (Study 
2), PGR protein was markedly lower in the endometrial cells, particularly in the 
epithelia. In Day 12 CO-treated ewes (Study 3), PGR protein was either very low or not 
detectable in the nuclei of the endometrial LE. In P4-treated ewes, PGR abundance was 
markedly reduced as compared with CO ewes, particularly in the endometrial LE and 
GE. In P4+RU-treated ewes, PGR protein was higher in endometrial stroma and GE, but 
not different in the LE.  
 
FIG. 3.3.  Effects of corn oil (CO), progesterone (P4) or P4 and RU486 on expression of 
progesterone receptor (PGR) protein in endometria from Day 9 (Study Two) and Day 12 
(Study Three) ewes.  Immunoreactive PGR protein was detected using a mouse 
monoclonal antibody against human PGR.  For the IgG control, normal mouse IgG was 
substituted for the primary antibody.  Sections were not counterstained.  Legend: LE, 
luminal epithelium; GE, glandular epithelium; S, stroma.  All photomicrographs are 
shown at the same width of field (420 µm).    
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IFNT and IFNT-stimulated Genes 
As illustrated in Figure 3.4, immunoreactive IFNT (17 kDa) was detected in 
uterine flushings from all P4-treated ewes on Day 12, but was markedly lower or absent 
in uterine flushings from Day 12 CO ewes. IFNT was not detected in uterine flushings 
from either CO or P4 ewes on Day 9 (Study 2) or on Day 12 if ewes received P4+RU 
treatment (Study 3). As determined by protein slot blot analyses, relative total amounts 
of IFNT protein in uterine flushings from Day 12 ewes in Study 3 were approximately 
155-fold greater (P < 0.0002) in P4 (12,126 ± 2,763 relative units) compared with CO 
ewes (77 ± 10 relative units).  
Cathepsin L (CTSL) is expressed only in endometrial LE and superficial GE in 
response to both P4 and IFNT (Gray et al. 2006; Song et al. 2005). Endometrial CTSL 
mRNA levels were not different (P > 0.10) on Day 9 in Study 2. In Study 3, endometrial 
CTSL mRNA levels were about 2-fold higher (P < 0.05) in P4 than CO ewes and about 
4-fold higher in P4 than P4+RU ewes on Day 12 (Figure 3.5A). As expected, CTSL 
mRNA was detected only in the endometrial LE and superficial GE of uteri from CO and 
P4 ewes in both studies (Figure 5C).  
Radical S-adenosyl methionine domain containing 2 (RSAD2), also known as 
viperin, is an IFNT-stimulated gene (Gray et al. 2006). RSAD2 mRNA was not detected 
in endometria from Day 9 ewes in Study 3 (Figure 3.5C). Endometrial RSAD2 mRNA 
levels were about 9-fold higher (P < 0.05) in endometria of P4 versus CO- or P4- versus 
P4+RU-treated ewes on Day 12 in Study 3 (Figure 3.5B). In situ hybridization analysis 
localized RSAD2 mRNA primarily to the stratum compactum stroma of the endometrium 
in Day 12 P4-treated ewes (Figure 3.5C). Thus, IFNT-stimulated genes are only induced 
in the endometrium from P4-treated Day 12 ewes with an elongated and filamentous 
conceptus that secretes IFNT.  
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FIG. 3.4.  Western blot analysis of IFNT in uterine flushings from Day 12 ewes.  In 
Study One, ewes were treated daily with CO or P4 from 36 h post-mating to Day 12 or 
P4 from 36 h post-mating to Day 8 and then P4 and RU486 (P4+RU) from Days 8 to 12.  
Proteins in uterine flushings were analyzed by 15% SDS-PAGE (30 µg/lane) and 
western blot analysis using rabbit anti-ovine IFNT serum.  IFNT was detected in uterine 
flushings from all ewes treated with P4.  Representative results from 3 ewes per 
treatment are presented.   
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FIG. 3.5.  Effects of treatments with corn oil (CO), progesterone (P4) or P4 and RU486 
on endometrial CTSL and RSAD2 mRNA.  [A] Steady-state levels of CTSL mRNA in 
endometria from Day 9 (Study Two) and Day 12 (Study One) ewes, as determined by 
slot blot analysis, increased only in endometria of P4-treated ewes on Day 12 (*, P<0.05).  
[B] Steady-state levels of RSAD2 mRNA in the endometrium of Day 12 ewes (Study 
One) increased only in endometria from P4-treated ewes on Day 12 (*, P<0.05).  [C] In 
situ localization of CTSL and RSAD2 mRNAs in endometria of Day 9 (Study Two) and 
Day 12 ewes (Study One) are presented. Cross-sections of uteri were hybridized with 
radiolabeled antisense or sense ovine cRNA probes for each respective gene.  Legend: 
LE, luminal epithelium; S, stroma; sGE, superficial glandular epithelium.  All 
representative photomicrographs are shown at the same width of field (630 µm).   
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LGALS15, SPP1, and Uterine SERPIN 
LGALS15, SPP1, and SERPIN are P4-induced genes expressed in endometrial 
epithelia during early pregnancy (Gray et al. 2004; Ing et al. 1989; Johnson et al. 2000). 
In Study 2, steady-state levels of LGALS15 mRNA were about 3-fold higher (P < 0.01) 
in endometria of P4- compared with CO-treated ewes on Day 9 (Figure 3.6A). Similarly, 
endometrial LGALS15 mRNA levels were approximately 2-fold higher (P < 0.01) in P4- 
compared with CO-treated ewes on Day 12 in Study 3 (Figure 3.6A). Further, LGALS15 
mRNA was approximately 59-fold and 136-fold lower (P < 0.01) in endometria of 
P4+RU-treated ewes compared with ewes receiving CO or P4, respectively. As expected, 
LGALS15 mRNA was present in LE and superficial GE of endometrium from Day 9 P4 
and Day 12 CO and P4-treated ewes, but absent in endometria from Day 9 CO ewes and 
Day 12 ewes that received P4+RU treatment (Figure 3.6B). The melanocytes present in 
the sub-epithelial stroma of Day 12 CO ewes were not positive for LGALS15 mRNA, but 
rather diffract light and appeared white under darkfield conditions. 
LGALS15 protein was localized predominantly to endometrial LE and superficial 
GE in uteri from Day 9 and Day 12 ewes (Figure 3.7A). In Day 9 ewes (Study 2), 
LGALS15 protein was more abundant at the apical surface of the endometrial LE in P4- 
compared with CO-treated ewes (denoted by arrowhead). LGALS15 protein was 
abundant in endometrial LE and superficial GE of uteri from Day 12 in CO- and P4-
treated ewes (Study 2). LGALS15 protein was also detected in LE and superficial GE of 
endometria from Day 12 P4+RU-treated ewes, but the immunoreactive protein was 
concentrated more toward the apical surface of the epithelia rather than uniformly 
distributed throughout the epithelia as in Day 12 CO- and P4-treated ewes.  The relative 
amount of LGALS15 protein in uterine flushings was determined in both studies. For 
Day 9 ewes, total LGALS15 protein in uterine flushings was not different (P > 0.10) in 
P4- compared with CO-treated ewes (Figure 3.7B); however, LGALS15 protein tended 
(P = 0.06) to be more abundant in uterine flushings from P4- compared with CO-treated 
ewes on Day 12 as well as in uterine flushings from ewes receiving P4 compared with 
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ewes treated with P4+RU (Figure 3.7C).   SPP1 (osteopontin) and SERPIN mRNAs were 
not detected in endometria of any ewes in either Study 1 or Study 2 (data not shown).  
 
  
FIG. 3.6. Effects of treatments with corn oil (CO), progesterone (P4) or P4 and RU486 
on endometrial LGALS15 mRNA. [A] Steady-state levels of LGALS15 mRNA in 
endometria from ewes on Day 9 (Study Two) and Day 12 (Study One), determined by 
slot blot analyses, indicated increased expression in endometria of P4-treated ewes on 
Days 9 and 12 (*, P<0.01) and lower (P<0.001) expression in endometria of P4+RU-
treated ewes compared to P4- or CO-treated ewes  [B] In situ localization of LGALS15 
mRNA in endometria from Day 9 (Study Two) and Day 12 ewes (Study One).  Cross-
sections of uteri were hybridized with radiolabeled antisense or sense ovine cRNA 
probes for LGALS15.  Legend: LE, luminal epithelium; S, stroma; sGE, superficial 
glandular epithelium.  The black melanocytes in the stratum compactum of Day 12 
endometria do not express LGALS15 mRNA, but appear white in a darkfield 
photomicrograph.  All representative photomicrographs are shown at the same width of 
field (420 µm). 
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FIG. 3.7.  Effects of treatment of ewes with corn oil (CO), progesesterone (P4) or P4 and 
RU486 on endometrial LGALS15 protein in the uterus.  [A] Immunolocalization of 
LGALS15 protein in endometria from Day 9 (Study Two) and Day 12 (Study Three) 
ewes revealed an increase in apical distribution in the luminal epithelium (LE) of P4-
treated ewes from Day 9 (denoted by arrowhead).  For the IgG control, normal rabbit 
IgG was substituted for the primary antibody.  Representative photomicrographs are 
shown at the same width of field (420 µm) with the exception of the higher 
magnification (210 µm width of field) images of Day 9 CO and P4 endometrial LE 
(upper righthand corner).  Sections were not counterstained.  Legend: LE, luminal 
epithelium; sGE, superficial ductal glandular epithelium; S, stroma.  [B] Total amounts 
of LGALS15 protein in uterine flushings from Day 9 ewes (Study Two) were not 
different between CO and P4-treated ewes.  [C] LGALS15 protein, in relative units (RU) 
with overall SE, in uterine flushings from Day 12 ewes (Study Three) tended to be 
higher (P<0.06) for ewes treated with P4 or P4+RU compared to CO. 
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Discussion 
Advancement of development of conceptuses at varying time points by 
administration of early exogenous progesterone has been described for both cattle 
(Garrett et al. 1988b; Mann et al. 2006) and sheep (Kleemann et al. 2001; Kleemann et 
al. 1994). In the present study, early exogenous P4 treatment accelerated growth of 
hatched blastocysts as evidenced by increased blastocyst diameter on Day 9 and the 
presence of elongated and filamentous conceptuses on Day 12 in uteri from P4-treated 
ewes. Indeed, blockade of P4 actions by administration of RU486 from Days 8 to 12 
resulted in loss of all embryos. These results indicate an unequivocal requirement for P4 
actions for maintenance of pregnancy in sheep, as in other mammals. Importantly, 
hatching of the blastocyst from the zona pellucida was not accelerated by early 
exogenous P4 and it did not prevent transport of embryos from the oviduct into the 
uterus. Therefore, early P4 effects are manifest after hatching of the blastocyst from the 
zona pellucida, which normally occurs on Day 8 (Spencer et al. 2004a). Thus, the zona 
pellucida may act as a barrier to embryotrophic factors in uterine histotroph, and 
hatching is required for them to either gain access to the blastocyst or for the blastocyst 
to respond in terms of blastocyst expansion on Day 9 or early transition from spherical to 
filamentous conceptuses by Day 12.   
Advancement of blastocyst growth coincided with functional development in the 
present study, because blastocysts from early P4-treated ewes secreted greater quantities 
of IFNT on Day 12 than blastocysts recovered from CO-treated ewes. In fact, IFNT 
production by the blastocyst is developmentally regulated and affected by uterine factors 
(Farin et al. 1990; Robinson et al. 2006). Further evidence for effects of IFNT was 
induction of RSAD2 in the stroma and increased CTSL and LGALS15 in LE and sGE of 
endometria of P4-treated ewes on Day 12.  CTSL, LGALS15, and RSAD2 are IFNT-
stimulated genes in the ovine uterus (Gray et al. 2006; Gray et al. 2004; Song et al. 
2005). Thus, timely communication between maternal endometrium and conceptus 
development allowed maintenance of synchrony and establishment of pregnancy in the 
present study. Since early exposure of the uterus to P4 accelerates development of the 
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luteolytic mechanism, it is essential that P4 stimulate development of the conceptus so 
that it secretes sufficient quantities of IFNT to abrogate development of the luteolytic 
mechanism (Spencer and Bazer 2004; Spencer et al. 2004a). In dairy cattle, an early 
increase in circulating concentrations of P4 was highly correlated with increased 
production of IFNT by the conceptus as well as decreased quantities of circulating 
prostaglandin metabolite, suggesting that the luteolytic mechanism is inhibited by 
advanced blastocysts (Mann et al. 2006; Mann and Lamming 2001).  
Our working hypothesis is that the stimulatory effects of P4 on blastocyst 
survival and growth are mediated by specific effects of P4 on the endometrium. During 
the pre-implantation period, P4 is essential for blastocyst survival and acts through 
receptors present in all endometrial cell types. Continuous exposure of the endometrium 
to P4 for 8 to 10 days down-regulates PGR expression in endometrial epithelia (Spencer 
et al. 1995b), so that PGR protein is not detectable in endometrial LE and GE in ewes 
after Days 11 and 13 of pregnancy, respectively (Spencer and Bazer 1995; Wathes and 
Hamon 1993). The paradigm of loss of PGR in uterine epithelia immediately before 
implantation is common across mammals (Carson et al. 2000; Spencer et al. 2004b). 
Thus, several genes induced by P4 in LE and superficial GE are implicated in conceptus 
implantation, including LGALS15, CST3, and CTSL, and, in GE, expression of genes 
including SPP1, SERPINs, and STC1 requires loss of epithelial cell PGR (Gray et al. 
2006; Gray et al. 2004; Johnson et al. 2000; Song et al. 2006a; Song et al. 2005; Song et 
al. 2006b; Spencer et al. 1999b). Loss of epithelial PGR may reprogram patterns of gene 
expression in the endometrial epithelia. 
One of the most abundant P4-regulated genes in sheep uteri is LGALS15 (Gray et 
al. 2004; Gray et al. 2005). Galectin proteins have a conserved carbohydrate recognition 
domain that binds beta-galactosides, thereby cross-linking glycoproteins as well as 
glycolipid receptors on the surface of cells and initiating biologic responses that include 
cell adhesion, growth, and differentiation (Cooper 2002; Yang and Liu 2003). In cyclic 
and pregnant ewes, induction of LGALS15 mRNA occurs between Days 10 and 12 in 
endometrial LE and superficial GE (Gray et al. 2004), which is associated with the 
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decline and loss of PGR from those epithelia (Spencer and Bazer 1995; Wathes and 
Hamon 1993). Further, P4 induction of LGALS15 mRNA in endometrial LE and 
superficial GE is inhibited by a PGR antagonist (Gray et al. 2006; Gray et al. 2004). Of 
particular importance, LGALS15 is a novel gene expressed only by LE and superficial 
GE in response to intrauterine infusions of IFNT in progestinized ewes (Gray et al. 2006; 
Gray et al. 2004). In the present study, LGALS15 mRNA was induced by early 
exogenous P4 in Study 2 (Day 9) and stimulated by IFNT in Sstudy 3 (Day 12). Further, 
administration of RU486, a PGR antagonist, ablated LGALS15 mRNA expression in 
endometrial epithelia which supports evidence that LGALS15 is induced by P4 (via 
down-regulation of the PGR) and further stimulated by IFNT from the developing 
conceptus.  
In the present study, LGALS15 protein was higher at the apical surface of 
endometrial LE of P4-treated ewes on Day 9 and tended to be more abundant in uterine 
flushings from P4-treated ewes on Day 12. Although secreted LGALS15 protein was not 
greater in the uterine flush from P4 ewes on Day 9, it was more concentrated near the 
apical surface of the LE of endometria.  It is likely that a factor from the conceptus 
during trophoblast outgrowth and elongation stimulates the secretion of proteins, such as 
LGALS15, from the endometrial epithelia. Nonetheless, stimulation of blastocyst growth 
and development in response to early exogenous P4 treatment was strongly associated 
with increases in endometrial LGALS15 mRNA in Studies 2 and 3 and LGALS15 
protein in uterine flushes in Study 3 (Day 12). Available results indicate that LGALS15 
protein is synthesized and secreted by endometrial LE and superficial GE into the uterine 
lumen, where it is absorbed by conceptus trophectoderm (Gray et al. 2004). Indeed, 
LGALS15 protein is detectable on the surface of the trophectoderm and within 
crystalline structures found inside the trophectoderm (Gray et al. 2004; Gray et al. 2005). 
Thus, the amount of LGALS15 protein present in the uterine lumen of Day 12 P4-treated 
ewes may have been greater than for CO ewes, except that the elongated and filamentous 
conceptuses from P4-treated ewes may have imbibed more of the secreted protein. In 
P4+RU-treated ewes, LGALS15 mRNA was not present in the endometrium, but 
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LGALS15 protein was detected in endometrial LE and abundant in uterine flushings. 
The crystalline nature of LGALS15 protein may be responsible for low levels of 
immunoreactive protein in LE which do not express LGALS15. Further, LGALS15 is a 
secreted lectin that presumably binds glycoconjugates that are part of the extracellular 
matrix and rather stable, potentially accounting for the low levels of LGALS15 protein 
observed in cells not expressing the gene. SPP1 and uterine SERPIN are well-
characterized progesterone-induced genes that appear specifically in the endometrial 
glands between Days 14 to 16 (SPP1) and 16 to 18 (SERPIN) of pregnancy (Johnson et 
al. 2003; Stewart et al. 2000). These genes were not responsible for effects of 
progesterone on pre-implantation blastocyst growth and development, because SPP1 and 
uterine SERPIN mRNAs were not detected in endometria from any ewes in the present 
studies.  
Collectively, these results illustrate that rate of development of blastocysts in 
utero is stimulated by actions of P4 on the uterus and support the hypothesis that P4 acts 
on the endometrium to down-regulate expression of PGR in epithelia and to induce 
expression of specific genes that encode secreted proteins, such as LGALS15, that 
stimulate blastocyst growth and development. Indeed, a large number of undefined 
components of histotroph, including other secreted proteins, amino acids, sugars and 
ions, may also be regulated by progesterone during the peri-implantation period of 
pregnancy to stimulate conceptus growth and development (Bazer 1975; Martin et al. 
2003). Results of the present study allow further development of the ovine model in 
which early exogenous P4 treatment advances conceptus development to allow it to 
maintain synchrony with the endometrium, as evidenced by advanced onset of IFNT 
production by the conceptus and induction of IFNT-stimulated genes in the endometrium 
that are hypothesized to be required for conceptus implantation and establishment and 
maintenance of pregnancy. Future studies will use genomic and proteomic approaches to 
identify the mechanisms by which progesterone acts on the endometrium to enhance 
blastocyst survival and growth after hatching from the zona pellucida. 
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CHAPTER IV 
TIGHT AND ADHERENS JUNCTIONS IN THE OVINE UTERUS: 
DIFFERENTIAL REGULATION BY PREGNANCY AND PROGESTERONE* 
Introduction 
Establishment and maintenance of pregnancy in mammals involves dynamic 
changes in the uterine epithelia that are regulated by steroid hormones, cytokines, and 
growth factors. These changes establish receptivity of the uterine luminal epithelium 
(LE) to the developing embryo, differentiated functions of glandular epithelium (GE) 
required for subsequent secretion of uterine histotroph, and protection of the developing 
semiallogeneic conceptus (embryo/fetus and associated extra-embryonic membranes) 
from the maternal immune system (Burghardt et al. 2002; Carson et al. 2000; Johnson et 
al. 2001a; Kirby et al. 1964; Muggleton-Harris and Johnson 1976; Spencer et al. 2004a). 
In domestic animals, the implantation cascade is characterized by preattachment 
elongation of the blastocyst followed by apposition, adhesion, and attachment of the 
trophectoderm to the LE (Guillomot et al. 1993). Uterine-dependent conceptus 
elongation ensues in response to cues from the endometrial LE and GE in the form of 
histotroph (Gray et al. 2001c) and possibly through stromal and serum-derived factors 
that bypass the epithelia via trafficking through the paracellular space into the uterine 
lumen to act directly on the conceptus.  
Regulation of epithelial organization, structure, and subsequent function is 
modulated by two forms of junctional complexes, tight junctions, and adherens 
junctions. Tight junctions are located on the plasma membrane and facilitate cellular 
polarity, cell-cell contact, and adhesion. Tight junctions function as barriers that regulate 
the passage of ions, water, and molecules through the paracellular space. In addition, 
tight junctions maintain the proper distribution of proteins and lipids within domains of  
________ 
*Reprinted with permission from: Satterfield MC. et al., Tight and Adherens Junctions 
in the Ovine Uterus: Differential Regulation by Pregnancy and Progesterone.  
Endocrinology, 2007 Aug;148(8) 3922-31.  Copyright 2007, The Endocrine Society.                                    
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the plasma membrane (Gonzalez-Mariscal et al. 2003). A growing class of proteins is 
classified into one of three families of molecules known to be associated with the 
formation of tight junctions. These proteins are: junctional adhesion molecules, 
occludins (OCLN), and claudins (CLDNs).  Transepithelial paracellular permeability 
can be regulated by both OCLN and CLDNs (Tsukita et al. 2001). Zona occludens 
contain members of a submembranous class of proteins [tight junction proteins (TJP)] 
that bind both CLDNs and OCLN (Wittchen et al. 1999) and function as a scaffold to 
bring structurally diverse proteins into close proximity at tight junctions (Gonzalez-
Mariscal et al. 2000a). The amount of OCLN and TJP1 protein present in a tissue is 
related inversely to the permeability of that tissue (Gonzalez-Mariscal et al. 2000b). 
Regulation of tight-junction-dependent transepithelial paracellular permeability is 
mediated by multiple factors including calcium (Gonzalez-Mariscal et al. 1985; 
Gonzalez-Mariscal et al. 1990), growth factors, kinases, and second messengers (Balda 
et al. 1991), as well as hormones including progesterone (P4), prolactin, and placental 
lactogen (Nguyen et al. 2001).  
Adherens junctions formed by classical cadherin/catenin complexes mediate 
epithelial organization and function. E-cadherins (CDH1) facilitate cell to cell adhesion 
within epithelia through homodimeric attachment to other CDH1 molecules on adjacent 
cells. These cadherins are first bound by intracytoplasmic ß-catenin (CTNNB1) (McCrea 
and Gumbiner 1991; McCrea et al. 1991). -Catenin (CTNNA1) is subsequently 
recruited to the complex (Aberle et al. 1994) and binds to the actin cytoskeleton to 
facilitate cellular organization and shape (Rimm et al. 1995). Stable cell to cell adhesion 
is mediated by the phosphorylation state of CTNNB1 (for review see Ref. (Lilien and 
Balsamo 2005)). Homodimeric CDH1 interactions as well as other cell adhesion 
molecules have also been implicated in the relative invasive capabilities of tumors (for 
review see Refs. (Cowin et al. 2005; Okegawa et al. 2002). During establishment of 
pregnancy, CDH1 and CTNNB1 may be important for maintaining the LE in a receptive 
state for implantation and blastocyst trophectoderm integrity during its rapid elongation 
to form a filamentous conceptus.  Our working hypotheses are that dynamic changes 
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occur in assembly of tight junctions and adherens junctions in the ovine endometrium 
during the peri-implantation period of pregnancy to change paracellular permeability, 
and that assembly of these junctional complexes is regulated by hormones of pregnancy. 
As a first step in testing this hypothesis, we determined effects of pregnancy and P4 on 
tight junction and adherens junction components in the ovine uterine endometrium. 
 
Materials and Methods 
Animals 
Mature ewes (Ovis aries) were observed for estrus (designated as Day 0) in the presence 
of a vasectomized ram and used in experiments only after exhibiting at least two estrous 
cycles of normal duration (16–18 Day). All experimental and surgical procedures were in 
compliance with the Guide for the Care and Use of Agriculture Animals in Research and 
Teaching and approved by the Institutional Animal Care and Use Committee of Texas 
A&M University.  
 
Experimental Design 
Study One  At estrus (Day 0), ewes were mated to either an intact or 
vasectomized ram as described previously (Spencer et al. 1999a) and then 
hysterectomized (n = 5 ewes/Day) on either Day 10, 12, 14, or 16 of the estrous cycle or 
Day 10, 12, 14, 16, 18, or 20 of pregnancy. Pregnancy was confirmed on Day 10–16 
after mating by the presence of a morphologically normal conceptus in the uterus. At 
hysterectomy, several sections ( 0.5 cm) from the midportion of each uterine horn 
ipsilateral to the corpus luteum were fixed in fresh 4% paraformaldehyde in PBS (pH 
7.2). After 24 h, fixed tissues were changed to 70% ethanol for 24 h and then dehydrated 
and embedded in Paraplast-Plus (Oxford Labware, St. Louis, MO). Several sections (1–
1.5 cm) from the middle of each uterine horn were embedded in Tissue-Tek OCT 
compound (Miles, Oneonta, NY), frozen in liquid nitrogen vapor, and stored at –80ºC. 
The remaining endometrium was physically dissected from myometrium, frozen in 
liquid nitrogen, and stored at –80ºC for subsequent RNA or protein extraction. In 
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monovulatory pregnant ewes, uterine tissue samples were marked as either contralateral 
or ipsilateral to the ovary bearing the corpus luteum. No tissues from the contralateral 
uterine horn were used in this study.  
 
Study Two  At estrus (Day 0), ewes were mated to intact rams and then assigned 
randomly to receive daily im injections from Days 1.5 to 9 of  either: 1) corn oil vehicle 
(CO; n = 6) or 2) 25 mg P4 (Sigma Chemical Co., St. Louis, MO; n = 6) in CO vehicle 
as described previously (Satterfield et al. 2006). All ewes were hysterectomized on Day 
9. Uteri were processed as described in Study 1.  
 
Study Three  At estrus (Day 0), ewes were mated to intact rams as described 
previously (Satterfield et al. 2006) and then assigned randomly to receive daily 
intramuscular (im) injections of either: 1) CO vehicle from Days 1.5 to 12 (CO, n = 8); 
2) 25 mg P4 (Sigma Chemical Co.) from Days 1.5 to 12 (P4, n = 7); or 3) 25 mg P4 
(Days 1.5 to 8, n = 5) followed by 75 mg RU486 (Sigma Chemical Co.), a P4 receptor 
antagonist, from Days 8 to 12 (P4 + RU). All ewes were hysterectomized on Day 12, and 
uteri were processed as described for Study 1. 
 
Immunohistochemistry  
Immunohistochemical localization of immunoreactive proteins in the ovine uteri 
were performed as described previously (Spencer et al. 1999c). Rabbit antibodies against 
tight-junction-associated proteins were purchased from Zymed Laboratories (San 
Francisco, CA) including: CLDN1 (no. 51–9000) used at a final concentration of 2.5 
µg/ml, CLDN2 (no. 51–6100) used at a final concentration of 1 µg/ml, CLDN3 (no. 34–
1700) used at 0.1 µg/ml, CLDN4 (no. 36–4800) used at 1 µg/ml, OCLN (no. 71–1500) 
used at 1 µg/ml, and TJP2 (no. 71–1400) used at 1 µg/ml. A Vectastain ABC antirabbit 
kit was used for detection of the aforementioned proteins after antigen retrieval with 
boiling citrate buffer as described previously (Taylor et al. 2000). Negative controls 
included substitution of the primary antibody with rabbit IgG at the same concentration. 
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Immunoreactive CTNNB1 protein was detected using an anti-ß-catenin (610153) 
antibody (BD Biosciences) at a final dilution of 1:250. Mouse IgG was substituted for 
the primary antibody as a negative control. A Vectastain ABC antimouse kit was used 
for detection of CTNNB1 protein after antigen retrieval with boiling citrate buffer. 
Immunoreactive proteins were visualized using diaminobenzidine tetrahydrochloride 
(Sigma Chemical Co.) as the chromagen. Sections were subsequently dehydrated and 
coverslips were affixed with Permount.  
Immunofluorescence Analyses 
Frozen sections (8 µm) of uteri embedded in OCT compound were cut with a 
cryostat and mounted on Superfrost/Plus microscope slides (Fisher Scientific, Pittsburgh, 
PA). Using methods described previously (Choi et al. 2001; Johnson et al. 2001b), 
sections were fixed in –20ºC methanol, permeabilized with 0.3% Tween 20 in 0.02 M 
PBS, blocked in antibody dilution buffer (two parts 0.02 M PBS, 1.0% BSA, and 0.3% 
Tween 20, and one part glycerol) containing 10% normal goat serum, and incubated 
overnight at 4ºC with anti-E-cadherin (CDH1) rabbit antiserum (no. 07-697; Upstate Cell 
Signaling Solutions, Lake Placid, NY) at a dilution of 1:350 or nonimmune rabbit serum 
at the same concentration. Immunoreactive protein was detected using a fluorescein-
conjugated goat antirabbit IgG (Molecular Probes, Eugene, OR). Sections were then 
rinsed and overlaid with a coverslip and Prolong Antifade mounting reagent (Molecular 
Probes).  
RNA Isolation 
Total cellular RNA was isolated from frozen endometrium from the uterine horn 
ipsilateral to the corpus luteum (Studies 2 and 3) using TRIzol reagent (Life 
Technologies, Inc., Bethesda, MD) according to the manufacturer’s recommendations. 
The quantity and quality of total RNA was determined by spectrometry and denaturing 
agarose gel electrophoresis, respectively.  
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Slot Blot Hybridization Analysis 
Steady-state levels of CDH1 and CTNNB1 mRNA in endometria were assessed 
by slot blot hybridization as described previously (Spencer et al. 1999c). Briefly, 
radiolabeled antisense cRNA probes were generated by in vitro transcription using 
linearized plasmid templates containing partial cDNAs, RNA polymerases, and [ -
32P]UTP. Denatured total endometrial RNA (20 µg) from each ewe in Studies 2 and 3 
was hybridized with radiolabeled cRNA probes. To correct for variation in total RNA 
loading, a duplicate RNA slot blot membrane was hybridized with radiolabeled antisense 
18S cRNA (pT718S; Ambion, Austin, TX). After washing, the blots were digested with 
ribonuclease A, and radioactivity associated with slots was quantified using a Typhoon 
8600 MultiImager (Molecular Dynamics, Piscataway, NJ). Data are expressed as relative 
units.  
In Situ Hybridization Analysis 
Location of CDH1 and CTNNB1 mRNAs in the ovine uterus was determined by 
radioactive in situ hybridization analysis as described previously (Spencer et al. 1999c). 
Radiolabeled antisense and sense cRNA probes were generated by in vitro transcription 
using linearized partial plasmid cDNA templates, RNA polymerases, and [ -35S]UTP. 
Deparaffinized, rehydrated, and deproteinated uterine tissue sections were hybridized 
with radiolabeled antisense or sense cRNA probes. After hybridization, washing, and 
ribonuclease A digestion, slides were dipped in NTB-2 liquid photographic emulsion 
(Kodak, Rochester, NY), and exposed at 4ºC for 10 Day. Slides were developed in 
Kodak D-19 developer, counterstained with Gill’s hematoxylin (Fisher Scientific, 
Pittsburgh, PA), and then dehydrated through a graded series of alcohol to xylene. 
Coverslips were then affixed with Permount (Fisher Scientific).  
Photomicroscopy 
Photomicrographs of in situ hybridization and immunocytochemistry slides were 
taken using a Nikon Eclipse E1000 photomicroscope (Nikon Instruments, Melville, NY). 
Digital images were captured using a Nikon DXM 1200 digital camera with ACT-1 
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software and assembled using Adobe Photoshop 7.0 (Adobe Systems, Seattle, WA). 
Fluorescence images of representative fields were recorded using a Zeiss Axioplan2 
microscope (Carl Zeiss, Thornwood, NY) with a Axiocam HR digital camera and 
Axiovision 4.3 software and assembled as previously described (Johnson et al. 1999a).  
Statistical Analyses  
Data from slot blot hybridization analyses were subjected to least-squares 
ANOVA using the General Linear Models procedures of the Statistical Analysis System 
(SAS Institute, Cary, NC). Slot blot hybridization data were corrected for differences in 
sample loading by using the 18S rRNA data as a covariate. Data are presented as the 
least-squares means with overall SE.  
Results 
Tight-Junction-Associated Proteins in Ovine Endometrium (study 1) 
Immunoreactive TJP2 and OCLN proteins were abundant in endometrial LE and 
GE on Day 10 of the cycle and pregnancy (Figure 4.1). In both cyclic and pregnant ewes, 
TJP2 and OCLN proteins were markedly decreased in the LE on Day 12. In cyclic ewes, 
TJP2 and OCLN protein remained low in LE and GE on Day 14 and then increased on 
Day 16; however, in pregnant ewes, TJP2 and OCLN proteins increased in both LE and 
GE on Day 14 and remained abundant in those epithelia on Day 16. Immunoreactive 
TJP2 and OCLN proteins were also observed in the conceptus trophectoderm from Day 
18 and 20 pregnant ewes. 
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FIG. 4.1.  Immunolocalization of TJP2 and OCLN proteins in the ovine endometrium 
during the estrous cycle and pregnancy (Study One).  Immunoreactive proteins were 
detected using specific rabbit polyclonal antibodies against the respective proteins.   For 
the IgG control, normal rabbit IgG was substituted for the primary antibody.  Sections 
were not counterstained.  Sections in lower panels are from areas of upper panels shown 
at higher magnification.  Legend: LE, luminal epithelium; GE, glandular epithelium; S, 
stroma; Tr, trophectoderm.  Bar = 10 µm. 
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Temporal and spatial alterations in the CLDN proteins were detected in uteri of 
cyclic and pregnant ewes (Figure 4.2). In cyclic ewes, immunoreactive CLDN1 protein 
decreased in the LE from Days 10 to 14 of the cycle and then increased on Day 16. 
There was also a decrease in CLDN1 protein in the LE between Days 10 to 12 of 
pregnancy, but CLDN1 protein was more abundant in the LE beginning on Days 14 to 
18 and there was a marked increase in CLDN1 protein in both LE and GE on Day 20 of 
pregnancy. CLDN1 protein was also detected in the trophectoderm of conceptuses on 
both Days 18 and 20 of pregnancy.  
The patterns of change in abundance of CLDN2, CLDN3, and CLDN4 proteins 
were similar in uteri of cyclic and pregnant ewes (Figure 4.2). The abundance of these 
proteins in LE and GE decreased between Day 10–12 in both cyclic and pregnant ewes. 
The remainder of the estrous cycle was characterized by low levels of CLDN2, CLDN3, 
and CLDN4 proteins on Day 14 followed by an increase on Day 16. However, in 
pregnant ewes, there was an increase in abundance of CLDN2, CLDN3, and CLDN4 
proteins on both Days 14 and 16. A more punctate expression pattern for these proteins 
was observed on Days 18 and 20 of pregnancy for CLDN2 and CLDN4 while CLDN3 
protein abundance increased throughout the LE and GE. CLDN2, CLDN3, and CLDN4 
proteins were detected in trophectoderm of conceptuses on both Days 18 and 20 of 
pregnancy. For all of the proteins analyzed in this study, no differences were detected in 
their abundance in LE of either intercaruncular or caruncular endometrium.   
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FIG. 4.2.  Immunolocalization of CLDN1, CLDN2, CLDN3, and CLDN4 proteins in 
ovine endometria during the estrous cycle and pregnancy (Study One).  Immunoreactive 
proteins were detected using specific rabbit polyclonal antibodies against the respective 
proteins.  For the IgG control, normal rabbit IgG was substituted for the primary 
antibody.  Sections were not counterstained. Sections in lower panels are from areas of 
upper panels shown at higher magnification. Legend: LE, luminal epithelium; GE, 
glandular epithelium; S, stroma; Tr, trophectoderm.  Bar = 10 µm. 
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CDH1 and CTNNB1 mRNA (study 1) 
CDH1 mRNA was localized to LE and GE of the ovine endometrium and was 
abundant on Day 10 of the estrous cycle and pregnancy (Figure 4.3). In both cyclic and 
pregnant ewes, CDH1 mRNA declined between Days 10 and 14 and then increased 
between Days 14 and 16 of pregnancy. Abundant CDH1 mRNA remained in 
endometrial LE and GE, as well as trophectoderm of conceptuses on Days 18 and 20 of 
pregnancy.  
Temporal and spatial changes in CTNNB1 mRNA were also detected in ovine 
uteri throughout the estrous cycle and early pregnancy (Figure 4.3).  CTNNB1 mRNA 
was abundant in LE, GE, and stroma on Day 10 of the estrous cycle.  A similar pattern 
was observed on Day 10 of pregnancy, but mRNA levels were lower in all cell types. By 
Day 12 of the cycle and pregnancy, less CTNNB1 mRNA was detected in GE and 
stratum compactum stroma and, to a lesser extent, in LE. CTNNB1 mRNAs then 
increased in LE and GE on Day 14 of both the cycle and pregnancy.  In cyclic ewes, 
there was a marked decline in CTNNB1 mRNA on Day 16 in both the LE and GE.  In 
contrast, CTNNB1 mRNA was abundant in uterine LE and GE of ewes between Days 16 
and 20 of pregnancy, as well as in trophectoderm of the conceptus on Days 18 and 20 of 
pregnancy.  For all of the mRNAs and proteins analyzed in this study, there were no 
differences in their abundance in LE of intercaruncular or caruncular endometria.  
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FIG. 4.3.  In situ localization of CDH1 and CTNNB1 mRNAs in ovine endometria 
during the estrous cycle and pregnancy (Study One).  Cross-sections of uteri were 
hybridized with radiolabeled antisense or sense ovine cRNA probes for each respective 
gene.  The left panel is brightfield photomicrographs, and the right panel is darkfeld 
photomicrographs.  Legend: LE, luminal epithelium; GE, glandular epithelium; S, 
stroma; Tr, trophectoderm.  Bar = 10 µm. 
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CDH1 and CTNNB1 Protein (study 1) 
Overall, levels of CDH1 protein in the endometrium paralleled changes in CDH1 
mRNA in both cyclic and pregnant ewes (Figure 4.4).  Immunoreactive CDH1 protein 
was particularly abundant in the endometrial GE of both cyclic and pregnant ewes and 
was located primarily at the apical region of epithelial cells. In cyclic ewes, CDH1 
protein decreased in abundance from Days 10 to 14 and then increased to Day 16.  
Indeed, immunoreactive CDH1 protein was not detectable in the LE of Day 14 cyclic 
ewes. In pregnant ewes, CDH1 protein in the LE also decreased after Day 10, was almost 
undetectable on Days 14 and 16, and then increased on Day 18. Some LE in uteri of 
Days 18 and 20 pregnant ewes was not present due to assimilation of LE by trophoblast 
giant binucleate cells of the conceptus, which begin to differentiate on Days 14 to 15 of 
pregnancy.  
Immunoreactive CTNNB1 protein was evaluated during the estrous cycle and 
early pregnancy by immunohistochemistry (Figure 4.4).  On Day 10 of the cycle or 
pregnancy, CTNNB1 protein was localized predominantly in LE and GE. By Day 12 of 
both the cycle and pregnancy, there was a marked reduction in CTNNB1 protein, 
particularly in the LE and to a lesser extent in the GE.  The pattern was maintained 
through Day 14; however, abundant CTNNB1 protein was detected in LE and GE on 
Day 16 of the estrous cycle. In uteri from Day 16 pregnant ewes, CTNNB1 protein 
increased in the GE and to a lesser and more varied extent in the LE.  By Day 18 of 
pregnancy, more abundant levels of CTNNB1 protein were detected in endometrial GE 
and LE.  Both mononuclear and binucleate cells of conceptus trophectoderm contained 
high levels of CTNNB1 protein on Days 18 and 20 of pregnancy. In particular, nuclear 
CTNNB1 protein was present in trophoblast giant binucleate cells (data not shown).  For 
all proteins analyzed in this study, no differences were observed in their abundance in the 
LE of intercaruncular and caruncular endometria.  
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FIG. 4.4. Immunolocalization of CDH1 and CTNNB1 proteins in ovine endometria 
during the estrous cycle and pregnancy (Study One).  Immunoreactive proteins were 
detected using specific rabbit polyclonal antibodies against the respective proteins.   For 
the IgG control, normal rabbit IgG was substituted for the primary antibody.  Sections 
were not counterstained.  Legend: LE, luminal epithelium; GE, glandular epithelium; S, 
stroma; Tr, trophectoderm.  Bar = 10 µm. 
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Progesterone Regulation of Tight-Junction-Associated Proteins (studies 2 and 3) 
To determine whether P4 regulates tight-junction-associated proteins, ewes were 
treated with either vehicle or P4 beginning on Day 1.5 postmating and then 
hysterectomized on either Day 9 or Day12.  This treatment regimen advances 
development of the conceptus and induces changes in gene expression in the uterine LE 
(Satterfield, Bazer et al. 2006).  Immunoreactive TJP2 protein was most abundant in LE 
and GE of uteri from CO-treated ewes on Days 9 and 12 (Figure 4.5).  Treatment with P4 
decreased the abundance of TJP2 protein in LE compared with CO treatment, whereas 
treatment with P4 and RU486 (P4 + RU) increased TJP2 protein, particularly in the GE. 
Similar results were found for immunoreactive OCLN protein (Figure 5), although the 
P4-induced loss of OCLN protein was more pronounced in LE and GE on Day 12.  
Furthermore, treatment of ewes with P4 and RU486 increased OCLN protein in both LE 
and GE.  Immunoreactive TJP2 and OCLN proteins were most abundant at the apical 
portions of the epithelial cells.  
CLDN1 protein was detected at low levels in LE and GE on Day 9 in both CO- 
and P4-treated ewes (Figure 4.6).  On Day 12, P4-treated ewes had less CLDN1 protein 
compared with CO controls, whereas administration of RU486 slightly increased 
CLDN1 protein in both LE and GE.  CLDN2, CLDN3, and CLDN4 proteins were most 
abundant in uterine LE of  CO-treated ewes on Days 9 and 12, decreased in LE of Day 
12 ewes treated with P4 and were most abundant in GE of RU486-treated ewes on Day 
12. For all of the proteins analyzed in this study, there were no differences in their 
abundance in LE of intercaruncular and caruncular endometria.  
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FIG. 4.5.  Effects of corn oil (CO), progesterone (P4), or P4 and RU486 (P4+RU) on 
TJP2 and OCLN protein in endometria from Day 9 (Study Two) and Day 12 (Study 
Three) ewes.  Immunoreactive OCLN and TJP2 proteins were detected using specific 
rabbit polyclonal antibodies.  For the IgG control, normal rabbit IgG was substituted for 
the primary antibody.  Sections were not counterstained.  Legend: LE, luminal 
epithelium; GE, glandular epithelium; S, stroma.  Bar = 10 µm. 
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FIG. 4.6.  Effects of corn oil (CO), progesterone (P4) or P4 and RU486 (P4+RU) on 
CLDN proteins in endometria from Day 9 (Study Two) and Day 12 (Study Three) ewes.  
Immunoreactive CLDNs 1, 2, 3, and 4 proteins were detected using specific rabbit 
polyclonal antibodies.  For the IgG control, normal rabbit IgG was substituted for the 
primary antibody.  Sections were not counterstained.  Legend: LE, luminal epithelium; 
GE, glandular epithelium; S, stroma.  Bar = 10 µm. 
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CDH1 and CTNNB1 mRNA in Studies 2 and 3 
Steady-state levels of CDH1 mRNA were not affected (P > 0.10) by treatment on 
Day 9 or 12 (Figure 4.7A).  On Day 9, endometrial CTNNB1 mRNA was lower (P < 
0.05) in P4-treated compared with CO-treated ewes (Figure 4.7B). On Day 12, P4 
treatment did not affect (P > 0.10) CTNNB1 mRNA in the endometrium; however, there 
was a 2-fold increase (P < 0.01) in CTNNB1 mRNA in endometria of RU486-treated 
ewes.  In situ hybridization analysis identified CTNNB1 mRNA in endometrial LE, GE 
and stroma of ewes (Figure 4.7C).  The reduction in CTNNB1 mRNA in endometria 
from Day 9 P4-treated ewes appeared to result from an overall decline in the LE, 
whereas RU486 treatment resulted in an increase in CTNNB1 mRNA in Day 12 ewes in 
all endometrial cell types.  For all of the mRNAs and proteins analyzed in this study, no 
differences were observed in their abundance in the LE of intercaruncular and caruncular 
endometria.  
 
CDH1 and CTNNB1 Protein in Studies 2 and 3 
Immunoreactive CDH1 protein was less abundant in the endometrial LE of P4-
treated ewes on Day 9 (Figure 4.8).  However, CDH1 protein abundance in CO-treated 
compared with P4-treated ewes was not different on Day 12.  Interestingly, the 
abundance of CDH1 protein decreased in LE of ewes treated with P4 and RU486 to Day 
12 after onset of estrus.   
Immunoreactive CTNNB1 protein was localized predominantly in endometrial 
LE and GE of both CO- and P4-treated ewes on Day 9 (Figure 4.8).  For CO-treated 
ewes, immunoreactive CTNNB1 protein was observed in GE on Day 12, but was not 
detectable in LE.  However, CTNNB1 protein was very low to undetectable in GE of P4-
treated ewes on Day 12. In contrast, CTNNB1 protein was abundant in GE and 
detectable in LE of RU486-treated ewes on Day 12.  For all of the proteins analyzed in 
this study, there were no differences in their abundance in LE of intercaruncular and 
caruncular endometria.  
 
 73
 
FIG. 4.7.  Effects of corn oil (CO), progesterone (P4) or P4 and RU486 (P4+RU) on 
CDH1 and CTNNB1 mRNA in endometria from Day 9 (Study Two) and Day 12 (Study 
Three) ewes.  (A & B) Steady-state levels of mRNAs were determined by slot blot 
hybridization analysis and are presented as relative units (RU) with standard error (SE).  
(C) Cross-sections of uteri were hybridized with radiolabeled antisense or sense ovine 
cRNA probes for each respective gene.  Legend: LE, luminal epithelium; GE, glandular 
epithelium; S, stroma.  Bar = 10 µm. 
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FIG. 4.8.  Effects of corn oil (CO), progesterone (P4) or P4 and RU486 (P4+RU) on 
CDH1 and CTNNB1 protein in endometria from Day 9 (Study Two) and Day 12 (Study 
Three) ewes.  Immunoreactive protein was detected using specific rabbit polyclonal 
antibodies.  For the IgG control, normal rabbit IgG was substituted for the primary 
antibody.  Sections were not counterstained.  Legend: LE, luminal epithelium; GE, 
glandular epithelium; S, stroma.  Bar = 10 µm. 
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Discussion 
Domestic animals are characterized as being nonmenstruating and having conceptuses 
that undergo a noninvasive type of implantation.  These two distinguishing 
characteristics indicate the unique importance of and requirement for elasticity of 
function of uterine epithelia that must adapt to establish the appropriate 
microenvironment based on the physiological status of the animal.  These adaptations are 
acutely monitored in response to appropriately timed cues from the ovary and paracrine 
effectors from the adjacent stroma and conceptus. In sheep, the spherical hatched 
blastocyst on Day 8 expands to Day 10 and then begins a morphological change to a 
tubular conceptus by Day 12 and subsequently undergoes rapid elongation into a 
filamentous conceptus by Day 14 (Rowson and Moor 1966a; Spencer et al. 2004a). The 
developing ovine conceptus undergoes elongation while maintaining superficial contact 
with the receptive LE before firm adhesion by Day 18 at which point the conceptus can 
no longer be easily flushed from the uterine lumen.  Elongation of the conceptus 
trophectoderm is required for the production of sufficient quantities of IFNT to elicit 
maternal recognition of pregnancy and inhibit development of the luteolytic mechanism 
(Farin et al. 1989; Gray et al. 2002; Guillomot et al. 1990; Spencer and Bazer 2004; 
Vallet et al. 1988). Beginning on Days 14 to 15, trophoblast giant binucleate cells begin 
differentiating from the mononuclear trophectoderm cells in the conceptus and then 
migrate and fuse with the endometrial LE in both the caruncular and intercaruncular 
areas of the uterus and with each other to form multinucleated syncytia (Wooding 1984). 
These peri-implantation events begin synepitheliochorial placentation in ruminants.  
Establishment and maintenance of the microenvironment within the uterine 
lumen to support pregnancy requires that epithelia serve as a selective transporter and/or 
barrier.  Junctional complexes within the epithelia maintain this unique 
microenvironment by regulating the passage of water, ions, and other small molecules, 
regulating localization of various transporters within the epithelia to maintain appropriate 
molecular gradients, and changing cell shape and polarity to alter cell to cell 
communication and function. Results from the present studies on changes in endometrial 
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tight-junction and adherens-associated proteins provide insight into the functional 
requirements of the epithelia for the maintenance of pregnancy in sheep. All tight-
junction- and adherens-associated proteins were moderately to abundantly present in the 
endometrial epithelia on Day 10 of the estrous cycle and pregnancy; however, by Day 
12, the junctional proteins in the LE decreased to very low or undetectable levels, 
resulting in a potentially "leaky" paracellular space for transport of molecules from the 
uterine stroma and/or selective movement of serum transudate directly to the conceptus.  
This decline in tight junction and adherens junction-associated proteins would 
theoretically decrease tight junctions and increase the availability of stromal-derived 
factors, such as hepatocyte growth factor, fibroblast growth factor 7, and insulin-like 
growth factors (IGF1 and IGF2), as well as factors from serum, such as glucose, insulin, 
and essential amino acids, in the uterine lumen. Indeed, many of the proteins present in 
the uterine lumen are not directly synthesized by the endometrial epithelia or conceptus 
(Lee et al. 1998b). During early pregnancy, tubular blastocysts begin to elongate on Day 
12 to form filamentous conceptuses, which involves proliferation and migration of 
trophectoderm cells.  Thus, accelerated blastocyst growth may result, in fact, from the 
influx of factors into the uterine lumen through the paracellular space as integrity of tight 
and adherens junctions decreases.  Indeed, blastocyst elongation and formation of a 
filamentous conceptus has not been achieved in vitro.  
The changes in tight junction and adherens junction-associated proteins observed 
in the present study are hypothesized to be promulgated by P4.  In both cyclic and 
pregnant ewes, P4 receptors (PGR) decline to undetectable levels in endometrial LE and 
GE between Days 10 and 12 after onset of estrus (Spencer and Bazer 1995; Wathes and 
Hamon 1993; Wathes and Lamming 1995).  This loss of PGR is induced by exposure of 
the endometrium to P4 for 8 to 10 days.  Indeed, early P4 administration accelerates the 
loss of PGR from LE and GE, advances onset of expression of P4-stimulated genes such 
as galectin-15, and enhances blastocyst growth and development (Satterfield et al. 2006). 
Results from Studies 2 and 3 regarding analyis of  tight-junction-associated proteins 
revealed that early P4 stimulated a decline in tight junction and adherens junction-
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associated proteins in ovine uterine epithelia.  This decline occurred in both cyclic and 
pregnant ewes because maternal recognition of pregnancy does not occur until Days 12 
to 13. In fact, Guillomot et al. (Guillomot et al. 1986; Guillomot et al. 1981) observed 
that horseradish peroxidase injected into the uterine lumen of pregnant ewes and cows 
accumulated in the intracellular spaces beneath the basement membrane and in the 
stroma.  This transport was mediated via transepithelial endocytotic activity (vesicles) as 
well as paracellular permeability and passage through intercellular spaces between tight 
junctions.  These phenomena were especially marked when circulating concentrations of 
P4 were high during late diestrus when PGR are absent from endometrial LE and GE.  
In addition to P4, the presence of the conceptus-affected tight-junction-associated 
proteins in the uterine LE.  Consistently, tight-junction-associated proteins were much 
more abundant in the LE of pregnant ewes compared with cyclic ewes on Day 14, 
suggesting that a conceptus-derived factor stimulates tight-junction-associated proteins 
within the LE.  During decidualization in mice, a stromal barrier surrounding the 
invading blastocyst uncharacteristically expresses tight-junction-associated proteins, 
which are believed to maintain an immunologically privileged environment assisting in 
the maintenance of pregnancy (Paria et al. 1999; Wang et al. 2004).  Indeed, a similar 
mechanism may exist in sheep, whereby the developing conceptus signals its presence 
and produces a factor that stimulates tight junction formation that acts as a functional 
barrier to the maternal immune system.  Simultaneously, reducing paracellular 
permeability of the LE may facilitate pregnancy recognition, allowing for sufficient 
quantities of IFNT to act on the LE and GE to inhibit luteolysis and induce genes 
encoding secreted proteins, such as galectin-15, cathepsin L, WNT7A, and cystatin C 
that may stimulate conceptus development and implantation.  Furthermore, tight junction 
formation may maintain IFNT-induced or stimulated proteins at high levels in the uterine 
lumen.  Expression of these tight-junction-associated proteins remains high to Day 20.  
The conceptus trophectoderm also expresses high levels of tight-junction-associated 
proteins, which is not unexpected because a sophisticated cellular organization is 
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required to facilitate the rapid morphological and developmental changes during this 
period.  
In the present studies, CDH1 and CTNNB1 mRNAs and proteins were abundant 
in the endometrial LE on Day 10 of the estrous cycle and pregnancy and then decreased 
in subsequent days corresponding with conceptus elongation.  The abundance of CDH1 
and CTNNB1 mRNAs increased on Days 16 and 14 of pregnancy, respectively.  
However, changes in levels of CDH1 protein within the LE did not parallel that of CDH1 
mRNA suggesting posttranscriptional regulation of CDH1 levels.  This phenomenon, 
based on discordant levels of mRNA and protein, began on Day 10 and continued on 
Day 12 when CDH1 protein was significantly lower than mRNA levels within LE, but 
not GE.  The mechanism responsible for this decline in CDH1 protein is not known, but 
may be physiologically important for the initiation of the implantation process. Indeed, 
in rats, CDH1 is lost from the epithelium before invasion of the blastocyst into the 
endometrial stroma.  These studies indicated a role for calcitonin in both in vitro and in 
vivo regulation of CDH1 expression during the period of implantation (Li et al. 2002). 
However in mice, the LE expresses abundant CDH1, which is highly localized to the 
apical domain at the implantation sites, whereas CDH1 is more diffusely localized at the 
inter-implantation sites (Jha et al. 2006). As the blastocyst begins to invade into the 
underlying stroma, these cells also uncharacteristically express CDH1 (Jha et al. 2006; 
Paria et al. 1999).  Similarly, CTNNB1 protein declines from Days 10 to14 within LE 
and to a lesser extent within GE, further supporting the decline in adherens junctions 
during the elongation process.  In mice, inhibition of CTNNB1 signaling in both the 
developing blastocyst and uterine endometrium may have a role in synchronizing 
preimplantation embryonic development (Li et al. 2005).  A similar mechanism may 
exist in sheep to synchronize events associated with the elongating conceptus and 
endometrial functions during this critical morphological transition. Results from this 
study indicate that two components of adherens junctions decline during the elongation 
process only to increase as the conceptus initiates implantation. The decline in adherens 
junction proteins also corresponds with loss of  PGR from LE and subsequent loss of the 
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antiadhesive glycocalyx molecule, mucin 1 (Johnson et al. 2001a).  These events may act 
in concert to allow the LE to become receptive to direct contact with conceptus 
trophectoderm enabling the elongation process to be initiated. The presence of abundant 
quantities of CDH1 protein and moderate levels of CTNNB1 protein within the GE 
throughout the estrous cycle and pregnancy results in a polarized epithelium that can 
more efficiently secrete uterine histotroph.  Previous research using the ovine uterine 
gland knockout ewe model established the requirement for secretions from the ovine 
uterine GE for conceptus survival beyond Day 12–14 (Gray et al. 2001c).  Increases in 
CDH1 and CTNNB1 proteins in the LE from Days 16 to 20 of pregnancy in ewes may 
be in response to aggressive adhesion and attachment of the elongating ovine conceptus 
to restrict invasion of the trophectoderm, thus maintaining appropriate contact for 
placental development and inhibiting adverse immunological reactions by the maternal 
endometrium.  
Adherens junction proteins, in a manner similar to tight junctions, return on Day 
16 of the cycle as the ewe returns to estrus.  A highly polarized epithelium exhibiting a 
high degree of cell-to-cell contact may be necessary to provide a microenvironment 
suitable for capacitating sperm, as well as structural stability necessary for the high 
contractile rate of this tissue and the high degree of water imbibition occurring at estrus.  
Results of Studies 2 and 3 illustrate a subtle, but potentially physiologically relevant 
discord between CDH1 mRNA and protein.  Although CDH1 mRNAs are not regulated 
by administration of P4 or blockade of its action, clearly P4 treatment resulted in a 
decline in CDH1 protein within the LE on Day 9 and a decline after RU486 
administration on Day 12.  CTNNB1 mRNA and protein decreased in response to P4 
administration to Day 9 and this may result in adherens junction breakdown and a 
decline in CDH1 protein as well.  A decline in CDH1 and CTNNB1 within the LE on 
Day 9 could be hypothesized to be part of the cascade of epithelial alterations associated 
with loss of PGR from LE prior to implantation.  
Collectively, results of the present study identify regulated changes within the 
epithelial architecture that modulate various functions of uterine epithelia.  These 
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organizational changes are under the control of both steroid hormones and conceptus-
derived factors.  Future studies will aim to identify additional constituents of the uterine 
microenvironment derived from nonepithelial sources via epithelial paracellular transport 
to enhance conceptus growth and development.  Identification of critical constituents of 
the uterine milieu of nonepithelial origin will give further insight into the role of the 
underlying stromal compartments in supporting growth and survival of the conceptus 
and ultimately decreasing periimplantation pregnancy losses. 
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CHAPTER V 
PROGESTERONE REGULATION OF THE ENDOMETRIAL WNT SYSTEM 
IN THE OVINE UTERUS 
 
Introduction 
In mammals, the period of uterine receptivity to the developing blastocyst is 
marked by specific histoarchitectural changes in the endometrial luminal (LE) and 
glandular epithelia (GE) (Burghardt et al. 2002; Carson et al. 2000; Satterfield et al. 
2007; Spencer et al. 2004a; Tranguch 2005).  Many of these changes occur coordinately 
with loss of progesterone receptors (PGR) from these epithelia, a phenomenon observed 
in all mammalian species studied to date (Brenner et al. 1991; Geisert et al. 1994; Lessey 
et al. 1988; Spencer and Bazer 1995; Spencer et al. 2004b; Tan et al. 1999).  In sheep, 8 
to 10 days of continuous progesterone (P4) exposure elicits loss of the PGR protein from 
the LE by Day 12 post-estrus followed by loss within the GE by Day 14 (Spencer and 
Bazer 1995) that is temporally associated with the onset of peri-implantation blastocyst 
elongation beginning on Day 12 to form a filamentous conceptus (Guillomot 1995).  
Indeed, blastocyst growth and development can be accelerated by prematurely increasing 
circulating levels of P4 in ruminants (Garrett et al. 1988b; Satterfield et al. 2006).  In 
sheep, exogenous P4 administered from 36 h post-mating increased blastocyst diameter 
on Day 9 and accelerated elongation to a filamentous conceptus by Day 12 that was 
correlated with loss of PGR within the LE and GE and induction of several genes 
hypothesized to stimulate conceptus growth and development including galectin 15 
(LGALS15) and cathepsin L (CTSL) (Satterfield et al. 2006).  In addition to induction of 
genes encoding secreted proteins, components of adherens and tight junctions in the 
endometrial LE were reduced by P4 treatment (Satterfield et al. 2007), which likely 
results in altered intracellular signaling and cell to cell communication as well as 
increased histotroph in the uterine lumen (Li et al. 2002; Orchard and Murphy 2002; 
Paria et al. 1999; Wang et al. 2004).  Recently, the WNT system has been implicated in 
the regulation of cell polarity and junctional complexes and their associated proteins 
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(Karner et al. 2006a; Karner et al. 2006b).  Moreover, many components of the WNT 
system expressed in the ovine uterine endometrium may modulate trophectoderm 
migration and proliferation (Hayashi et al. 2007). 
WNT genes are homologous to the Drosophila segment polarity gene wingless 
(wg).  In humans and mice, the WNT family encodes a group of 19 highly conserved 
secreted glycoproteins that regulate cell and tissue growth and differentiation as well as 
components of junctional complexes (Davies 2002; Davies and Fisher 2002; Robinson et 
al. 2000).  WNTs associate with their extracellular surface receptors, frizzled (FZD), in 
both an autocrine and paracrine manner, to mediate intracellular signal transduction 
pathways (Dale 1998).  The ten FZDs are a family of seven transmembrane G protein-
coupled receptors that possess an extracellular cysteine-rich domain for WNT binding 
(Liu et al. 1999; Wang et al. 1996).  FZD then binds to low-density lipoprotein receptor-
related proteins 5 and 6 (LRP5/6) which serve as coreceptors (Pinson et al. 2000).  
Another family of proteins, termed secreted FZD-related proteins (SFRPs) produced by 
six different genes, exerts inhibitory effects on WNT signaling by competing with WNT 
ligands for the FZD receptor and forming a nonfunctional complex with FZDs in a 
dominant-negative manner (Bafico et al. 1999; Kawano and Kypta 2003).  WNT 
signaling is also antagonized by four Dickkopf (DKK) genes which encode secreted 
proteins that bind the LRP coreceptor (Nusse 2001).  In the canonical WNT signaling 
pathway, FZD receptors inhibit glycogen synthase kinase 3 beta (GSK3B), resulting in 
stabilization of the transcriptional regulator beta-catenin (CTNNB1) (Logan and Nusse 
2004; Pandur et al. 2002b).  Nuclear CTNNB1 interacts with transcription factors, most 
notably members of the transcription factor 7 (T-cell specific, HMG-box) (TCF7/LEF) 
family, to regulate transcription of genes such as JUN (c-Jun) (Mann et al. 1999), 
LEF1/TCF7 (Roose et al. 1999), MET (c-Met) (Boon et al. 2002), and MSX2 (msh 
homeobox homolog 2) (Hussein et al. 2003; Willert et al. 2002).  The noncanonical or 
planar cell polarity pathways, activated by WNT5A and WNT11, mediate cell polarity, 
cell movements during gastrulation, and other processes modifying the actin 
cytoskeleton via small GTPases of the Rho family, such as Rho, Rac, and Cdc42 
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(Huelsken and Birchmeier 2001; Kuhl et al. 2000; Pandur et al. 2002a; Yamanaka et al. 
2002).  Rac activation stimulates c-Jun N-terminal kinase (JNK) activity (Boutros et al. 
1998; Habas et al. 2003; Veeman et al. 2003).  JNK activation plays essential roles in 
organogenesis by regulating cell survival, apoptosis, and proliferation (Nishina et al. 
2004). 
A recent encompassing study cataloged members of the WNT signaling family 
and a number of downstream target genes present in the ovine endometrium and 
identified roles for WNT signaling in regulation of trophectoderm migration and 
proliferation (Hayashi et al. 2007).  We hypothesize that P4 actions on the ovine uterus 
include a transient reduction in various components of the WNT signaling system that, 
in turn, reduces the expression of genes encoding tight junction associated proteins and 
adherens junctions, thereby increasing the availability of histotroph and stimulating 
blastocyst growth and development (Satterfield et al. 2007).  Thus, this study evaluated 
the WNT system in an ovine model of advanced blastocyst growth and development 
reported by our laboratory (Satterfield et al. 2006). 
 
Material and Methods 
Animals 
Mature Suffolk-type ewes (Ovis aries) were observed for estrus (designated as 
Day 0) in the presence of a vasectomized ram and used in experiments only after 
exhibiting at least two estrous cycles of normal duration (16-18 days).  All experimental 
and surgical procedures were in compliance with the Guide for the Care and Use of 
Agriculture Animals in Research and Teaching and approved by the Institutional Animal 
Care and Use Committee of Texas A&M University. 
 
Experimental Design 
Study One  As described previously (Satterfield et al. 2006), ewes were mated at 
estrus to intact Suffolk rams and then assigned randomly to receive daily i.m. injections 
from Days 1.5 to 9 of either corn oil vehicle CO (n=6); or 25 mg progesterone (P4, n=6; 
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Sigma Chemical Co., St. Louis, MO).  All ewes were hysterectomized on Day 9.  At 
hysterectomy, sections (~0.5 cm) from the mid-portion of each uterine horn ipsilateral to 
the CL were fixed in fresh 4% paraformaldehyde in PBS (pH 7.2).  After 24 h, fixed 
tissues were changed to 70% ethanol for 24 h, dehydrated through a graded series of 
alcohol to xylene, and then embedded in Paraplast-Plus (Oxford Labware, St. Louis, 
MO).  The remaining endometrium was physically dissected from myometrium, frozen 
in liquid nitrogen, and stored at -80oC for subsequent RNA or protein extraction.  In 
monovulatory pregnant ewes, uterine tissue samples were marked as either contralateral 
or ipsilateral to the ovary bearing the CL.  No tissues from the contralateral uterine horn 
were used for further analysis. 
Study Two  As described previously (Satterfield et al. 2006), ewes were mated at 
estrus to intact Suffolk rams and assigned randomly to receive daily intramuscular (i.m.) 
injections of either: (a) CO vehicle from Days 1.5 to 12 (n=8); (b) 25 mg P4 from Days 
1.5 to 12 (n=7); or (c) 25 mg P4 from Days 1.5 to 12 and 75 mg RU486 (Sigma), a PGR 
antagonist, from Days 8 to 12 (P4+RU, n=5).  All ewes were hysterectomized on Day 12, 
and the uteri were processed as described for Study One. 
 
RNA Isolation 
Total cellular RNA was isolated from frozen ipsilateral endometrium using 
Trizol reagent (Gibco-BRL, Bethesda, MD) according to manufacturer’s 
recommendations.  The quantity and quality of total RNA was determined by 
spectrometry and denaturing agarose gel electrophoresis, respectively. 
 
Slot Blot Hybridization Analysis 
Steady-state levels of WNT2, WNT4, WNT5A, DKK1, LEF1, MSX1, and MSX2 
mRNA in endometria were assessed by slot blot hybridization as described previously 
(Spencer et al. 1999c).  Briefly, radiolabeled antisense ovine cRNA probes (Hayashi et 
al. 2007) were generated by in vitro transcription using linearized plasmid templates 
containing partial cDNAs, RNA polymerases, and [α-32P]-UTP.  Denatured total 
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endometrial RNA (20 µg) from each ewe in Studies One and Two was hybridized with 
radiolabeled cRNA probes.  To correct for variation in total RNA loading, a duplicate 
RNA slot blot membrane was hybridized with radiolabeled antisense 18S cRNA 
(pT718S; Ambion, Austin, TX).  Following washing, the blots were digested with 
ribonuclease A and radioactivity associated with slots was quantified using a Typhoon 
8600 MultiImager (Molecular Dynamics, Piscataway, NJ).  Data are expressed as 
relative units (RU) with overall standard errors (SE). 
 
In Situ Hybridization Analysis 
Cell-specific location of WNT2, WNT2B, WNT4, WNT5A, WNT5B, WNT7A, 
WNT11, FZD6, DKK1, GSK3B, LEF1, MSX1, and MSX2 mRNAs in the ovine uteri was 
determined by radioactive in situ hybridization analysis as described previously (Spencer 
et al. 1999c).  Radiolabeled antisense and sense ovine cRNA probes were generated by 
in vitro transcription using linearized partial plasmid cDNA templates (Hayashi et al. 
2007), RNA polymerases, and [α-35S]-UTP.  Deparaffinized, rehydrated and 
deproteinated uterine tissue sections were hybridized with radiolabeled antisense or 
sense cRNA probes.  After hybridization, washing and ribonuclease A digestion, slides 
were dipped in NTB-2 liquid photographic emulsion (Kodak, Rochester, NY), and 
exposed at 4oC for between 10 and 60 days determined by intensity of radioactive signal 
of slides placed on MR Kodak film for 16 h.  All slides for each respective gene were 
exposed to photographic emulsion for the same period of time.  Slides were developed in 
Kodak D-19 developer, counterstained with Gill’s hematoxylin (Fisher Scientific, 
Fairlawn, NJ), and then dehydrated through a graded series of alcohol to xylene.  
Coverslips were then affixed with Permount (Fisher).  Images of representative fields 
were recorded under brightfield or darkfield illumination using a Nikon Eclipse 1000 
photomicroscope (Nikon Instruments Inc., Lewisville, TX) fitted with a Nikon 
DXM1200 digital camera. 
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Semi-Quantitative RT-PCR Analysis
WNT7A and WNT11 mRNA levels in ovine endometria were assessed using 
semi-quantitative RT-PCR as described previously (Stewart et al. 2000).  Briefly, 
endometrial total RNA was treated with RQ1 RNase Free-DNase1 (Promega) and then 
ethanol-precipitated. The cDNA was synthesized from total RNA (5 µg) using random 
and oligo (dT) primers and SuperScript II Reverse Transcriptase (Life Technologies).  
Newly synthesized cDNA was acid-ethanol precipitated, resuspended in 20 µl sterile 
water, and stored at –20°C. The cDNAs were diluted (1:10) in sterile water before use in 
PCR. Primers for WNT7A and WNT11 were derived from conserved sequences of the 
porcine and bovine gene, respectively using primer 3 (Rozen and Skaletsky 2000).  
Primer sequences for WNT7A were (Forward) 5’-CCTGGAGGAGAACATGAAGC-3’ 
and (Reverse) 5’-CAGTAA TTGGGTGACTTCTCG-3’ and for WNT11 were (Forward) 
5’-TTCCCGATGCTCCTATGAAGG-3’ and (Reverse) 5’-ACAGCACATGAGG 
TCACAAGC-3’ which amplified a 261 bp and 430 bp fragment, respectively.   The 
PCR amplification was conducted as follows for WNT7A and WNT11: (1) 95°C for 5 
min; (2) 95°C for 30s, 52°C for 40s (for WNT7A), 55°C for 40s (for WNT11), and 72°C 
for 1 min for 32 cycles; and (3) 72°C for 10 min.  Housekeeping beta actin (ACTB) 
primers were forward (5'-ATGAA GATCCTCACGGAACG-3') and reverse (5'-
GAAGGTGGTCTCGTGAATGC-3'), which amplified a 270 bp product.  PCR 
amplification was conducted as follows for ACTB: (1) 95°C for 5 min; (2) 95°C for 30 s, 
57°C for 30 s, and 72°C for 1 min for 25 cycles; and (3) 72 °C for 10 min. After PCR, 
equal amounts of reaction product were analyzed using a 1.5% agarose gel, and PCR 
products were visualized using ethidium bromide staining. The amount of DNA present 
was quantified by measuring the intensity of light emitted from correctly sized bands 
under u.v. light using a ChemiDoc EQ system and Quantity One software (Bio-Rad).  
Amplified PCR products of the predicted size were subcloned into the pCRII cloning 
vector using a T/A Cloning kit (Invitrogen, Carlsbad, CA) and sequenced in both 
directions using an ABI PRISM Dye Terminator Cycle Sequencing kit and ABI PRISM 
automated DNA sequencer (Applied Biosystems, Foster City, CA) to confirm identity. 
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Immunohistochemistry 
Immunocytochemical localization of immunoreactive JUN, phosphorylated JUN 
(p-JUN), CREB, p-CREB, and TCF7L2 protein in the ovine uterus was performed as 
described previously (Gray et al. 2004; Hayashi et al. 2007; Taylor et al. 2000).  Proteins 
were localized using the following antibodies: rabbit Anti-c-JUN (06-225) at 1:2000, 
rabbit Anti-phospho-c-JUN (06-659) at 1:200, rabbit Anti-CREB (06-863) at 1:500, and 
rabbit Anti-phospho-CREB (06-519) at 1:1000 at 1:300 (Upstate Cell Signaling 
Solutions, Lake Placid, NY).  Negative controls for these antibodies included 
substitution of the primary antibody with non-immune rabbit IgG (Sigma).  
Immunoreactive TCF7L2 protein was localized using a mouse Anti-TCF4 monoclonal 
antibody (05-511; Upstate Cell Signaling Solutions, Lake Placid, NY) at a 1:2000 final 
dilution.  Negative controls for TFC7L2 included substitution of the primary antibody 
with mouse IgG (Sigma).  A Vectastain ABC anti-rabbit or anti-mouse kit (Vector 
Laboratories, Burlingame, CA) was utilized for detection of all proteins following 
antigen retrieval with boiling citrate buffer as described previously (Taylor et al. 2000).  
Immunoreactive protein was visualized using diaminobenzidine tetrahydrochloride 
(Sigma) as the chromagen.  Sections were dehydrated and coverslips affixed with 
Permount (Fisher). 
 
Photomicroscopy 
Photomicrographs of in situ hybridization and immunocytochemistry slides were 
taken using a Nikon Eclipse E1000 photomicroscope (Nikon Instruments, Melville, NY).  
Digital images were captured using a Nikon DXM 1200 digital camera and assembled 
using Adobe Photoshop 7.0 (Adobe Systems, Seattle, WA). 
 
Statistical Analyses 
Data from slot blot hybridization and RT-PCR analyses were subjected to least-
squares analysis of variance using the General Linear Models procedures of the 
Statistical Analysis System (SAS Institute, Cary, NC).  Slot blot hybridization data were 
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corrected for differences in sample loading by using the 18S rRNA data as a covariate.  
Data are presented as the least-squares means (LSM) with overall standard error (SE).  
Analysis of RT-PCR data incorporated the ACTB values as a covariate in the statistical 
model to correct for differences in the amounts of reverse transcriptase cDNA analyzed 
for each uterus.  In all analyses, error terms used in tests of significance were identified 
according to the expectation of the mean squares for error. 
 
Results 
Progesterone Regulation of Non-Canonical WNT mRNAs 
WNT5A, WNT5B, and WNT11 are members of the WNT family that signal via 
the non-canonical or planar cell polarity pathway signaling molecules (Logan and Nusse 
2004) and are expressed in ovine uterine endometrium during early pregnancy (Hayashi 
et al. 2007).  In Study One, steady-state levels of WNT5A mRNA in endometria were not 
different (P>0.10) between CO- and P4-treated ewes (Figure 5.1A).  WNT5A mRNA was 
detected in both LE and stromal cells of the endometrium with the preponderance of 
WNT5A mRNA in stratum compactum stromal cells underlying LE (Figure 5.1C).  In 
Study Two, endometrial WNT5A mRNA levels were not different (P>0.10) between CO- 
and P4-treated ewes on Day 12 (Figure 5.1A); however, in situ hybridization analyses 
revealed that WNT5A mRNA was clearly reduced in LE of both CO- and P4-treated 
ewes on Day 12 as compared to endometria of CO- and P4-treated ewes on Day 9.  The 
endometrium of P4+RU-treated ewes had increased (P<0.03) endometrial WNT5A 
mRNA levels on Day 12 (Figure 5.1A), and WNT5A mRNA was present in stromal cells 
and LE (Figure 5.1C).  WNT5B mRNA was detected in both LE and stromal cells (data 
not shown).  Endometrial WNT5B mRNA levels were not affected (P>0.10) by treatment 
(data not shown). 
Although steady-state levels of WNT11 mRNA did not differ (P>0.10) between 
endometria of CO- and P4-treated ewes on Day 9 (Figure 5.1B), in situ hybridization 
analyses revealed a clear reduction or absence of WNT11 mRNA in LE of endometria 
from P4-treated ewes (Figure 5.1C).  Endometrial WNT11 mRNA levels were lower 
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(P<0.005) in P4- as compared to CO-treated ewes on Day 9 and also in Day 12 as 
compared to Day 9 ewes regardless of treatment (Figure 5.1B).  In situ hybridization 
revealed that WNT11 mRNA was reduced in GE of both P4 and P4+RU ewes as 
compared to CO ewes on Day 12 (Figure 5.1C).  Interestingly, WNT11 mRNA was 
present in LE cells of uteri from P4+RU ewes, but not in LE of either CO- or P4-treated 
ewes on Day 12 (Figure 5.1C). 
 
Downstream Targets of Non-Canonical WNT Signaling 
JUN is a transcriptional regulator of non-canonical WNT signaling (Logan and 
Nusse 2004).  Immunoreactive JUN was abundant in LE, GE and stromal cells of CO-
treated ewes on Day 9 (Figure 5.2).  An increased amount of JUN protein was observed 
in nuclei of LE and sGE in uteri of P4 as compared to CO ewes on Day 9.  In Study Two, 
immunoreactive JUN was abundant in LE of CO-treated ewes on Day 12 and also 
detected in GE and stromal cells.  A clear loss of JUN protein from LE and GE occurred 
in uteri of P4 as compared to CO ewes on Day 12. 
Immunocytochemical analysis of activated JUN (p-JUN) in Study One revealed 
low levels of p-JUN in LE of CO-treated ewes and higher levels in the stratum 
compactum stromal cells (Figure 5.2).  An increased abundance of p-JUN was noted in 
nuclei of LE from P4-treated ewes on Day 9.  In Study Two, p-JUN was detected in LE, 
GE, and stromal cells of CO-treated ewes, but there were no differences in p-JUN in 
nuclei of LE or GE between CO- and P4-treated ewes.  An increased abundance of p-
JUN protein was detected in stromal cells of P4+RU ewes with little or no detectable p-
JUN observed in LE (Figure 5.2). 
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FIG. 5.1.  Effects of treatments with corn oil (CO), progesterone (P4) or P4 and RU486 
on WNT5A and WNT11 mRNAs in ovine endometria.  [A] Steady-state levels of WNT5A 
mRNA in endometria from Day 9 (Study One) and Day 12 (Study Two) ewes, as 
determined by slot blot analysis.  WNT5A mRNA transcripts in P4+RU treated ewes 
were more abunandant (p<0.03) than for CO- and P4-treated ewes on Day 12.  [B] 
Steady-state levels of WNT11 mRNA were determined by quantification of ethidium 
bromide intensity scanned on a phosphoimager.  ACTB mRNA levels were utilized as a 
covariate for normalization of individual samples.  WNT11 mRNA decreased (p<0.005) 
with P4 and P4+RU treatment in Study Two.  Data are presented as relative units with 
standard error.  [C] In situ localization of WNT5A and WNT11 mRNAs in endometria of 
Day 9 (Study One) and Day 12 ewes (Study Two) are presented. Cross-sections of uteri 
were hybridized with radiolabeled antisense or sense ovine cRNA probes for each 
respective gene.  Legend: LE, luminal epithelium; S, stroma; GE, glandular epithelium.   
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Progesterone Regulation of Canonical WNT mRNAs 
Several members of the canonical WNT signaling family including, WNT2, 
WNT2B, WNT4, and WNT7A, are expressed in the ovine uterus (Hayashi et al. 2007).  In 
Study One, steady-state levels of endometrial WNT2 mRNA were reduced (P<0.05) in 
P4 as compared to CO-treated ewes on Day 9.  In Study Two, WNT2 mRNA levels were 
not different (P>0.10) between CO- and P4-treated ewes on Day 12, but higher levels 
(P<0.0002) of WNT2 mRNA were observed in stromal cells of P4+RU-treated ewes 
(Figure 5.3A and 5.3C).  WNT2B and WNT4 mRNAs were constitutively expressed at 
low levels in endometrial stromal cells and not affected by treatment in either study (data 
not shown). 
Semi-quantitative RT-PCR analysis determined that WNT7A mRNA was lower 
(P<0.03) in endometria of P4 as compared to CO ewes on Day 9 (Figure 5.3B).  As 
expected, WNT7A mRNA was observed only in endometrial LE and sGE (Figure 3C).  
WNT7A mRNA was very low to undetectable in endometria of both CO- and P4-treated 
ewes on Day 12 and lower (P<0.01) than in endometria from Day 9 ewes (Figure 5.3B); 
however, an increase (P<0.002) in WNT7A mRNA levels occurred in endometria of 
P4+RU as compared to P4 ewes on Day 12. 
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FIG. 5.2.  Effects of corn oil (CO), progesterone (P4) or P4 and RU486 on localization 
of c-JUN and p-JUN proteins in endometria from Day 9 (Study One) and Day 12 (Study 
Two) ewes using specific antibodies against c-JUN and p-JUN proteins generated in 
rabbits.  For the IgG control, normal rabbit IgG was substituted for the primary antibody.  
Legend: LE, luminal epithelium; S, stroma; sGE, superficial glandular epithelium; GE, 
glandular epithelium. 
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FIG. 5.3.  Effects of treatments with corn oil (CO), progesterone (P4) or P4 and RU486 
on endometrial WNT2 and WNT7A mRNAs.  [A] Steady-state levels of WNT2 mRNA in  
endometria from Day 9 (Study One) and Day 12 (Study Two) ewes, as determined by 
slot blot analysis.  WNT2 mRNA transcripts were reduced by P4 treatment to Day 9 
(p<0.05).  In Study Two, RU486 markedly increased (p<0.0002) WNT2 mRNA 
expression.  [B] Steady-state levels of WNT7A mRNA were determined by 
quantification of ethidium bromide intensity scanned on a phosphoimager.  ACTB 
mRNA levels were utilized as a covariate for normalization of individual samples.  
WNT7A mRNA decreased (p<0.03) with P4 treatment in Study One.  In Study Two, 
administration of RU486 increased (p<0.002) endometrial WNT7A mRNA.  Data are 
presented as relative units with standard error. [C] In situ localization of WNT2 and 
WNT7A mRNAs in endometria from Day 9 (Study One) and Day 12 ewes (Study Two) 
are presented. Cross-sections of uteri were hybridized with radiolabeled antisense or 
sense ovine cRNA probes for each respective gene.  Legend: LE, luminal epithelium; S, 
stroma; GE, glandular epithelium.    
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WNT Receptors and Signaling Components 
The most abundant receptor for WNT signaling in the ovine uterus is FZD6 
(Hayashi et al. 2007).  Steady-state levels of FZD6 mRNA in the endometrium were not 
affected (P>0.10) by treatment in either study (data not shown).  In situ hybridization 
analysis found that FZD6 mRNA was abundant in LE and GE in both CO and P4-treated 
ewes on Day 9 (Figure 5.4B).  On Day 12, FZD6 mRNA abundance was lower in LE 
and GE in both CO and P4 ewes as compared to endometria from Day 9 ewes.  In situ 
hybridization localized low levels of FZD8 mRNA to LE and GE of Day 9 and Day 12 
ewes, but expression was not affected (P>0.10) by treatment in either study (data not 
shown).  GSK3B mRNA was predominantly in LE and GE of uteri from all ewes on 
Days 9 and 12 and abundance was not affected (P>0.10) by treatment (data not shown). 
DKK1 is a secreted inhibitor of WNT signaling.  DKK1 mRNA levels were 
higher (P<0.01) in endometria of CO and P4 ewes on Day 12 as compared to Day 9, but 
not affected (P<0.01) by P4 treatment in either study (Figure 5.4A).  However, DKK1 
mRNA levels were reduced (P<0.02) in endometria of P4+RU- as compared to P4-
treated ewes on Day 12.  In situ hybridization revealed that DKK1 mRNA was present in 
the stratum compactum stromal cells of both CO- and P4-treated ewes, but not P4+RU-
treated ewes on Day 12 (Figure 5.4B). 
In Study One, TCF7L2 was predominantly in nuclei of LE cells (Figure 5.5A) 
and was more abundant in LE and GE of uteri from P4-treated ewes on Day 9.  TCF7L2 
was also abundant in the LE of CO ewes on Day 12, but was reduced in LE of uteri from 
P4-treated ewes.  Interestingly, TCF7L2 was abundant in LE and GE of uteri from 
P4+RU-treated ewes. 
LEF1 mRNA was not different (P>0.10) in endometria of treated ewes on either 
Day 9 or Day 12 (Figure 5.5B).  In situ hybridization analyses found that LEF1 mRNA 
was present at low abundance in most endometrial cell types on Day 9, but was more 
abundant in LE/sGE of uteri from CO and P4 ewes on Day 12 with decreased expression 
in stratum compactum stromal cells (Figure 5.5C); however, this increase was not 
observed in LE/sGE of uteri from P4+RU treated ewes on Day 12 (Figure 5.5C). 
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FIG. 5.4.  Effects of treatments with corn oil (CO), progesterone (P4) or P4 and RU486 
on endometrial FZD6 and DKK1 mRNAs.  [A] Steady-state levels of DKK1 mRNA in 
the endometria from Day 9 (Study One) and Day 12 (Study Two) ewes, as determined 
by slot blot analysis.  DKK1 mRNA transcripts were ablated (p<0.02) by administration 
of RU486 in Study Two.  [B] In situ localization of FZD6 and DKK1 mRNAs in 
endometria of Day 9 (Study One) and Day 12 ewes (Study Two) are presented. Cross-
sections of uteri were hybridized with radiolabeled antisense or sense ovine cRNA 
probes for each respective gene.  Legend: LE, luminal epithelium; S, stroma; GE, 
glandular epithelium.   
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FIG. 5.5.  Effects of corn oil (CO), progesterone (P4) or P4 and RU486 on localization 
of TCF7L2 protein and LEF1 mRNAs in endometria from Day 9 (Study One) and Day 
12 (Study Two) ewes.  [A] Immunoreactive protein was detected using specific 
antibodies against TCF7L2 protein generated in mice.  For the IgG control, normal 
mouse IgG was substituted for the primary antibody.  [B] Steady-state levels of LEF1 
mRNA in endometria from Day 9 (Study One) and Day 12 (Study Two) ewes, as 
determined by slot blot analysis.  Steady-state levels of LEF1 mRNA did not differ by 
treatment in Studies One or Two.  [C] In situ localization of LEF1 mRNA in endometria 
of Day 9 (Study One) and Day 12 ewes (Study Two) are presented. Cross-sections of 
uteri were hybridized with radiolabeled antisense or sense ovine cRNA probes for each 
respective gene.  Legend: LE, luminal epithelium; S, stroma; GE, glandular epithelium.  
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FIG. 5.6.  Effects of corn oil (CO), progesterone (P4) or P4 and RU486 on localization 
of CREB and p-CREB proteins in endometria from Day 9 (Study One) and Day 12 
(Study Two) ewes.  Immunoreactive proteins were detected using specific antibodies 
against CREB, and p-CREB proteins generated in rabbits.  For the IgG control, normal 
rabbit IgG was substituted for the primary antibody.  Legend: LE, luminal epithelium; S, 
stroma; GE, glandular epithelium. 
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CREB, a target gene for WNT signaling (Chen et al. 2005), was detected in all 
cell types and treatment groups on Days 9 and 12, but was not affected by treatment in 
either study (Figure 5.6).  Immunoreactive p-CREB was abundant in the nuclei of LE, 
GE, and stromal cells of CO ewes on Day 9 (Figure 5.6).  The abundance of p-CREB 
increased in LE of P4-treated ewes on Day 9 compared to CO controls.  On Day 12, a 
slight reduction in p-CREB was observed in LE of CO-treated ewes compared to Day 9, 
but this was not apparent in GE or stromal cells.  Lower amounts of p-CREB were 
observed in LE, GE and stroma of P4- as compared to CO-treated ewes on Day 12, and 
p-CREB was less abunandant in LE of uteri from P4+RU-treated ewes as compared to 
P4-treated ewes on Day 12. 
 
WNT Regulated Genes 
MSX1 and MSX2 are homeobox genes induced by WNTs via the canonical 
pathway.  MSX1 mRNA levels were reduced (P<0.01) by P4 in Study One (Figure 5.7A).  
MSX1 mRNA was abundant in LE and GE of CO ewes on Day 9 and was reduced 
predominantly in GE of P4-treated ewes (Figure 5.7B).  In Study Two, MSX1 mRNA 
levels were not different (P>0.10) between CO- and P4-treated ewes on Day 12 and were 
localized to the deep GE; however, MSX1 mRNA levels were higher (P<0.001) in 
endometria of P4+RU- as compared to P4-treated ewes, increasing in GE of deep, 
middle, and superficial uterine glands (Figure 5.7A and 5.7B).  MSX2 mRNA levels 
were not affected by P4 treatment in either study, but increased (P<0.03) in endometria 
of P4+RU ewes on Day 12 (Figure 5.7A), specifically in endometrial glands (Figure 
5.7B). 
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FIG. 5.7.  Effects of corn oil (CO), progesterone (P4) or P4 and RU486 on localization 
of MSX1 and MSX2 mRNAs in endometria from Day 9 (Study One) and Day 12 (Study 
Two) ewes.  [A] Steady-state levels of MSX1 and MSX2 mRNAs in endometria from 
Day 9 (Study One) and Day 12 (Study Two) ewes, as determined by slot blot analysis.  
MSX1 mRNA levels were reduced (p<0.01) by P4 treatment in Study One.  There was 
no difference in MSX1 mRNA between CO- and P4-treated ewes on Day 12; however, 
administration of RU486 increased MSX1 mRNAs levels above levels for control ewes 
(p<0.02) and tended (p<0.09) to decrease levels below those detected for ewes treated 
with P4 alone.  MSX2 mRNAs were expressed at low levels on Day 9, independent of 
treatment, and were not different between CO- and P4-treated ewes to Day 12, but 
P4+RU-treated ewes expressed more (p<0.03) MSX2 mRNA.  [B] In situ localization of 
MSX1 and MSX2 mRNAs in endometria of Day 9 (Study One) and Day 12 ewes (Study 
Two) are presented. Cross-sections of uteri were hybridized with radiolabeled antisense 
or sense ovine cRNA probes for each respective gene.   
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Discussion 
These studies revealed complex effects of day of pregnancy, P4 and PGR on 
expression of WNTs and their inhibitors in ovine uterine endometria.  A decrease in 
WNT5A, WNT7A and WNT11 mRNAs was observed specifically in endometrial LE 
between Days 9 and 12, and WNT7A and WNT11 mRNAs decreased in LE in response 
to early P4 treatment as assessed on Day 9.  Those changes in epithelial WNT 
expression paralleled changes in epithelial PGR protein (Satterfield et al. 2006), 
suggesting direct regulation of those genes by PGR.  Indeed, WNT7A expression is 
stimulated by progestins in human endometrial epithelial cells (Oehler et al. 2002).  In 
contrast, estrogen stimulates expression of WNT11 in breast cancer cells (Lin et al. 2007).  
Given the antagonistic actions between estrogen and progesterone, P4 may suppress 
WNT11 gene expression.  Indeed, the loss of PGR induced by P4 may be responsible for 
the decrease in  WNT5A, WNT7A and WNT11 expression in uterine LE during early 
pregnancy.  In addition to those WNTs, results of the present study indicated that DKK1 
mRNA increased in endometrial stromal cells between Days 9 and 12 and decreased to 
undetectable levels in ewes treated with RU486, a PGR antagonist, in Study Two.  Given 
that DKK1 expression increases in response to P4 in human endometria (Tulac et al. 
2006), it is likely that DKK1 is also regulated by liganded PGR in ovine endometrial 
stromal cells.  The collective loss of WNTs from uterine LE and the increase in DKK1, a 
WNT signaling inhibitor, suggests that canonical and non-canonical WNT signaling is 
reduced in uterine LE between Days 9 and 12 of pregnancy and this is hypothesized to 
be responsible for functional changes in the LE that support blastocyst growth and 
development. 
WNT5A and WNT11 signal via the non-canonical or planar cell polarity 
pathway that influences cell polarity and cell migration via activation of Rho kinase and 
JNK-JUN pathways (Karner et al. 2006b).  Similarly, canonical WNT signaling through 
CTNNB1 has numerous functions including regulation of cell differentiation and 
adhesion as well as changes in cell shape mediated via the actin microfilament 
cytoskeletal network (Widelitz 2005).   Collectively, the temporal and/or P4-induced 
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loss of WNT5A, WNT11 and WNT7A expression from LE and/or GE is closely correlated 
to changes in LE cell shape and histoarchitecture.  Human cell culture models utilizing 
non-adhesive versus adhesive uterine epithelial cells have indicated that adhesive cells 
capable of trophoblast attachment exhibit, a lack of ZO-1 expression, tracer leakiness of 
the paracellular space, and atypical patterns in adherens junction formation (Thie et al. 
1996).  Further, the actin-based cytoskeleton lacked a polar organization in adhesive 
cells which also had fewer well formed desmosomes (Thie et al. 1996).  Similarly, we 
reported distinct temporal and spatial alterations in occludin, tight junction protein 2, and 
claudin 1-4 proteins in endometria of cyclic and early pregnant ewes (Satterfield et al. 
2007).  In that study, dynamic changes in tight junction formation were characterized by 
an abundance of tight junction proteins on Day 10 of the estrous cycle and pregnancy 
that decreased significantly by Day 12.  Early P4 administration that advanced blastocyst 
development on Day 9 and 12 was associated with loss of tight-junction-associated 
proteins. Further, cadherin 1 and CTNNB1, which form adherens junctions, were 
abundant in endometrial glands, but decreased after Day 10 of pregnancy in LE and then 
increased by Day 16 with the onset of implantation.  Of particular note, regulation of 
tight junction associated proteins, principally claudins, by WNT signaling was reported 
for other cell types (Mankertz et al. 2004; Miwa et al. 2001).  Therefore, the transient 
loss of WNTs in ovine uterine LE between Days 9 and 12 may be responsible for the 
decline in expression of genes encoding components of tight and adherence junctions.  
This loss is correlated to the onset of blastocyst growth and elongation into a filamentous 
conceptus.  The physiological impact of a loss in epithelial tight junctions immediately 
preceding elongation may increase selective movement of serum or stromal derived 
molecules into the uterine lumen to stimulate the elongation of the blastocyst.  Indeed, 
P4 modulates changes in HGF, FGF7, and several members of the IGF family as well as 
increases the abundance of glucose and essential amino acids including, arginine, leucine 
and glutamine in the uterine lumen (H. Gao, G. Wu, G. A. Johnson, T.E. Spencer and 
F.W. Bazer, unpublished results).  Further, many of the proteins present in the uterine 
lumen are not directly synthesized by endometrial epithelia or the conceptus (Lee et al. 
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1998b).  The return of tight junctions in endometrial cells in response to pregnancy 
associated signals from the conceptus is hypothesized to have multiple roles in 
supporting pregnancy, including concentrating IFNT in appreciable quantities to inhibit 
luteolysis, to regulate appropriate contact between the newly implanting conceptus and 
the maternal endometrium, and by providing an immunoprotective barrier to inhibit 
targeting of the conceptus by the maternal immune system. 
In canonical WNT signaling, following stabilization and nuclear translocation, 
CTNNB1 protein complexes with TCF/LEF transcriptional activators to stimulate 
transcription of WNT target genes.  In contrast, non-canonical WNT signaling occurs 
directly in response to receptor activation and results in activation of the Rho-ROCK and 
JNK-JUN pathways.  Interestingly, available results indicate a similar trend in WNT 
signaling between the two pathways.  Indeed, in the present study, P4 induced a transient 
rise followed by a rapid decline in p-JUN, TCF7L2, and p-CREB, a previously 
characterized WNT target gene (Chen et al. 2005).  These results are expected based on 
the decline in their upstream regulators, WNT5A, WNT11, WNT7A, FZD6, and CTNNB1 
along with increasing abundance of the WNT inhibitor DKK1.  Curiously, quantitative 
analysis of LEF1 mRNA indicated relatively static expression, while in situ 
hybridization analyses revealed that cell-specific effects of P4 treatment to Day 12 to 
increase LEF1 mRNA in the LE.  The upregulation of LEF1 in the LE may be critical 
for stimulating transcription of genes encoding paracrine factors which enhance 
conceptus development and morphogenesis during early pregnancy.  This upregulation 
slightly precedes upregulation of WNT7A [ reference] and may act cooperatively to 
induce transcription of WNT7A stimulated genes. 
Knowledge gained from studies with our sheep model of early pregnancy, 
parallel that reported for mouse and human with respect to conserved mechanisms for 
maintaining appropriate conceptus/maternal synchrony and communication.  Indeed, in 
mice, prior to Day 4, Wnt/Ctnnb1 signaling is not detected in uteri of non-pregnant 
mice; however, on the morning of Day 4 the blastocyst emits a signal that activates the 
Wnt/Ctnnb1 signaling pathway first in circular smooth muscle of the myometrium and 
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subsequently in uterine LE at the site of implantation (Mohamed et al. 2005).  Inhibition 
of Wnt signaling using secreted frizzled related protein 2 resulted in a decline in the 
percentage of implanting blastocysts (Mohamed et al. 2005).  In the sheep, WNT7A 
mRNA is lost in LE by Day 12 and is susbsequently upregulated in pregnant, but not 
cyclic ewes, between Days 14 and 16 in response to conceptus derived IFNT (Kim et al. 
2003).  To date, the blastocyst derived factor responsible for the induction of the 
Wnt/Ctnnb1 signaling pathway in the mouse has not been identified. 
Collectively, broad analysis of components of both the canonical and non-
canonical WNT signaling pathways as well as downstream targets of these pathways 
reveal a general decline in WNT signaling following the essential loss of PGR from 
uterine epithelia prior to conceptus elongation.  Interestingly, signals from the elongated 
conceptus reactivate the WNT signaling network via secretion of IFNT.  The transient 
loss of WNT signaling may indeed have an essential role in synchronizing the 
developing conceptus and maternal endometrium prior to initiation of the implantation 
process as proposed for mice.  Receptivity of the endometrium is characterized by 
changes in both form and function of the epithelia.  In sheep, changes in both tight and 
adherens junctions reflect temporal changes in WNT signaling.  Although limited, 
available results illustrate that expression of tight junction associated proteins is 
regulated by members of the WNT signaling family.  These findings from studies of 
early pregnancy in sheep support the idea that alterations in junctional complexes prior 
to conceptus elongation are mediated by a loss in WNT signaling during this critical 
period and that these structural and functional changes may synchronize conceptus-
maternal communications to initiate implantation. 
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CHAPTER VI 
PROGESTERONE REGULATION OF CANDIDATE PROGESTAMEDINS AND 
THE IGF SYSTEM IN AN OVINE MODEL OF ACCELERATED CONCEPTUS 
DEVELOPMENT 
 
Introduction 
Early conceptus growth and development requires the production of secretions 
which emanate from uterine luminal (LE) and glandular (GE) epithelia to form 
histotroph (for reviews see (Bazer 1975; Carson et al. 2000; Fazleabas et al. 1994; Kane 
et al. 1997; Roberts and Bazer 1988).  In sheep, absence of uterine glands results in 
failure of the blastocyst to elongate and survive beyond Day 14 of pregnancy (Gray et al. 
2002; Gray et al. 2001c).  Indeed, an estimated 20% of blastocysts are lost between 
hatching of blastocysts from the zona pellucida and firm adhesion to the uterine 
endometrium signifying the end of implantation, which corresponds to the time of 
maternal recognition of pregnancy in domesticated livestock (Ayalon 1978; Diskin and 
Sreenan 1980; Maurer and Chenault 1983; Roche et al. 1981).  Ovarian progesterone 
(P4) is the predominant steroid hormone responsible for the production and secretion of 
uterine factors during this critical period (Spencer et al. 2004b). However, detecable 
progesterone receptor (PGR) protein is lost first within the (LE) and then the (GE) by 
Day 13 of pregnancy (Spencer and Bazer 1995; Wathes and Hamon 1993).  Loss of the 
PGR is thought to be required for initiation of epithelial gene expression required for 
uterine receptivity and blastocyst growth.  Indeed, loss of epithelial PGR is a common 
phenomenon across all mammals studied to date and is likely critical for uterine 
receptivity (Geisert et al. 1994; Lessey et al. 1988; Press and Greene 1988; Spencer and 
Bazer 1995; Spencer and Bazer 2002; Tan et al. 1999).  The endometrial stromal cells 
continue to localize PGR protein throughout pregnancy, thus it has been hypothesized 
that stromal derived factors regulated by P4 act on the adjacent epithelia as 
progestamedins to mediate P4-induced changes in epithelial gene expression.  Our 
laboratory identified fibroblast growth factor 7 (FGF7), FGF10, and hepatocyte growth 
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factor (HGF) in the ovine endometrium produced by the PGR-positive uterine stroma 
that may act to modulate P4 actions via their respective receptors in epithelia and 
trophectoderm of the conceptus, i.e., fibroblast growth factor receptor 2 (FGFR2) and 
met proto-oncogene (MET) (Chen et al. 2000a; Chen et al. 2000b).  FGF7 is an 
established paracrine growth factor of mesenchymal origin that stimulates epithelial cell 
proliferation and differentiation (Rubin et al. 1995) and mediates effects of P4 in primate 
endometria (Koji et al. 1994).  Like FGF7, FGF10 is a specific mitogen for epithelial 
cells (Igarashi et al. 1998; Lu et al. 1999).  HGF is a pleiotropic mesenchymal growth 
factor that has potent mitogenic, morphogenic, and motogenic activities on epithelial 
cells (Montesano et al. 1991; Nakamura et al. 1989; Stoker et al. 1987), angiogenic 
properties (Okada et al. 1999) and is an inhibitor of tumor growth and invasion (Shima et 
al. 1991).  Interestingly, HGF regulates human endometrial epithelial cell proliferation 
and motility (Sugawara et al. 1997). 
We have used an ovine model of accelerated blastocyst development achieved by 
the administration of exogenous P4 to elicit a premature increase in circulating 
concentrations of this hormone in blood of ewes (Satterfield et al. 2006).  This treatment 
increased blastocyst growth on Day 9 and accelerated morphological transformation 
from a spherical blastocyst to a filamentous conceptus on Day 12.  We hypothesized that 
the accelerated growth and development of the blastocyst was mediated by specific and 
accelerated changes in expression of endometrial genes.  This hypothesis was supported 
by the observation that genes encoding secreted proteins expressed by the LE, such as 
LGALS15 and CTSL, were advanced and increased by P4 treatment (Satterfield et al. 
2006).  We endeavored to determine the regulatory role of P4 on growth factor families 
which have been implicated in early conceptus development and/or uterine function. 
The insulin-like growth factor (IGF) family consists of IGF1, IGF2, and their 
receptors IGF1R and IGF2R, as well as seven high affinity IGF binding proteins 
(IGFBPs 1-7) which modulate IGF activity and bioavailability (for review see (Wang 
and Chard 1999).  IGF1 and IGF2 possess both mitogenic and differentiative properties 
and are implicated in early embryonic and placental development in a multitude of 
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species including humans, rodents, pigs, and domesticated ruminants (Baker et al. 1993; 
D'Ercole 1987; DeChiara et al. 1990; Gluckman et al. 1992; Wathes et al. 1998; Zhou 
and Bondy 1992).  In humans, IGF1R has high affinity for IGF1 and moderate affinity 
for IGF2 and is the primary functional receptor expressed in the endometrium during 
pregnancy (Wang and Chard 1999).  In sheep, IGF1R is localized to the LE, GE, and to 
a lesser extent, caruncular stromal cells and myometrium, as well as the pre-implantation 
blastocyst (Hayashi et al. 2005; Stevenson et al. 1994; Watson et al. 1999).  IGFBPs can 
both enhance or retard IGF actions (Holly and Perks 2006).  IGFBPs bind IGFs with 
high affinity and they can be cleaved by proteases yielding free IGF to act on adjacent 
cells expressing the IGF1R.  IGFBP proteases include, matrix metalloproteinases 
(MMPs), kallikreins, cathepsins, pregnancy associated plasma protein A (PAPPA), 
calpain, and serine proteases (Bunn and Fowlkes 2003; Ghosh et al. 2005; Rajah et al. 
1995).  Collectively, the mechanisms regulating IGF actions involve, with equal 
importance, the availability of receptors, the IGFBPs, and the activity of available 
proteases to regulate local concentrations of free IGF .  Gene mutagenesis studies in the 
mouse indicated critical roles for both Igf1 and Igf2 in embryonic, placental, and fetal 
growth; with Igf1 null mice being infertile (Baker et al. 1993; DeChiara et al. 1990; Liu 
et al. 1993).  Interestingly, uterine growth is not dependant upon Igf1 production by the 
uterus, but it is supported by systemic Igf1.  In pigs, the proteolytic cleavage of IGFBPs, 
to yield free IGF, has been associated with the elongation period of conceptus 
development (Lee et al. 1998a).  Early studies in the cow revealed the presence of 
mRNAs encoding IGFBPs 1-5 within the endometrium during early conceptus 
elongation (Keller et al. 1998).  Interestingly, early embryonic and fetal development in 
the cow can be stimulated by components of the GH-IGF system (Moreira et al. 2002a; 
Moreira et al. 2002b). 
Based on available information from the literature, we hypothesized that P4 
regulates expression of the stromal growth factors, FGF7, FGF10, and HGF to act as 
progestamedins on the adjacent epithelium and conceptus trophectoderm, and members 
of the IGF system to enhance the morphological transformation of spherical hatched 
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blastocysts of less than 1 mm into elongated filamentous conceptuses of over 190 mm in 
just 2 days (Guillomot et al. 1993).  To address this hypothesis, we utilized a previously 
characterized model of accelerated conceptus development induced by premature 
exposure of the uterus to P4 (Satterfield, Bazer et al. 2006).  The objectives of the 
present study were to determine the hormonal regulation of candidate progestamedins, 
FGF7, FGF10, and HGF in the ovine endometrium and identify members of the IGF 
system that may augment blastocyst growth and development in response to early P4. 
 
Materials and Methods 
Animals 
Mature Suffolk-type ewes (Ovis aries) were observed for estrus (designated as 
Day 0) in the presence of a vasectomized ram and used in experiments only after 
exhibiting at least two estrous cycles of normal duration (16-18 Days).  All experimental 
and surgical procedures were in compliance with the Guide for the Care and Use of 
Agriculture Animals in Research and Teaching and approved by the Institutional Animal 
Care and Use Committee of Texas A&M University. 
 
Experimental Design 
Study One  As described previously (Satterfield et al. 2006), ewes were mated at 
estrus to intact Suffolk rams and then assigned randomly to receive daily i.m. injections 
from Days 1.5 to 9 of either corn oil vehicle (CO; n=6) or 25 mg progesterone (P4; n=6) 
(Sigma Chemical Co., St. Louis, MO).  All ewes were hysterectomized on Day 9.  At 
hysterectomy, sections (~0.5 cm) from the mid-portion of each uterine horn ipsilateral to 
the CL were fixed in fresh 4% paraformaldehyde in PBS (pH 7.2).  After 24 h, fixed 
tissues were changed to 70% ethanol for 24 h, dehydrated through a graded series of 
alcohol to xylene, and then embedded in Paraplast-Plus (Oxford Labware, St. Louis, 
MO).  The remaining endometrium was physically dissected from myometrium, frozen 
in liquid nitrogen, and stored at -80oC for subsequent RNA or protein extraction.  In 
monovulatory pregnant ewes, uterine tissue samples were marked as either contralateral 
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or ipsilateral to the ovary bearing the CL.  No tissues from the contralateral uterine horn 
were used for further analysis. 
Study Two  As described previously (Satterfield et al. 2006), ewes were mated at 
estrus to intact Suffolk rams and assigned randomly to receive daily intramuscular (i.m.) 
injections of either: (a) CO vehicle from Days 1.5 to 12 (n=8); (b) 25 mg P4 from Days 
1.5 to 12 (n=7); or (c) 25 mg P4 (Days 1.5 to 8, n=5) and 75 mg of RU486 (Sigma), a 
PGR antagonist, from Days 8 to 12 (P4+RU).  All ewes were hysterectomized on Day 12, 
and the uteri were then processed as described for Study One. 
 
RNA Isolation 
Total cellular RNA was isolated from frozen ipsilateral endometrium (Studies 
One and Two) using Trizol reagent (Gibco-BRL, Bethesda, MD) according to 
manufacturer’s instructions.  The quantity and quality of total RNA was determined by 
spectrometry and denaturing agarose gel electrophoresis, respectively. 
 
Real-Time PCR Analysis 
The cDNA was synthesized from uterine total RNA (5 µg) using random primers 
(Invitrogen, Carlsbad, CA), oligo (deoxythymidine) primers, and SuperScript II Reverse 
Transcriptase (Invitrogen) as described previously (Stewart et al. 2000). Newly 
synthesized cDNA was acid-ethanol precipitated, resuspended in 20 µl water, and stored 
at –20ºC. PCR analysis of FGF7, FGF10, and HGF mRNA expression was performed 
using an ABI PRISM 7700 (Applied Biosystems, Foster City, CA) with SYBR Green 
PCR Master Mix (Applied Biosystems) as the detector, according to manufacturer’s 
recommendations, as described previously (Kim et al. 2003). Primers were designed to 
amplify cDNAs of less than 100 bp to maximize efficiency (Table 1). PCR cycle 
parameters were 95ºC for 15 sec and 60ºC for 1 min for 40 cycles. Data were analyzed 
by using GeneAmp 5700 SDS software (version 1.4, Applied Biosystems). The threshold 
line was set in the linear region of the plots above the baseline noise, and threshold cycle 
(CT) values were determined as the cycle number at which the threshold line crosses the 
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amplification curve.  PCR without template or template substituted with total RNA was 
used as a negative control to verify experimental results. The results are expressed as raw 
CT values for each target gene mRNA. 
 
In Situ Hybridization Analysis 
Location of IGF1, IGF2, IGF1R, IGFBP1, IGFBP2, IGFBP3, IGFBP4, PAPP-A, 
IGFBP5, IGFBP6, IGFBP7, MET, and FGFR2 mRNAs in ovine uteri was determined 
by radioactive in situ hybridization analysis as described previously (Spencer et al. 
1999c).  Radiolabeled antisense and sense cRNA probes were generated by in vitro 
transcription using linearized partial plasmid cDNA templates (Chen et al. 2000a; Chen 
et al. 2000b; Hayashi et al. 2007), RNA polymerases, and [α-35S]-UTP.  Deparaffinized, 
rehydrated and deproteinated uterine tissue sections were hybridized with radiolabeled 
antisense or sense cRNA probes.  After hybridization, washing and ribonuclease A 
digestion, slides were dipped in NTB-2 liquid photographic emulsion (Kodak, Rochester, 
NY), and exposed at 4oC for between 5 and 30 days based on intensity of radioactive 
signal of slides placed on MR Kodak film for 16 h.  All slides for each respective gene 
were exposed to photographic emulsion for the same period of time.  Slides were 
developed in Kodak D-19 developer, counterstained with Gill’s hematoxylin (Fisher 
Scientific, Fairlawn, NJ), and then dehydrated through a graded series of alcohol to 
xylene.  Coverslips were then affixed with Permount (Fisher).  Images of representative 
fields were recorded under brightfield or darkfield illumination using a Nikon Eclipse 
1000 photomicroscope (Nikon Instruments Inc., Lewisville, TX) fitted with a Nikon 
DXM1200 digital camera. 
 
Slot Blot Hybridization Analysis 
Steady-state levels of MET, FGFR2, IGF1, IGF2, IGFBP1, IGFBP2, IGFBP3, 
IGFBP4, PAPPA, IGFBP5, IGFBP6, and IGFBP7 mRNAs in endometria were assessed 
by slot blot hybridization as described previously (Spencer et al. 1999c).  Briefly, 
radiolabeled antisense cRNA probes were generated by in vitro transcription using 
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linearized plasmid templates containing partial cDNAs, RNA polymerases, and [α-32P]-
UTP.  Denatured total endometrial RNA (20 µg) from each ewe in Studies One and Two 
was hybridized with radiolabeled cRNA probes.  To correct for variation in total RNA 
loading, a duplicate RNA slot blot membrane was hybridized with radiolabeled antisense 
18S cRNA (pT718S; Ambion, Austin, TX).  Following washing, the blots were digested 
with ribonuclease A and radioactivity associated with slots was quantified using a 
Typhoon 8600 MultiImager (Molecular Dynamics, Piscataway, NJ).  Data are expressed 
as relative units (RU). 
 
Radioimmunoassay 
Total IGF1 protein was determined in uterine flushings using an IGF1 RIA kit 
(Mediagnost, Reutlingen, Germany) according to manufacturer’s instructions.  Briefly, 
samples of uterine flushings were prepared by acidification with acidification buffer at a 
rate of 10:1 uterine flush, to buffer.  Total counts, standards, non-specific binding, and 
quality controls samples (duplicate) and unknown samples (triplicate) were then mixed 
with appropriate reagents in 12 x 75 mm polypropylene tubes.  Samples remained at 4ºC 
for 48 h and were centrifuged at 3500 g for 30 min following addition of appropriate kit 
components.  All tubes except total counts were decanted gently and blotted to remove 
excess liquid.  Tubes were then quick spun to ensure that all precipitates were located at 
the bottom of the tube and quantified using a gamma counter.  Assay results were 
calculated using the AssayZap Version 3.1 program (Biosoft, Ferguson, CA). 
 
Photomicroscopy 
Photomicrographs were taken using a Nikon Eclipse E1000 photomicroscope 
(Nikon Instruments, Melville, NY).  Digital images were captured using a Nikon DXM 
1200 digital camera and assembled using Adobe Photoshop 7.0 (Adobe Systems, Seattle, 
WA). 
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Statistical Analyses 
Data from RIA, slot blot hybridization, and real-time PCR analyses were 
subjected to least-squares analysis of variance using the General Linear Models 
procedures of the Statistical Analysis System (SAS Institute, Cary, NC).  Slot blot 
hybridization data were corrected for differences in sample loading by using the 18S 
rRNA data as a covariate.  Data are presented as the least-squares means (LSM) with 
overall standard error (SE).  Analysis of PCR data incorporated the cyclophilin values as 
a covariate in the statistical model to correct for differences in the amounts of reverse 
transcriptase cDNA analyzed for each uterus.  In all analyses, error terms used in tests of 
significance were identified according to the expectation of the mean squares for error.  
Data are presented as LSM of untransformed values. 
 
Results 
We previously reported that premature exposure of the endometrium to P4 
beginning on Day 1.5 post-estrus increased blastocyst diameter 2.2-fold on Day 9 and 
accelerated the morphological transformation of the spherical blastocyst into a 
filamentous conceptus by Day 12.  Administration of the PGR antagonist, RU486, from 
Day 8 to Day 12, resulted in demise of conceptuses on Day 12.  In addition, early P4 
resulted in premature loss of PGR from LE and GE, although ewes receiving RU486 
exhibited a return of PGR protein to GE on Day 12 (Satterfield et al. 2006). 
 
FGF7, FGF10, and HGF and their Receptors 
FGF7, FGF10, and HGF expressed in stromal cells of ovine endometria (Chen et 
al. 2000a; Chen et al. 2000b) are hypothesized to act via their respective epithelial 
specific receptors to mediate P4 action and modulate epithelial gene expression and 
function (Chen et al. 2000a; Chen et al. 2000b).  Real-time PCR was used to measure 
steady-state levels of FGF, FGF10, and HGF mRNA in endometria (Figure 6.1A and 
6.1B).  In Study One, FGF7 mRNA levels were 13.9-fold higher (P<0.02) in endometria 
of P4 than CO ewes on Day 9; however, FGF7 mRNA levels did not differ (P>0.10) in 
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between endometria of P4 and CO ewes on Day 12.  In contrast, FGF7 mRNA levels 
were 5.7 fold lower (P<0.03) in endometria of P4+RU treated ewes compared to P4-
treated ewes on Day 12.  FGF10 mRNA levels were not different (P>0.10) between CO- 
and P4-treated ewes on either Day 9 or Day 12; however, FGF10 mRNA was reduced 
24.3-fold (P<0.005) in P4+RU- compared to P4-treated ewes on Day 12.  In Study One, 
HGF mRNA levels were 6.3-fold higher (P<0.001) in endometria of P4 as compared to 
CO ewes on Day 9; however, HGF mRNA levels did not differ (P>0.10) between 
endometria of P4 and CO ewes on Day 12.  In contrast, HGF mRNA levels were 6.8-
fold lower (P<0.04) in endometria of P4+RU- compared to P4-treated ewes. 
Endometrial MET mRNA levels tended to be higher (P<0.07) in endometria of 
P4-treated ewes on Day 9 (Figure 6.1C).  MET mRNA levels were higher (P<0.05) in 
P4-treated as compared to CO ewes on Day 12, and endometria of P4+RU-treated ewes 
had lower (P<0.04) levels of MET mRNA compared to P4-treated ewes.  In situ 
hybridization localized MET mRNA to endometrial LE and GE (Figure 6.1D).  
Endometrial FGFR2 mRNA levels were not different (P>0.10) between CO and P4-
treated ewes on Day 9 or Day 12, but P4+RU treated ewes had higher (P<0.001) levels 
of FGFR2 mRNA compared to P4-treated ewes on Day 12 (Figure 6.1C).  FGFR2 
mRNA was predominantly present in endometrial LE and GE and decreased within 
these cells types from Day 9 to Day 12 (Figure 1D). 
 
IGF1, IGF2 and the IGF1R 
Steady-state mRNA levels of IGF1 were not different (P>0.10) in between 
endometria of CO and P4 treated ewes on Day 9 or Day 12, although IGF1 mRNA was 
reduced (P=0.0002) in endometria of CO ewes on Day 12 compared to Day 9 (Figure 
6.2A).  IGF1 mRNA was present primarily in caruncular and intercaruncular stromal 
cells (Figure 6.2B).  IGF2 mRNA levels were also not different (P>0.10) between CO 
and P4-treated ewes in Study One; however, IGF2 mRNA levels tended (P<0.06) to be 
lower in P4+RU- compared to P4-treated ewes (Figure 6.2A).  IGF2 mRNA was present 
only in stromal cells of ewes receiving CO or P4 to Days 9 and 12.  In contrast, IGF2 
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mRNA was most abundant in LE of uteri from P4+RU ewes (Figure 6.2B).  Steady-state 
mRNA levels of IGF1R were not different between ewes on Day 9 or Day 12 (data not 
shown); however, IGF1R mRNA was localized predominantly in uterine LE and GE 
(Figure 6.2B). 
 
IGF1 Protein Levels within the Uterine Flush 
Results of the radioimmunoassay to detect IGF1 protein in uterine flushings  
following removal of IGFBPs by acidification indicated that total IGF1 was 2-fold lower 
(P=0.0007) in the uterine lumen of P4-treated ewes on Day 9 (Figure 6.3), but not 
different (P>0.10) in the uterine lumen on Day 12. 
 
 
 
 
FIG. 6.1.  Effects of treatments with CO, P4, or P4+RU on endometrial FGF7, FGF10, 
and HGF mRNAs.   [A-B] Steady-state levels of FGF7, FGF10, and HGF mRNAs in 
endometria from Day 9 (Study One) and Day 12 (Study Two) ewes were determined by 
real-time PCR.  In Study One, P4 increased amounts of FGF7 (P<0.02) and HGF 
(P<0.001) mRNAs 13.9- and 6.3 fold, respectively on Day 9, but not on Day 12.  In 
contrast, P4+RU treated ewes reduced FGF7(P<0.03), FGF10 (P<0.005), and HGF 
(P<0.04) 5.7-, 24.3-, and 6.8-fold, respectively.  Data are presented as raw CT values 
using cyclophilin as a covariate.   
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FIG. 6.1.cont.  [C] Steady-state levels of MET and FGFR2 mRNA in endometria from 
Day 9 (Study One) and Day 12 (Study Two) ewes.  MET mRNA tended to increase 
(P<0.07) in P4-treated ewes on Day 9 and increased (P<0.05) in P4-treated ewes on Day 
12.  P4+RU-treated ewes had lower (P<0.04) quantities of MET mRNA compared to P4-
treated ewes on Day 12.  FGFR2 mRNA was not different (P>0.10) between CO and P4-
treated ewes on either Day 9 or Day 12; however, P4+RU treated ewes had higher 
(P<0.001) quantities of FGFR2 mRNA compared to P4-treated ewes on Day 12.  [D] In 
situ localization of epithelial specific FGFR2 and MET which act as receptors for FGF7 
and FGF10 and HGF, respectively.  Cross-sections of uteri were hybridized with 
radiolabeled antisense or sense ovine cRNA probes for each respective gene.  Legend: 
LE, luminal epithelium. 
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FIG. 6.2.  Effects of treatments with CO, P4, or P4+RU on endometrial IGF1, IGF2, and 
IGF1R mRNAs.  [A] Steady-state levels of IGF1 and IGF2 mRNAs in endometria from 
Day 9 (Study One) and Day 12 (Study Two) ewes, as determined by slot blot analysis.  
IGF1 and IGF2 mRNAs were not affected (P>0.10) by P4 treatment on Day 9 or Day 12.  
P4+RU-treated ewes had lower (P<0.03) quantities of IGF2 mRNA than P4-treated ewes.  
[B] In situ localization of IGF1, IGF2 and IGF1R mRNAs in endometria of Day 9 
(Study One) and Day 12 ewes (Study Two) are presented.  Cross-sections of uteri were 
hybridized with radiolabeled antisense or sense ovine cRNA probes for each respective 
gene.  Legend: LE, luminal epithelium; S, stroma; GE, glandular epithelium. 
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FIG. 6.3.  Effects of CO, P4, or P4+RU on total IGF1 protein in uterine flushings.  Total 
IGF1 protein in uterine flushings was determined by radioimmunoassay following 
acidification of samples to remove IGFBPs.  Total IGF1 protein was reduced (P=0.0007) 
by P4 on Day 9,but there was no effect (P>0.10) of treatment on Day 12.   
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Stromal IGFBPs 
Seven high affinity IGF binding proteins have been identified to date that 
modulate IGF bioavailability (Holly and Perks 2006; Tamura et al. 2007).  Steady-state 
levels of endometrial IGFBP mRNAs are presented in Figure 4 and their localization by 
in situ hybridization in Figs. 6.5 and 6.6.  In situ hybridization analysis revealed that 
IGFBPs 2, 4, 5, 6, and 7 were expressed predominantly in stromal cells of 
intercaruncular and caruncular endometria (Figure 6.5 and 6.6).  IGFBP5 was also 
expressed in LE on Day 9. 
IGFBP2 mRNA levels were not different (P>0.10) between CO and P4-treated 
ewes on Days 9 and 12 or between CO ewes on Days 9 and 12; however, IGFBP2 
mRNA was 2-fold greater (P<0.02) in P4+RU- compared to P4-treated ewes on Day 12 
(Figure 6.4).  IGFBP4 and its known protease, PAPPA, were unaffected (P>0.10) by P4 
treatment on Days 9 and 12 and were not different (P>0.10) between CO ewes on Days 9 
and 12.  IGFBP5 mRNA was decreased (P<0.01) in P4 ewes on Day 9.  There was no 
difference (P>0.10) in IGFBP5 mRNA between CO and P4-treated ewes on Day 12 or 
between CO ewes on Days 9 and 12; however, IGFBP5 mRNA levels were 3-fold 
greater (P<0.0001) in P4+RU- compared to P4-treated ewes.  IGFBP6 mRNA was not 
different (P>0.10) between CO and P4-treated ewes on Day 9, but IGFBP6 mRNA was 
lower (P<0.03) in P4-treated than CO- and P4+RU-treated ewes on Day 12.  IGFBP6 
mRNA levels did not differ (P>0.10) between CO ewes on Days 9 and 12.  IGFBP7 
mRNA did not differ (P>0.10) between CO and P4-treated ewes on Day 9 or Day 12 
although, however IGFBP7 mRNA levels were 2-fold greater (P<0.001) in P4+RU- 
treated than P4-treated ewes on Day 12.  IGFBP7 mRNA levels tended to be lower 
(P<0.07) in endometria of CO ewes on Day 12 as compared to Day 9. 
IGFBP5 mRNA decreased to undetectable levels in the LE between Day 9 and 
Day 12 (Figure 6.5).  Interestingly, IGFBP5 and IGFBP7 mRNAs were also localized to 
stromal cells immediately surrounding the uterine vasculature (Figs. 6.5 & 6.6).  
IGFBP5 mRNA was increased in stroma and myometrium of P4+RU ewes on Day 12.  
IGFBP7 mRNA was also localized to the myometrium in CO ewes on Day 9 and was 
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reduced by P4 (data not shown).  IGFBPs 2, 4, 6 mRNAs and PAPPA mRNA were 
undetectable in stromal cells specifically surrounding the uterine vasculature and in 
myometrium. 
 
 
 
FIG. 6.4.  Effects of CO, P4, or P4+RU on endometrial IGFBP2, IGFBP4, IGFBP5, 
IGFBP6, IGFBP7, and PAPPA mRNAs. [A] Steady-state levels of IGFBP2, IGFBP4, 
IGFBP5, IGFBP6, IGFBP7, and PAPPA mRNAs in endometria from Day 9 (Study 
One) and Day 12 (Study Two) ewes, as determined by slot blot analysis.  In Study One, 
IGFBP5 was reduced (P<0.01) by P4 on Day 9.  In Study Two, IGFBP2 (P<0.04), 
IGFBP5 (P<0.0001), and IGFBP7 (P<0.0001) increased in P4+RU treated ewes on Day 
12.  IGFBP6 mRNA was decreased (P<0.03) in P4- compared to CO- and P4+RU-
treated ewes on Day 12.  There was no effect of treatment on IGFBP4 or PAPPA on 
either Day 9 or Day 12.         
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FIG. 6.5.  Localization of stromal IGFBPs in ovine endometria.  In situ localization of 
IGFBP2, IGFBP4, and IGFBP5 mRNAs in endometria of Day 9 (Study One) and Day 
12 ewes (Study Two).  Cross-sections of uteri were hybridized with radiolabeled 
antisense or sense ovine cRNA probes for each respective gene.  Legend: LE, luminal 
epithelium; S, stroma; GE, glandular epithelium; CAR, caruncular stroma.  
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FIG. 6.6.  Localization of stromal IGFBPs in ovine endometria.  In situ localization of 
IGFBP6, IGFBP7, and PAPPA mRNAs in endometria of Day 9 (Study One) and Day 12 
ewes (Study Two).  Cross-sections of uteri were hybridized with radiolabeled antisense 
or sense ovine cRNA probes for each respective gene.  Legend: LE, luminal epithelium; 
S, stroma; CAR, caruncular stroma; and BV, blood vessel. 
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IGFBPs 1 and 3 in the Uterine LE 
In situ hybridization analyses revealed that IGFBP1 and IGFBP3 mRNAs were 
present specifically in LE and sGE (Figure 6.7A).  Endometrial IGFBP1 mRNA was 9-
fold higher (P<0.02) in P4-treated ewes on Day 9 (Figure 6.7B).  IGFBP1 levels 
increased 28-fold from Day 9 to Day 12 in CO ewes, but there was no difference 
(P>0.10) in IGFBP1 mRNA between CO- and P4-treated ewes on Day 12.  IGFBP1 
mRNA was 10-fold lower (P<0.0001) in P4+RU- compared to P4-treated ewes on Day 
12.  IGFBP3 mRNA was increased 3-fold (P<0.005) in P4-treated ewes on Day 9 
(Figure 6.7A).  IGFBP3 mRNA levels increased 6.4 fold (P<0.03) in endometria of CO 
ewes on Day 12 as compared to Day 9.  In Study Two, IGFBP3 mRNA was reduced 2-
fold (P<0.03) in P4+RU- compared to P4-treated ewes.  In situ hybridization detected 
mRNAs for IGFBP1 and IGFBP3 in LE and superficial GE of the ovine endometria 
(Figure 6.7B). 
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FIG. 6.7.   Effects of treatments with CO, P4, or P4+RU on endometrial IGFBP1 and 
IGFBP3 mRNAs.  [A] Steady-state levels of IGFBP1 and IGFBP3 mRNAs in 
endometria from Day 9 (Study One) and Day 12 (Study Two) ewes determined by slot 
blot analysis.  IGFBP1 (P>0.02) and IGFBP3 (P>0.005) mRNAs were increased by P4 
on Day 9,but not on Day 12.  However, P4+RU-treated ewes expressed less IGFBP1 
(P<0.0001) and IGFBP3(P<0.03) mRNAs than CO- and P4-treated ewes.  [B] In situ 
localization of IGFBP1 and IGFBP3 mRNAs in endometria of Day 9 (Study One) and 
Day 12 ewes (Study Two).  Cross-sections of uteri were hybridized with radiolabeled 
antisense or sense ovine cRNA probes for each gene.  Legend: LE, luminal epithelium. 
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Discussion 
This study determined the role of P4 in regulating candidate stromal derived 
growth factors hypothesized to act on uterine epithelia as progestamedins and members 
of the IGF system.  Results indicate that P4 differentially regulates FGF7, FGF10, HGF, 
MET, FGFR2, IGF1, IGF2, IGFBP1, IGFBP2, IGFBP3, IGFBP5, IGFBP6, and 
IGFBP7 in a temporal and spatial manner which is hypothesized to result in a uterine 
environment conducive to blastocyst growth and development.  Indeed, FGF7 and HGF 
mRNAs were increased by P4 treatment on Day 9.  Further, inhibition of P4 action with 
RU486, a PGR antagonist, decreased expression of all three candidate progestamedins 
(FGF7, FGF10, and HGF), supporting the hypothesis that these growth factors act as 
progestamedins to mediate P4 actions on uterine epithelia.  Indeed, P4 upregulation of 
FGF7 and HGF coincides with loss of PGR protein from the epithelia (Satterfield et al. 
2006) suggesting that these molecules may mediate P4 effects on epithelial gene 
expression and function.  Further, we have previously reported that genes encoding 
secreted proteins expressed in the LE such as LGALS15 and CTSL were increased by P4 
treatment (Satterfield et al. 2006).  Indeed, expression of LGALS15 and CTSL requires 
loss of PGR from uterine epithelia (Gray et al. 2006; Satterfield et al. 2006; Song et al. 
2005), but it has yet to be determined if these genes are regulated by either FGF7 or 
HGF acting via FGFR2 or MET on LE.  Roles for FGF7, FGF10, and HGF in mediating 
the actions of steroid hormones has also been reported for the primate uterus with FGF7 
being produced in stromal cells in response to P4 (Koji et al. 1994); while HGF regulates 
human endometrial cell proliferation and motility (Sugawara et al. 1997) and mediates 
estrogen actions in the primate uterus (Brenner et al. 1997). 
HGF regulates epithelial morphology and function (Kamalati et al. 1999).  
Alterations in epithelial junctional complexes occur in several forms of cancer in 
response to HGF actions via MET/beta catenin (CTNNB1) complexes (Davies et al. 
2001; Hiscox and Jiang 1999; Murai et al. 2004).  These alterations increase the invasive 
properties of cells.  During pregnancy, we reported a transient reduction in CTNNB1 and 
CDH1 localized to the membranes of uterine epithelia following treatment of ewes with 
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P4 to Day 9 that upregulated expression of HGF (Satterfield et al. 2007).  These 
alterations along with a reduction in tight junction complexes at the same time increase 
permeability of uterine epithelia to stromal and/or serum derived factors such as glucose, 
amino acids, ions and growth factors which may stimulate blastocyst growth and 
development.  Receptors for these growth factors are also expressed by ovine conceptus 
trophectoderm (Chen et al. 2000a; Chen et al. 2000b); therefore, FGF7, FGF10, and 
HGF may stimulate conceptus proliferation and differentiation directly.  Indeed, HGF 
signaling in the trophoblast is aberrantly regulated during preeclampsia (Kauma et al. 
1999; Nasu et al. 2000) and results in increased trophoblast apoptosis (Dash et al. 2005).  
The anti-apoptotic role of HGF was linked to glycogen synthase kinase-3beta and beta 
catenin which acted in concert to increase expression of inducible nitric oxide synthase. 
The IGF system plays a critical role in many developmental processes and is a 
primary determinant of prenatal and postnatal fetal growth.  Available results indicate 
that IGF1 is not regulated by P4, although a reduction in steady-state mRNA levels was 
observed between Days 9 and 12 of pregnancy.  In contrast, IGF2 is regulated by P4 in a 
cell specific manner suggesting differential roles for IGF2 in uterine function and 
conceptus development.  The induction of IGF2 mRNA in LE following P4 inhibition 
suggests that P4 suppresses IGF2 expression in LE.  In contrast, increased expression 
within the caruncular and stratum compactum stromal cells by P4 suggests a more 
classical epithelial/mesenchymal role for IGF2 in pregnancy, possibly increasing the 
secretory activity of the epithelia via its receptor in LE and GE.  This idea is supported 
by evidence that, in human endometria, IGF1 is preferentially expressed during the 
proliferative phase while IGF2 is expressed in the mid to late secretory phase and in 
early pregnancy to regulate differentiated functions of the endometrium (Giudice et al. 
1993). 
IGF is hypothesized to act on the developing conceptus as well.  Indeed, both 
ovine and bovine conceptuses express IGF1R (Watson et al. 1999).  Previous research, 
primarily utilizing in vitro cultured embryos, elucidated both proliferative and anti-
apoptotic roles for IGF1 (Block et al. 2003; Byrne et al. 2002; Sirisathien and Brackett 
 125
2003).  The protective effects of IGF1 increased during periods of heat stress (Jousan 
and Hansen 2007).  Extension of the roles of IGF1 to the elongation stage of conceptus 
development has not been achieved to date.  Since blastocysts do not elongate in culture, 
it is not possible to monitor the effects of IGF1 on conceptus development during the 
morphological transformation from spherical to tubular and filamentous conceptuses. 
Interestingly, although IGF1 mRNA levels did not differ on Day 9, total IGF1 
protein in uterine flushings was reduced by half in P4-treated ewes.  Total IGF1 on Day 
12 did not differ between treatment groups similar to the pattern of mRNA expression.  
It is possible that a very narrow window exists on Day 9 whereby the developing 
blastocyst has relatively unrestricted access to free IGF prior to upregulation of epithelial 
IGFBPs 1 and 3.  If so, the reduction in total IGF1 protein may result from its rapid 
utilization by blastocysts.  This access may be attenuated by rapid upregulation of LE 
specific IGFBPs to sustain a more constant level of total IGF protein.  It is important to 
remember that only free IGF is available to the conceptus and that measures of total 
IGF1 protein based on our RIA is not a true measures of bioavailability, but only total 
quantity of IGF.  Interestingly, early conceptus development in cows can be stimulated 
by components of the GH-IGF system (Moreira et al. 2002a; Moreira et al. 2002b).  
Administration of bovine somatototropin (bST) enhances pregnancy rates in lactating 
dairy cows, possibly via alterations in the IGF system (Moreira et al. 2001; Moreira et al. 
2000),  and also increased pregnancy rate, conceptus length, and IFNT secretion on Day 
17 (Bilby et al. 2006a; Bilby et al. 2006b).  These effects were accompanied by 
increased circulating concentrations of IGF1 in serum.  In mice, systemic IGF1 rather 
than local IGF1 mediates estrogen-induced uterine growth and proliferation(Sato et al. 
2002) 
As modulators of IGF bioavailability, the IGFBPs present dynamic complexity to 
understanding IGF functions.  Temporal and spatial alterations in expression of IGFBPs 
in P4-advanced uteri provide insight into potential regulatory functions of these 
molecules.  IGFBPs 1-6 have been identified and characterized in ovine endometria 
during early pregnancy (Gadd et al. 2000; Gadd et al. 2002; Osgerby et al. 1999; 
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Reynolds et al. 1997) results of the present study using in situ hybridization revealed that 
IGFBPs 2, 4, 5, 6, and 7 are expressed predominantly by stromal cells on Days 9 and 12 .  
Interestingly, the majority of these IGFBPs were most abundant in ewes treated with 
RU486, a PGR antagonist.  These findings suggest that IGFBPs localized to the stroma 
sequester IGF which inhibits their ability to effect actions on uterine epithelia.  A 
reduction in availability of free IGF may, in part, account for the early demise of 
blastocysts in P4+RU-treated ewes. 
IGFBP1 and IGFBP3 were specifically expressed within LE and superficial GE.  
Both IGFBP1 and 3 were expressed at low levels on Day 9 in CO-treated ewes and 
strongly induced by P4 suggesting that these modulators of IGF action have a critical 
role in regulating early conceptus development and may act as mediators of cross-talk 
between the uterus and developing conceptus.  This hypothesis is supported by the 
reduction of IGFBP1 and IGFBP3 mRNAs following inhibition of P4 actions with 
RU486.  Limited results exists on the presence of IGFBPs in the uterine lumen; however,  
IGFBP3 is the predominant IGFBP in the uterine lumen during early pregnancy in sheep 
(Peterson et al. 1998) and cattle (Keller et al. 1998).  Interestingly, treatment of ewes 
with P4 for 10 days resulted in proteolysis of IGFBP3 which would theoretically 
increase bioactive IGF available to the conceptus; however, treatment with P4 for 15 
days subsequently decreased protease activity via apparent upregulation of an 
unidentified protease inhibitor.  Thus, available studies support P4-induction of IGFBP3 
and actions of proteases to cleave IGFBP3 to release free IGF for rapid utilization by 
developing blastocysts.  Other IGFBPs were present in the uterine lumen at significantly 
lower abundances (Keller et al. 1998; Peterson et al. 1998), but further supporting the 
importance of IGFBPs from uterine epithelia.  Interestingly, these studies did not 
identify IGFBP1 in uterine flushings despite expression of IGFBP1 within the adjacent 
epithelium and its regulation by P4. 
The upregulation of IGFBP1 during the peri-implantation period of pregnancy is 
not a unique event to sheep.  Indeed, IGFBP1 is a highly upregulated gene within the 
human secretory endometrium during the period of uterine receptivity to implantation 
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(Kao et al. 2002).  Similarly, IGFBP1 is the primary secretory product of uterine 
decidual cells in the baboon (Fazleabas et al. 1993).  IGFBP1 has actions independent of 
the IGF system (Gleeson et al. 2001; Irwin and Giudice 1998).  IGFBP1 contains an 
RGD sequence and can act as a ligand for integrins such as α5β1.  IGFBP1 stimulated 
migration of human trophoblast cells was attenuated by mutation of the RGD sequence 
to WGD or pretreatment with an inhibitory peptide (Gleeson et al. 2001). 
Curiously, in humans, overexpression of IGFBP1 has been detected during 
preeclampsia, a condition in pregnancy believed to result from superficial invasion of the 
placental trophoblast into the maternal endometrium resulting in fetal growth retardation 
and possibly pregnancy loss (Anim-Nyame et al. 2003; Giudice et al. 1997).  These 
findings support a role for IGFBP1 as an integrin ligand responsible for maintaining 
appropriate fetal/maternal contact and regulating the invasion of the embryo into the 
endometrium, a process believed to be aberrantly regulated in the development of 
preeclampsia.  At present, the mechanisms by which this may occur are unknown.  
Similar observations were made in mice following overexpression of IGFBP1 which 
resulted in abnormal trophoblast invasion and differentiation, increased placental mass, 
and intrauterine fetal growth retardation (Ben Lagha et al. 2006; Crossey et al. 2002).  
An increase in placental mass coincident with fetal intrauterine growth retardation 
indicates that IGFBP1 mediated invasion by developing blastocysts manifests long-term 
consequences resulting in placental insufficiency.  Despite markedly different 
implantation schemes between primates, rodents, and ruminants, IGFBP1 is a highly 
upregulated gene within endometria of all these mammals.  The upregulation of this 
gene during implantation across species with differing implantation schemes suggests a 
critical conserved function for conceptus development and survival, although the 
mechanism remains elusive.  In sheep, elongation of the spherical blastocyst is a uterine 
dependent event (Flechon et al. 1986) that correlates with loss of PGR and the anti-
adhesive MUC1 glycocalex from the LE exposing LE integrins (Johnson et al. 2001a; 
Spencer and Bazer 1995) and induction of the integrin ligand IGFBP1.  IGFBP1 may 
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play a central role in mediating blastocyst/uterine interactions required for elongation 
and implantation. 
The present study is a first step in identifying progesterone regulated genes 
which are implicated in enhancing elongation of the blastocyst; a process required for 
the production of sufficient IFNT to block the luteolytic mechanism and maintain 
pregnancy.  In this study, IGFBPs 1 and 3 as well as FGF7 and HGF were identified as 
potential critical regulators of endometrial function and/or conceptus development.  
Future studies will mechanistically dissect the role of each of these factors in sustaining 
pregnancy. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 129
CHAPTER VII 
SUMMARY AND CONCLUSIONS 
 
Summary 
Progesterone is unequivocally required for successful pregnancy and mediates 
peri-implantation conceptus growth and development via actions on the endometrium.  
This research utilized a model of accelerated conceptus development achieved via early 
administration of P4 (beginning 36 h after mating) to elucidate mechanisms of P4 
actions including expression of P4-regulated genes important for blastocyst growth and 
development in sheep.  Results of the present studies are the first to identify endometrial 
P4 regulated genes in the sheep utilizing a model of early exogenous P4 treatment.   
The importance of an early rise circulating concentrations of P4 to promote 
conceptus growth and development and production of IFNT is well established (Mann et 
al. 2006; Mann and Lamming 2001).  Further, administration of early exogenous 
progesterone illustrated that this treatment advances uterine functions and accelerates 
conceptus growth and development in sheep (Kleemann et al. 1994) and cattle (Garrett 
et al. 1988b).  The acceleration of conceptus growth is believed to result from an 
increased or advanced secretory capacity of the endometrium as evidenced by alterations 
in secreted proteins from bovine endometrium on Day 5 following early P4 (Garrett et al. 
1988b); however, no specific proteins were identified in that study.  Data from UGKO 
ewes illustrated a requirement for secretions from LE and GE to support conceptus 
development beyond Day 14 (Gray et al. 2002; Gray et al. 2001c).  Despite the 
importance of secreted factors from the endometrium, little is known about functions of 
components of uterine histotroph and temporal changes in expression of these molecules 
associated with different stages of implantation.   
Indentifying mechanisms whereby progesterone regulates conceptus growth and 
development utilizing a molecular biology approach is a first step in determining 
strategies to reduce the economic losses associated with pregnancy failure in in domestic 
species of livestock.  Development and characterization of an ovine model of accelerated 
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conceptus development during the peri-implantation period was undertaken (CHAPTER 
III).  As expected, early administration of progesterone resulted in a premature and 
sustained rise in circulating concentrations of P4.  Administration of P4 from Days 1.5 to 
Day 9 increased mean blastocyst diameter 2.2-fold over blastocysts from CO ewes.  
Administration of P4 from Days 1.5 to Day 12 advanced the morphological 
transformation from a spherical blastocyst to a filamentous conceptus.  Administration 
of the PGR antagonist RU486 from Days 8 to Day 12 to block progesterone action 
resulted in demise of conceptuses.  These observations demonstrate the ability of P4 to 
enhance blastocyst growth and development in sheep.  The premature exposure of the 
endometrium to P4 accelerated loss of PGR from LE and GE which may initiate 
reprogramming of the epithelia to increase secretory activity due directly to loss of PGR 
or via upregulation of a stromal cell-derived factor responsive to P4.  Western blot and 
protein slot blot analyses revealed that elongated filamentous conceptuses on Day 12 
produced greater quantities of IFNT than spherical or tubular conceptuses from CO ewes, 
with no IFNT being detected from ewes receiving RU486.  The increase in IFNT is 
important for multiple reasons.  First, IFNT is the pregnancy recognition signal and 
higher levels of IFNT should improve the likelihood for successful maternal recognition 
of pregnancy.  Second, IFNT induces or enhances the expression of a number of genes 
important for endometrial function and implantation.  To determine if the increase in 
IFNT increased expression of known IFNT stimulated genes in the endometrium in a 
manner synchronous to the stage of the conceptus, slot blot and in situ hybridization 
techniques were employed.  Indeed, CTSL and RSAD2, two previously characterized 
IFNT stimulated genes (Song et al. 2007; Song et al. 2005), were upregulated early in 
P4-treated ewes on Day 12 as compared to CO or P4+RU-treated ewes.  Collectively, 
these findings establish and characterize a model system that can be explored to 
understand P4 actions on the uterine endometrium. 
LGALS15, a recently characterized molecule in the ovine endometrium induced 
by P4 and further stimulated by IFNT, is hypothesized to enhance conceptus 
development and elongation via its adhesive properties (Farmer et al. 2007; Gray et al. 
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2006; Gray et al. 2004; Lewis et al. 2007).  In support of this hypothesis, results of the 
present studies confirmed that LGALS15 was indeed induced by P4 and stimulated by 
IFNT (CHAPTER III).  Further, the increase in LGALS15 protein expressed along the 
apical surface of the LE increased in uterine flushings in response to early P4 treatment.  
LGALS15 expression was ablated by administration of RU486.  Collectively, available 
data from UGKO ewes (Gray et al. 2004) and present findings support a role for 
LGALS15 in early conceptus growth and development.   
 Existing information regarding uterine histotroph indicate the existence of factors 
of non-endometrial origin in the uterine lumen (Lee et al. 1998b).  The specific identity 
and origin of many of these factors is unknown as is the mechanism by which these 
factors reach the uterine lumen.  Interestingly, evidence obtained by injection of tracer 
compounds into the uterus suggested that molecules may enter the uterine luminal space 
via trafficking through the paracellular space between adjacent epithelial cells 
(Guillomot et al. 1986; Guillomot et al. 1981).  The permeability of this space is 
regulated by abundance of specific tight junction associated proteins that are inversely 
proportional to permeability of the tissue (Gonzalez-Mariscal et al. 2000b).   
We hypothesized that the uterine luminal microenvironment is altered by 
changes in endometrial epithelial junctional complexes (CHAPTER IV).  Utilization of 
immunocytochemistry allowed for identification of a transient downregulation of tight 
junction associated proteins from Days 10 to 12 of the estrous cycle and pregnancy 
followed by an increase in tight junction proteins in uterine epithelia on Day 14 of 
pregnancy but not the cycle.  Further, the decline in tight junction associated proteins 
was accelerated by administration of early exogenous P4.  A similar decline in 
components of adherens junctions, specifically CDH1 and CTNNB1 occurred in 
endometrial LE during the period of conceptus elongation and in response to P4.  These 
findings suggest the period of blastocyst elongation is initiated when there is a general 
decline in tight and adherens junction proteins in the epithelium, thus increasing the 
permeability of the epithelium to stromal and serum derived molecules such as HGF, 
FGF7, glucose, and/or essential amino acids.  These factors may further regulate 
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morphological changes of spherical blastocysts into filamentous conceptuses.  A return 
of junctional complexes to the epithelium in response to pregnancy on Day 14 has 
multiple implications such as reducing permeability to sequester IFNT to act first on 
adjacent epithelia to inhibit formation of the luteolytic mechanism prior to upregulating 
a number of IFNT stimulated genes in stromal cells.  Further, an increase in epithelial 
integrity in response to more aggressive adhesion and attachment of the conceptus 
following elongation may limit and regulate the extent of superficial invasion of the 
conceptus.  Indeed, decidual cells surrounding the invading embryo uncharacteristically 
express tight and adherens junctions proteins in mice (Paria et al. 1999; Wang et al. 
2004).  In addition, reducing the permeability of the epithelium during implantation may 
limit maternal immune reponses to the conceptus and provide a somewhat 
immunoprivileged environment.  Future studies combining proteomics and genomics 
will identify factors of non-endometrial and stromal origin that enhance blastocyst 
growth and development.   
WNT genes are homologous to the Drosophila segment polarity gene wingless 
(wg).  In humans and mice, the WNT family encodes a group of 19 highly conserved 
secreted glycoproteins that regulate cell and tissue growth and differentiation as well as 
regulate components of junctional complexes (Davies 2002; Davies and Fisher 2002; 
Robinson et al. 2000).  Recently, the WNT system has been implicated in the regulation 
of cell polarity and junctional complexes and their associated proteins (Karner et al. 
2006a; Karner et al. 2006b).  Moreover, many components of the WNT system are 
expressed in the ovine uterine endometrium and modulate trophectoderm migration and 
proliferation (Hayashi et al. 2007).  These results coupled with our observations of 
decreased organization of both tight and adherens junctions in response to P4 support the 
hypothesis that components of the WNT signaling family may be involved in mediating 
changes in ovine epithelia in response to P4.   
Intitially, we endeavored to establish hormonal regulation of a number of WNTs 
and their downstream signaling and transcriptional partners previously identified in adult 
ovine endometria (Hayashi et al. 2007) (CHAPTER V).  Analyses of WNT signaling 
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molecules in the model of P4-induced accelerated blastocyst development indicated that 
WNT5A, WNT11, WNT2, WNT7A, FZD6, TCF7L2, JUN, p-JUN, p-CREB, MSX1, and 
MSX2 were downregulated in ovine endometrium between Days 9 and 12 in either a P4-
dependent or P4-independent manner.  DKK1, an inhibitor of WNT signaling, increased 
from Day 9 to Day 12.  Further, inhibiting P4 action with RU486, increased endometrial 
WNT5A, WNT11, WNT2, WNT7A, TCF7L2, p-CREB, MSX1, and MSX2 while ablating 
DKK1 and LEF1, compared to ewes receiving P4 alone to Day 12.  These findings 
confirm a correlation between the decline in tight and adherens junctions during this 
period of pregnancy and support the hypothesis that WNT signaling molecules may 
mediate changes in uterine epithelia to alter the uterine microenvironment.   
In addition to potentially mediating changes in epithelial histoarchitecture and 
function, a decline in WNT signaling followed by a conceptus stimulated increase in the 
epithelium at the site of implantation occurred in ewes as has been observed in mice.  
This may be a novel mechanism whereby the blastocyst and uterine endometrium 
become developmentally synchronized to intiate appropriately timed conceptus/maternal 
communications required for successful implantation (Mohamed et al. 2005).  Indeed, 
inhibition of WNT signaling via infusion of a WNT antagonist decreased the number of 
implanting blastocysts (Mohamed et al. 2005).  Our observations, along with those 
previously described by Hayashi et al. (Hayashi et al. 2007), suggest that a similar 
mechanism exists in sheep, whereby the maternal endometrium is synchronized by 
signals from the conceptus following downregulation of all inherent endometrial WNT 
signals.  Indeed, WNT7A is a novel IFNT stimulated gene expressed in endometrial LE 
on Day 14 of pregnancy, but not the cycle (Kim et al. 2003).   
The mechanism(s) whereby P4 mediates its effects on the epithelium despite a 
loss of the PGR from both LE and GE is a conundrum hindering understanding of 
progesterone modulated events affecting uterine functions essential to implantation and 
successful establishment and maintenance of pregnancy.  One mechanism involves 
activation of expression of stromal cell-derived growth factors by P4 act via PGR and 
actions of these “progestamedins” in a paracrine manner on adjacent epithelia to induce 
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functional differentiation and gene expression.  Our laboratory identified FGF7, FGF10, 
and HGF as potential stromal mediators of progesterone action (i.e. progestamedins) 
(Chen et al. 2000a; Chen et al. 2000b).  When analyzed in the early P4 model, there were 
increases in FGF7 and HGF mRNA abundance on Day 9, but not on Day 12.  Further, 
the receptor for HGF, MET, was increased in epithelia by P4 on boths Days 9 and 12.  
The administration of the PGR antagonist, RU486, decreased the expression of FGF7, 
FGF10, and HGF mRNAs.  These results are the first to identify hormonal regulation of 
these growth factors by P4 in the ovine endometrium and support the hypothesis of 
stromal derived signals mediating epithelial function in response to P4.  In addition, the 
receptors for FGF7, FGF10, and HGF are present on conceptus trophectoderm (Chen et 
al. 2000a; Chen et al. 2000b) and may directly stimulate conceptus development.  The 
existence of these stromal-derived growth factors in the uterine lumen and their potential 
trafficking through the epithelial paracellular space has not been determined. 
The IGF system plays a critical role in many developmental processes and is a 
primary determinant of prenatal and postnatal fetal growth.  Therefore we hypothesized 
that the enhanced growth and development observed in response to early exogenous P4 
may in part be due to modulation of the IGF system by P4.  Results of the present study 
indicate that P4 regulates multiple members of the IGF system including, IGF1, IGF2, 
IGFBP1, IGFBP2, IGFBP3, IGFBP5, IGFBP6 and IGFBP7.  Interstingly members of 
the IGF system were regulated in a temporal and spatial pattern that suggests differing 
roles for these family members during the peri-implantation period.  IGF1 protein in the 
uterine lumen was reduced immediately prior to conceptus elongation and could 
represent a critical period wherein IGF1 is rapidly utilized by the developing blastocyst 
resulting in an overall decrease in IGF1 levels in uterine fluid.  IGFBP2, IGFBP5, 
IGFBP6, and IGFBP7 were expressed predominantly in endometrial stromal cells and 
were relatively low during the period of conceptus elongation.  Interestingly, they were 
upregulated following blockade of P4 action with RU486.  The demise of blastocysts 
observed in this treatment group may, in part, be due to sequestration of IGFs by these 
binding proteins in the stroma, thus limiting IGF bioavailablility to blastocysts.  In 
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contrast, IGFBP1 and IGFBP3 were induced by P4 in LE and increased from Day 9 to 
Day 12.  This period coincides with loss of PGR and elongation of the conceptus 
indicating that IGFBP1 and IGFBP3 may indeed regulate blastocyst growth, 
development, and elongation.  Indeed, IGFBP1 is a highly upregulated secretory product 
in human, baboon, and mouse during implantation and it is believed to attenuate the 
proliferative actions of IGF on the endometrium.  Further, IGFBP1 has IGF independent 
actions as an integrin ligand.  Therefore, in sheep, upregulation of IGFBP1 during the 
elongation period allows IGFBP1 to serve as an effective adhesion molecule for 
apposition of the blastocyst to LE, facilitating the process of expansion and elongation.  
IGFBP1 and IGFBP3 mRNAs were reduced in response to RU486 further implicating 
them as critical for conceptus growth and survival.  Future studies will mechanistically 
dissect the role of these P4-regulated growth factors in blastocyst growth and 
development. 
 
Conclusions 
Results of the present studies establish and characterize a viable model for 
increasing our understanding of a number of factors important for implantation 
including: identification of P4-regulated genes, identification of novel mechanisms by 
which P4 mediates its action on different cell types, identification of molecules that act 
on the conceptus to stimulate conceptus elongation, and a mechanism by which factors 
secreted into the uterine lumen in response to P4 can be identified.  Future studies will 
employ genomic and proteomics approaches to identify P4 regulated genes in ovine 
endometria and developing conceptuses.  A proteomics approach using mass 
spectroscopy techniques will be used to identify components of uterine histotroph 
present during the period of conceptus elongation and further elucidate regulation of 
these molecules by P4.  Melding the disciplines of genomics and proteomics will allow 
increased understanding of the origins of molecules present in the uterine lumen during 
the putative window of receptivity for implantation and provide insight into mechanisms 
by which these molecules are trafficked within the endometrium.  Ultimately, results 
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from these and future studies will identify selection criteria and strategies for reducing 
early embryonic losses in economically important species of livestock. 
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